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1.1 Introduction 
The importance of oxygen for biological systems. 
Oxygen plays a key role in many of the important processes of life, such as respi-
ration and metabolism, the means by which most organisms derive the energy needed to 
sustain life. On the basis of the requirement of oxygen for their metabolic processes, 
living organisms can be divided into two categories: aerobic organisms, that do require 
oxygen, and anaerobic organisms that do not require oxygen. To obligate anaerobic 
organisms oxygen is even toxic: they can't survive in its presence. The so called faculta-
tive anaerobic organisms fall in both categories: they can adapt their metabolism and live 
under both aerobic and anaerobic conditions. Both aerobic and anaerobic organisms can 
be autotrophic, using C02 as a carbon source, or heterotrophic, using organic materials, 
such as carbohydrates, as a carbon source, (for general introductions see [1] or [2]) 
Anaerobic organisms include photo-autotrophic organisms (such as Rhodospi-
rillales) and chemo-autotrophic organisms (such as Methanobacteriaceae) in which C02 
takes over the role that oxygen has in aerobic organisms, as well as a large number of 
heterotrophic organisms that use other inorganic substrates such as sulfate, nitrate and 
fumarate instead of oxygen. 
Most aerobic organisms, which form the bulk of the biomass on earth, participate 
in the so called oxygen cycle (see [3] for a general introduction). Aerobic photo-
autotrophic organisms, such as plants, algae and cyanobacteria, utilize light energy 
through photosynthesis to synthesize carbohydrates from CO2 and H2O while at the same 
time releasing O2 into the atmosphere. Aerobic heterotrophic organisms, such as fungi, 
most animals and many bacteria, use a complex series of enzyme-catalyzed oxidation and 
reduction reactions using organic materials such as glucose as the initial reducing agent 
and 0 2 as the terminal oxidizing agent. The end products of metabolism in these 
organisms are C02 and H20, which are returned to the atmosphere, thus completing the 
oxygen cycle. The autotrophes use oxygen in the same way as the heterotrophes do, but 
in the former organisms oxygen production exceeds oxygen consumption. Aerobic 
chemo-autotrophic bacteria use chemical energy, through the oxidation of inorganic 
substrates such as NH4+, Fe2+, H2S and H2, to synthesize carbohydrates, without oxygen 
production. 
The actual (heterotrophic) oxidation mechanism, called respiration, is not a direct 
chemical reaction but a series of electron transfers through a number of compounds that 
accept and release electrons, alternating between a reduced and an oxidized form, known 
as the 'oxidative phosphorylation' or 'respiratory chain'. Reducing power is generated 
through the reversible biochemical reactions of substances such as nicotinamide-adenine 
dinucleotide (NAD), flavins, and cytochromes which can exist in reduced and oxidized 
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forms. By participating in the respiratory chain, the reduced form is continually regen-
erated from the oxidized form. In aerobic organisms, the reductant NADH is the initial 
electron donor in the chain; as the strongest oxidizing agent, oxygen is the final electron 
acceptor. Its vital role in living organisms is essentially as a substance on which the last 
link in the chain, cytochrome c oxidase, can 'dump' electrons. The respiratory chain is 
coupled to ATP synthesis, the hydrolysis of which is the driving force for many of the 
biochemical processes that take place in living organisms [4], but besides the generation 
of ATP, oxygen is also used in biological systems for other purposes, such as the solubi-
lization and detoxification of aromatic compounds [5] and as a source of oxygen atoms 
in the biosynthesis of various biomolecules in metabolic pathways [6]. 
The importance of iron for biological systems. 
Iron is an essential mineral nutrient for all living organisms (except for a Lacto-
bacillus that appears to maintain high levels of manganese instead of iron [7]), and is the 
most common transition metal in biology. The processes and reactions in which iron 
participates are numerous and crucial for the survival of organisms, and include DNA 
synthesis (ribonucleotide reductase [8]), energy production (cytochromes in the respira-
tory chain [9]), energy conversion (in connection with photosynthetic reaction centers 
[10]), oxygen transport (as a part of for instance hemoglobin and myoglobin [11]), 
oxygenation (detoxification of xenobiotics; e.g. cytochrome P-450 [12]), antioxidation 
(e.g. superoxide dismutase [13]), nitrogen fixation (as a part of all nitrogenase proteins 
[14]) and many other metabolic processes. 
The redox properties of iron are essential for the reactions that are catalyzed by 
the enzymes that contain this metal. Iron is a transition element, so designated because its 
ions have partially filled d-orbitals, as a consequence of which it can form ions with 
different valencies. Although iron can exist in many redox states it is found in biological 
systems mainly as ferrous Fell iron (Fe2+, d6) and ferric Felll iron (Fe3+, d5); in fewer 
cases as ferryl FelV iron (Fe4+, dA). These ions have a maximal coordination number of 
6, i.e. six ligands can bind the ion in a complex, but four- and particularly five-coordinate 
complexes are also encountered (section 1.2 and refs. herein). The possibility to 
transform from one redox state to the other, and vice versa, accounts for the biological 
usefulness of iron as an electron donor and acceptor, i.e. as a redox center. The redox 
potential of the electron transfer to and from the ion depends on the nature and geometry 
of the ligands that bind the iron to the protein, or to the cofactor that incorporates it, and 
on the protein environment of the metal-containing center [15, 16]. Ligand substitutions 
or modification, whether the result of the evolution of the protein, or caused instan-
taneously by, for instance, substrate-binding or protein-protein interactions (chapter 4 of 
this thesis) therefore further expands the applicability of iron in biological systems. 
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In the classification of metal ions in 'hard' and 'soft' acids [17], Fe?* can be 
considered as almost a 'hard' acid, with a preference for ligands which are 'hard' bases, 
such as hydroxyl (tyrosine), carboxyl (aspartic acid and glutamic acid) and other oxygen-
containing groups; still it does have a biologically affirmed affinity for sulfur ligands such 
as cysteine and nitrogen ligands such as porphyrin. Fe2+ is intermediate between a 'hard' 
and a 'soft' acid and can accommodate both the oxygen-based 'hard' ligands and 'soft' 
ligands containing nitrogen and sulfur; examples are histidine, cysteine, methionine, 
porphyrin and inorganic sulfur. All of the ligands mentioned here are encountered in iron-
proteins [18]. In the case when one of the coordination spheres is unoccupied, the possi-
bility exists of binding a sixth non-protein ligand, which may be O2, H2O, OH", a sub-
strate molecule (e.g. aniline) or an inhibitor molecule (e.g. CO). 
Iron in proteins is found in heme groups in which a single iron atom is bound to 
the N-atoms in the porphyrin of the heme moiety and to, mostly, histidine, methionine 
and cysteine residues; in iron-sulfur clusters in which the irons are bridged by sulfide and 
bound to the protein by, mostly, cysteines residues; in oxo-bridged di-iron centers and as 
a single iron-atom, bound directly to the protein, in which case the iron-binding residues 
are, for instance, cysteine, tyrosine, histidine and / or aspartate. On this basis, iron-
containing proteins can be subdivided into four groups [19]: 
I In the first group are the heme proteins, which include oxygen-carriers 
(like hemoglobin and myoglobin [11]), oxygen activators (like peroxidases [20, 21], 
cytochrome c oxidase [22] and cytochromes P-450 [12]) and electron-transfer heme 
proteins (like cytochromes [23]). 
II Proteins that contain iron-sulfur clusters form the second group. Many of 
these proteins are strictly electron-transport proteins, like rubredoxins [24] and ferre-
doxins [25, 26]; in other cases electron-transfer is combined with catalytic activity, such 
as the reduction of N2 by nitrogenase [27]. Of the iron-sulfur proteins only mitochondrial 
aconitase is known to have a solely catalytic function: the transformation of citrate to 
isocitrate in the citric acid cycle [28]. 
III The third group consists of proteins that directly bind a single iron atom, 
and includes some dioxygenases [29-31], monooxygenases [32-34] and bacterial super-
oxide dismutases [35] (all oxygen activators). Strictly speaking rubredoxins also fall into 
this group (discussed below). 
IV Finally, the fourth group is formed by proteins containing oxo-bridged 
dinuclear iron centers (reviewed in [36]), including hemerythrin, ribonucleotide reduc-
tase, purple acid phosphatase and methane monooxygenase. 
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1.2 Redox enzymes: iron-sulfur and heme proteins. 
Proteins that are involved in electron transfer reactions are generally known as 
redox proteins. Both its capability to bind a specific substrate and the value of its redox 
potential determine the function of a redox protein in a biological system. In principal, in 
the living cell, the limits for redox potentials (versus standard hydrogen electrode) are set 
by the redox couples H 2 0 / 0 2 (+830 mV) and H2 / H+ (-420 mV) [37]; there are, 
nevertheless, proteins with higher and lower physiologically relevant redox potentials, 
such as CO dehydrogenase, an iron-sulfur-nickel protein with a redox potential of -540 
mV [38], and lignin peroxidase, a heme protein for which a redox potential of+1.5 V has 
been reported for its high-valent iron-oxo intermediate [39]. A common property of all 
these proteins is the presence of a redox active group. Some contain an organic redox-
active cofactor, like flavin or pyrroloquinone, others contain a transition metal, such as 
copper or iron (previous section), as a part of a cofactor that can accept and donate one 
or more electrons. Within the scope of this thesis only iron-containing redox proteins 
that have hemes or iron-sulfur clusters as cofactors will be discussed. 
Iron-sulfur proteins. 
Four 'basic' types of iron-sulfur clusters can be distinguished, that contain either 
one, two, three or four iron atoms (reviewed in [40]). Iron-sulfur clusters that have a 
more complex composition than these basic clusters, such as the clusters found in the 
nitrogenase MoFe protein, are usually referred to as 'superclusters'. The simplest form is 
Cys-S,, „S-Cys Cys-S S, S-Cys 
Fe B Fe" 'Fe 
Cys-S S-Cys Cys-S a S-Cys 
,„S-Cys , S-Cys 
"" a97 
F6 ocl32 S F e 
C l _ | N S D°V S +4i> S 
..-•••"
Fe\_\l m .,- F e \ t S \ l 
Cys-S s Fe c y s " S S Fe 
\ V ß62 
S-Cys NS-Cys 
Figure 1 
Schematic representation of basic iron-sulfur clusters. A: Rubredoxin-type mononuclear Fe-S 
cluster. B: Dinuclear [2Fe-2S] cluster. C: [3Fe-4S] partial cubane. D: The [4Fe-4S] cubane 
cluster of the nitrogenase Fe protein from A. vinelandii. 
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mononuclear iron as found in rubredoxin: a single iron atom tetrahedrally coordinated by 
the sulfur atoms of four cysteine residues that are part of the protein's peptide chain (Fig. 
1A) [24]. Strictly speaking the rubredoxin-type of cluster is not a cofactor since the iron 
is bound directly, and only, to the protein. The other basic iron-sulfur clusters contain 
sulfide ions, the so called acid-labile sulfur, that are bound to the iron atoms in different 
stoichiometries, forming a proper core structure, or cluster, which is linked to cysteine 
residues [41] or, in some cases, to histidine residues [42] of the peptide chain. Clusters 
containing two iron atoms, [2Fe-2S], are found in ferredoxins and in many other 
enzymes, such as the 'Shethna' protein [43] which is a subject of this thesis. In these 
dinuclear type of clusters the two iron atoms are bridged by two acid-labile sulfur atoms 
and each iron atom is coordinated to the protein by two cysteine residues (Fig. IB) [26, 
44]. A special case is the [2Fe-2S] cluster in the so called 'Rieske'-type proteins, in 
which the iron atoms are coordinated by two cysteine residues and two histidine residues 
[45]. Clusters containing three iron atoms, [3Fe-4S], are also found in ferredoxins [46, 
47], sometimes in combination with a separate four-iron [4Fe-4S] cluster, hence the 
designation 7Fe ferredoxins. A [3Fe-4S] cluster can be thought of as a [4Fe-4S] four-
iron cluster with one iron missing (Fig. 1C). The [4Fe-4S] clusters, usually referred to as 
'cubanes', have a cubical structure with acid-labile sulfurs on four of the corners of the 
cubical and iron atoms on the remaining four corners (Fig. ID); the iron atoms are 
coordinated to the protein by cysteine residues [48]. Like [2Fe-2S] clusters, [4Fe-4S] 
clusters are very common in nature; they are found in numerous redox enzymes. 
The nitrogenase of Azotobacter vinelandii, which is one of the major research 
subjects of this thesis, catalyzes the reduction of N2 to NH3 (see chapters 3 and 4 for the 
reaction mechanism, [27] for a review). The enzyme complex consists of two dissociable 
metallo-proteins. The Fe protein is a y2 homo-dimer that contains a single [4Fe-4S] 
cluster, coordinated by four cysteine residues; each of the subunits provides two of these 
Cys-S— 
a 275 
, S , O2CCH2 
y \
 c \ CH2CH2CO2 
S — Fe Fe — S 0 / 
s \/ '--.s v / ~T Homocitrate 
- F e S F e — S - ~ F e " ' S Mo 1 
\ A A / 1 "-°2C S — Fe Fe ^ — S JT<? „ . 0
 \ / ° N5i-Hiscc442 
Figure 2 
The iron-molybdenum cofactor. Schematic representation of the FeMoco cofactor of the nitro-
genase MoFe-protein from A. vinelandii. [50] 
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Figure 3 
The P-cluster. Schematic representation of the oxidized form of the P-cluster of the nitrogenase 
MoFe protein from A. vinelandii. Upon reduction Fel and Fe2 exchange protein coordination by 
the amide N of Cys a88 and by Ser ß 188, respectively, for coordination by S1 [50]. 
residues, so that the [4Fe-4S] cluster bridges the gap between them [49] (Fig. ID). The 
second protein, called the MoFe protein is an 0^2 hetero-tetramer that contains two 
types of superclusters: two P-clusters, [8Fe-7S], and two M-clusters, or FeMoco cofac-
tors, that contain molybdenum and homocitrate besides iron and sulfur. The FeMoco 
cofactors are presumably the substrate-binding site of the enzyme, i.e. the site where N2 
is bound and reduced to NH3; the Fe protein provides the MoFe protein with the elec-
trons that are required for this reduction. The structure of the P-cluster depends on its 
oxidation state. In the oxidized state it can best be described as a [4Fe-4S] cubane and a 
[4Fe-3S] partial cubane that are connected (Fig. 3) and bound to the a and ß subunits, 
respectively, by six cysteines, serine ßl88 and the amide N of cysteine <x88. Upon reduc-
tion of the cluster two Fe atoms (labeled 'Fel' and 'Fe2' in the figure) of the [4Fe-3S] 
partial cubane change position and exchange protein coordination by serine ßl88 (Fe2) 
and the amide N of cysteine cc88 (Fel) for a ligand supplied by the central sulfur atom 
labeled 'SI'[50]. The FeMoco cofactors have an even more complex structure (Fig. 2) 
but can be interpreted, basically, as a dimer of XFesSi (X being Fe or Mo): partial 
cubanes linked by three non-protein sulfur ligands. Homocitrate is bound to the 
molybdenum in the cofactor. At least one cysteine and one histidine residue bind the 
cofactor to the protein [50]. 
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Heme proteins. 
The redox-centers in heme proteins are structurally very different from the iron-
sulfur clusters. The heme cofactor consists of a protoporphyrin IX that contains a single 
iron atom; several heme groups may be present in a single heme protein. As is the case 
for iron-sulfur clusters, the ligands that bind the heme, and the surrounding peptide 
chain, largely determine the redox potential of the protein. The iron atom in the heme 
binds to the four equatorial nitrogens in the center of the protoporphyrin ring; in addition 
it can form two axial bonds on either side of the heme plane with amino acid residues 
from the protein chain and with external ligands (as mentioned above). These binding 
residues are referred to as the fifth and sixth ligand. Three types of hemes are distin-
guished: the a-type heme has a long phytyl 'tail' attached to the protoporphyrin and is 
found in e.g. cytochrome c oxydase; fr-type hemes, found in e.g. cytochromes b, have 
two vinyl-groups attached to the porphyrin and are comparable to the heme in Fig. 4, 
except for the two thioether linkages that are formed between the vinyl-groups and 
cysteines residues in the protein, which are characteristic for the c-type hemes that are 
found in cytochromes c. 
\ N A R 
L ° R , y~N x 
° As
 0 
My° o. 
N 
r*\ His. /N 
O 
HOOC COOH 
Figure 4 
Schematic representation of a c-type heme. The N atoms in the porphyrin are the four equato-
rial ligands for the iron in its center. The axially coordinated histidine is the fifth ligand. In some 
proteins a sixth ligand is coordinated axially from the other side of the heme plane. 
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Cytochromes are typically classified on the basis of the heme type that is con-
tained in the protein. The c-type cytochromes, one of the subjects of this thesis, are 
divided into three classes [51, 52]. The class I cytochromes c, found in a variety of 
eukaryotes and prokaryotes, contain axial histidine and methionine ligands. In class II 
cytochromes c', found in photosynthetic bacteria, the heme is five-coordinate with only a 
histidine as the fifth ligand. Class III cytochromes cj, found in a restricted class of 
sulfate-reducing bacteria, contain four hemes, each coordinated by two histidines. 
The so called microperoxidases, that are the topic of chapter 2 of this thesis, are 
mini-enzymes that can be prepared by proteolytic digestion of cytochromes c [53]. As a 
consequence of the thioether links in cytochromes c, a short residual peptide chain 
remains bound to the heme after digestion. This peptide contains the motif Cys-(Xaa)2-
Cys-His, which includes the two heme-binding cysteines and histidine, the fifth ligand. 
The molecule shown in Fig. 4 can, in fact, be seen as a microperoxidase. Lack of a 
specific substrate-binding site enables these mini-enzymes to use a variety of substrates. 
They are able to catalyze peroxidase-type reactions as well as cytochrome /'-450-type 
reactions and are used, as a model system, to study the catalytic mechanism of these 
reactions [54-56]. Cytochromes P-450, that contain a single five-coordinate fc-type heme 
with cysteine as the fifth ligand, constitute a family of enzymes that play a key role in the 
oxidative and peroxidative biotransformation of a large variety of xenobiotic chemicals 
(detoxification) [5]. By using hydrogen peroxide in the oxidation of various organic and 
inorganic substrates, peroxidases function as antioxidants [20]. Peroxidases, for which 
the X-ray structures have been determined, contain a single five-coordinate è-type heme 
with histidine as the fifth ligand [57], or tyrosine, in the case of catalase [58]. 
1.3 The deleterious properties of oxygen. 
Oxygen toxicity. 
Although the oxidative power of oxygen can be controlled and efficiently 
converted to a form (ATP) that can be stored and subsequently used, aerobic metabolism 
has its disadvantages as well. The interior of a cell is a reducing environment, and many 
of the components are thermodynamically capable of reacting directly with dioxygen, 
thus bypassing, or damaging, the enzymes that control the beneficial reactions of dioxy-
gen or other metabolic processes. Nitrogenase is an example of an enzyme that is 
particularly sensitive to oxygen-inactivation [59-61] (chapter 3 of this thesis). Although 
these reactions are generally slow and activation is often required, in aerobic cells reac-
tions take place that produce small but significant amounts of partially reduced forms of 
dioxygen, especially superoxide anion (02»), hydroxyl radical (HO») and hydrogen 
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peroxide (H202) (Fig. 5) [18]; in addition to these reduced forms, also the chemically or 
photo-activated singlet ' 0 2 , represents a reactive, toxic form of oxygen [62]. All of these 
oxygen-species can carry out deleterious reactions with lipids, DNA and proteins being 
the major targets [63]. It is unknown how dioxygen initiates the sequence of chemical 
reactions that attack the biological targets in vivo; there is, however, no question that 
superoxide anion and hydrogen peroxide are formed during the normal course of aerobic 
metabolism [64, 65]. 
Superoxide anion can cause damage to proteins by itself [66], but the most 
commonly proposed mechanism for superoxide anion toxicity in relation to proteins 
containing transition metals is the so called 'Site Specific Haber-Weiss Reaction', which 
involves conversion of superoxide anion to oxygen and the generation of destructive 
hydroxyl radicals [67, 68] (Fig. 6). This mechanism is based on the idea that most 
reducing agents in the cell are too bulky to come into close proximity of sequestered 
oxidized metal ions, such as copper and iron, that are bound to proteins. Superoxide 
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Formation of reactive oxygen species. Some of the reactions through which toxic intermediates 
can be formed from molecular oxygen. [18] 
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Initiation: radical formation —»» X-
X- + RH »• XH + R-
Propagation: R- + O2 »» ROO-
ROO- + RH *- ROOH + R-
Termination: R. + ROO- »• ROOR 
2 ROO- —*> ROOOOR —»• 02 + ROOR 
Figure 6 
Left: The Haber-Weiss reaction (Fe^Fe2*) and the Fenton reaction (Fe2+->Fe3+). 
Right: The free-radical autoxidation mechanism. R is any organic substrate. Not all possible 
oxidation products, such as ROH and others, are shown. HO», formed through the Fenton reac-
tion, on the left, can act as an initiator for this chain reaction. [79] 
anion, however, in addition to being a powerful reducing agent, is very small and could 
penetrate the protein to reach these metal ions and reduce them. The reduced metal ions 
could then react with hydrogen peroxide (the Fenton reaction [69]), generating the 
hydroxyl radical, an extremely powerful and indiscriminate oxidant, which would imme-
diately attack at a site near the location of the bound metal ion, thus damaging the 
protein or the metal-containing cofactor. In addition to this, the hydroxyl radical is an 
effective initiator of free-radical autoxidation reactions [70] in which dioxygen reacts 
with an organic substrate radical (Fig. 6). The highly reactive free radicals, produced by 
this mechanism, will indiscriminately react with vulnerable sites on enzymes, substrates 
and other cell components, causing serious damage. Oxygen free-radical attack on 
proteins yields many possible products [71 and refs. herein]: HO», and possibly RO» 
intermediates of free-radical autoxidation, can cause cross-links within the protein or 
with other proteins; HO» and 02»" can modify amino acid residues, especially 
methionine, tryptophan, histidine and cysteine; HO» in combination with 0 2 can cause 
lesions, presumably by hydrolysis of peptide-bonds, especially those of proline residues, 
which may result in fragmentation of the protein; finally free radicals can cause specific 
disintegration of metal-containing cofactors (section 1.4). The consequence of these 
radical modifications is often inactivation of the enzyme. 
Protection mechanisms. 
In vivo, enzymatic and nonenzymatic antioxidants (scavengers) neutralize the 
harmful oxygen species (Fig. 7). Superoxide anion, for example, can be scavenged by 
superoxide dismutase (SOD), an enzyme present in all aerobic organisms, which cata-
lyzes the conversion of two of these radicals into hydrogen peroxide and dioxygen [13]. 
Hydrogen peroxide formed by superoxide dismutase, and by the uncatalyzed reaction of 
hydroperoxy radicals, is scavenged by catalase, a heme protein that catalyzes the conver-
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SOD 2 02-- + 2 H+ »• 02 + H2O2 
CAT 2 H2O2 »• 2 H2O + 02 
PX H2O2 + RH2 »• 2 H2O + R 
GPX H2O2 + 2 GSH »• GSSG + 2 H2O 
Figure 7 
Reactions of enzymatic scavengers. SOD: superoxide dismutase; 
CAT: catalase; PX: peroxidase; GPX: glutathion peroxidase. R is an 
organic or inorganic substrate, GSH is glutathion (y-Glu-Cys-Gly). 
sion of hydrogen peroxide into water and dioxygen; peroxidases catalyze an analogous 
reaction in which H 20 2 is reduced to water by various reducing substrates [20]. 
Examples of nonenzymatic oxidant scavengers are ascorbic acid (vitamin C) and 
a-tocopherol (vitamin E) [72]. Glutathion (GSH) can act as a nonenzymatic scavenger 
by itself or as the substrate of glutathion peroxidase, an enzymatic scavenger [73]. 
Finally, metal chelating proteins, such as ferritin, transferrin and lactoferrin, prevent the 
(not site-specific) Haber-Weiss reaction catalyzed by trace amounts of unsequestered, 
oxidized metal ions in the cell, an thus may, in this respect, also be considered to be a 
part of the group of nonenzymatic antioxidants [74, 75]. 
1.4 Inactivation of iron-containing proteins. 
The reactions described above, which cause oxidative damage, are perfectly valid 
in vitro; in aqueous solutions the presence of both dioxygen and iron-proteins will result 
in the formation of superoxide anion. Oxy-hemoglobin and oxy-myoglobin are known to 
undergo a slow, spontaneous redox reaction in which the heme-iron is oxidized to the 
ferric form and the oxygen is reduced to superoxide anion [76, 77]. Also reduced ferre-
doxins, which contain iron-sulfur clusters, are subject to spontaneous oxidation which 
produces superoxide anion [78]. Once formed, superoxide anion will rapidly dispro-
portionate in aqueous solution (except at very high pH) to form hydrogen peroxide and 
dioxygen [79]. Superoxide anion, hydrogen peroxide and trace amounts of free Felll will 
result in Haber-Weiss and Fenton reactions that produce hydroxyl radicals. Furthermore, 
site-specific Haber-Weiss and Fenton chemistry can take place at the iron-containing 
centers in the proteins [80]. 
In the case of iron-sulfur and heme proteins site-specific damage can result in loss 
of the integrity of the iron-containing cofactor in the protein: free radicals will react with 
the metal-binding center, rather than escape from the site of their generation [80]. As 
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explained above, the amino acid residues, that are especially prone to modification by 
HO« and 02»" (methionine, tryptophan, histidine and cysteine [81]) are all encountered as 
ligands in iron-proteins, but also the iron itself and the acid-labile sulfur atoms in iron-
sulfur proteins may be involved in the disintegration of the cofactor [82]. 
It should be noted, however, that many iron-containing proteins are not affected 
by dioxygen and that oxidative inactivation does not always involve Haber-Weiss and 
Fenton reactions. In the case of iron-sulfur proteins, inactivation probably does involve 
Haber-Weiss and Fenton chemistry, but inactivation of heme proteins by oxygen seems 
to require the formation of high-valent FelV-oxo compounds during catalysis, which by 
themselves, or through the generation of free radicals, cause degradation of the heme 
moiety. Both types of oxidative inactivation are discussed below. 
Oxidative inactivation of iron-sulfur proteins 
It was already noted decades ago that under non-reducing conditions, i.e. in the 
presence of oxidizing substances, some iron-sulfur proteins can be very unstable [83]. 
Wang and colleagues [60] demonstrated that after 1 minute exposure to 20% oxygen in 
argon the activity of the nitrogenase Fe protein from A. vinelandii was reduced to less 
than 20%. The authors also noticed loss of Fe from the protein which indicates that its 
[4Fe-4S] cluster is destroyed in the inactivation process. Although the actual mechanism 
of cluster disintegration is uncertain, it has been speculated that loss of electrons from 
the cluster, beyond a certain point, results in partial free radical formation at the bridging 
sulfurs and cysteine ligands, which is then followed by coupling reactions between free 
radicals and hydrolytic degradation of the oxidized center by solvent [82]. Upon oxida-
tion of aconitase, its active [4Fe-4S] cluster is rapidly transformed to the inactive 
[3Fe-4S] form (a normal, reversible process for this enzyme), followed by a slower, total 
destruction of the cluster [84]; also a polysulfide-containing degradation product is 
formed [85]. Research on synthetic clusters has further confirmed that iron-sulfur 
clusters are easily destroyed by oxidation [86]. 
Recent studies on the in vivo inactivation of [4Fe-4S] containing dehydratases 
showed that superoxide anion can act as a potent oxidant of the iron-sulfur cluster; also 
in this case Fell was released from the cluster [87, 88]. Since superoxide anion acts as an 
oxidant towards ferrous iron in the cluster, rather than as a reductant towards ferric iron, 
at least in vivo, this inactivation does not occur through a Haber-Weiss-type of reaction. 
02-- + 2H+ + [2FeII-2FeIII-4S] »• [FeII-3FeIII-4S] + H2O2 
[FeII-3FeIII-4S] *• [3FeIII-4S] + Fell 
Figure 8 
Oxidation of an [4Fe-4S] cluster by superoxide anion, according to Liochev [89]. 
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The hypothetical, alternative reaction mechanism proposed by Liochev [89] is shown in 
Fig. 8. The product of this mechanism, H202, will next react normally according to the 
Fenton reaction with the Fell that is released from the cluster; consequently, also 
through this mechanism, HO» radicals are formed. 
Iron-sulfur clusters are commonly found not only in anaerobic organisms, but 
also in aerobic organisms. Not all protein-bound iron-sulfur clusters are inactivated by 
oxygen. Those proteins that contain stable iron-sulfur clusters tend to share the common 
feature that the cluster is bound to a region of the protein that is inaccessible to solvent 
and oxidants. Recent studies on a bacterial [4Fe-4S] HiPIP protein from Chromatium 
vinosum have shown that modification of the binding pocket of the cluster, to become 
more hydrophilic, results in destabilization of the cluster, probably because oxidants 
dissolved in aqueous solution can gain access to the cluster [90]. This hypothesis is 
sustained by the fact that crystal structures of two of the oxygen-sensitive iron-sulfur 
proteins that were used as examples above, the nitrogenase Fe protein [49] and aconitase 
[91], show that the cluster is positioned on the surface of these proteins, i.e. exposed to 
the solvent. Furthermore, it has been demonstrated that in synthetic iron-sulfur clusters 
the polarity of the surrounding group is important to the stability of the cluster [86]. 
Evidence is given in chapter 3 of this thesis that complex formation of the nitrogenase Fe 
protein with the nitrogenase MoFe protein results in stabilization of the [4Fe-4S] cluster 
in the Fe protein. This may be the result of shielding of the cluster from the solvent solu-
tion or of stabilization of the cluster by the protein environment of the complex. 
A final remark must be made about the fact that, in some cases, the interaction of 
oxygen with iron-sulfur clusters is not deleterious but even functional to an organism. It 
appears that at least in one situation, the FNR protein of E. coli, the loss of the integrity 
of the cluster in the presence of oxygen is the key to the sensing of oxygen levels 
(reviewed in [82]). Other proteins, which contain oxo-bridged iron centers, can even use 
oxygen as a substrate, such as methane monooxygenase [92] and ribonucleotide 
reductase [93]. 
Formation of FelV-oxo compounds in heme proteins. 
Interactions of oxygen with heme proteins are in general not destructive, and 
oxygen, or one of its partially reduced forms (see Fig. 5), is used as a substrate by many 
of the enzymes that contain a heme cofactor. For those heme proteins that do not inter-
act with oxygen, such as the electron-transporting cytochromes c, X-ray structures show 
that the heme-iron is in some cases five-, but more often six-coordinate and buried in the 
interior of the protein, almost completely surrounded by the polypeptide chain, in an 
essentially hydrophobic environment [94]. In itself this does, however, not explain why 
these proteins are not inactivated by oxygen: the other heme proteins, oxygen carriers 
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and oxygen activators, possess an unoccupied sixth coordination site, situated within a 
pocket that is usually referred to as 'hydrophobic', but that has in fact a polar site around 
the central iron [79], often occupied by a water molecule, where dioxygen or hydrogen 
peroxide can bind, or where, in the case of cytochrome P-450, even iron-carbon or iron-
nitrogen bonds with the substrate can be formed. In microperoxidases the protein envi-
ronment is absent and the heme completely exposed to the solvent. Nevertheless, also 
these proteins are stable in the presence of oxygen. Apparently, different from what was 
observed for iron-sulfur proteins, the hydrophylicity of the heme-binding pocket, and 
consequently its accessibility for oxygen, does not make heme proteins susceptible to 
inactivation by oxygen. It seems therefore that oxygen, by itself, is not capable of causing 
damage to heme proteins. This may change, however, when the heme protein becomes 
catalytically active. 
It is a well established fact that, in vitro, heme proteins possess various enzymatic 
activities, such as cytochrome P-450 [95] and peroxidase activities [96, 97]. In contrast 
to their stability in the presence of oxygen, hydrogen peroxide is known to cause oxida-
tive damage to many heme proteins, including hemoglobins, myoglobins and cyto-
chromes c [98-101], microperoxidases [102] and hemin [103]. Is seems therefore that 
oxidative inactivation of heme proteins requires the formation of reactive intermediates 
such as those formed during the catalysis of hydrogen peroxide-dependent reactions. 
In the initial 'resting' state the heme-iron in oxygen activating enzymes is predo-
minantly Felll, probably with water as the sixth ligand (Fig 9). In the activated state 
(compound I and II) iron is present in the FelV, ferryl, form. Microperoxidases, 
cytochromes P-450 and heme peroxidases go through these reactive intermediate states 
with such unusually high oxidation levels of the iron center [104-106]. In (micro)-
peroxidases FelV-oxo complexes can be formed by heterolytic or homolytic splicing of 
hydrogen peroxide; heterolytic splicing yields compound I, homolytic splicing yields 
compound II (Fig. 9). For the peroxidase reaction under physiological conditions, it is 
believed that the oxidation proceeds in one-electron steps, i.e. compound I is formed 
through heterolytic splicing of hydrogen peroxide and subsequent abstraction of an elec-
tron from the substrate yields compound II [20, 107, 108]. Formation of an FelV-oxo 
compound in cytochrome P-450 involves reduction, by an external electron donor, of the 
FeII-02 compound in this enzyme, followed by heterolytic cleavage of the O-O bond, 
which yields H20 and the FelV-oxo compound I homologue (Fig. 9) [109, 110] (In 
cytochrome P-450 this compound has not yet been fully characterized, hence the desig-
nation 'homologue'). It is often assumed that the formation of a reactive FelV-oxo heme 
group is, by itself, sufficient to initiate inactivation of heme proteins. This raises the 
question how cytochrome P-450 and peroxidases control the reaction mechanism of the 
oxy-heme group, favoring catalysis over inactivation. 
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The cysteine axial ligand in cytochrome P-450 is a strong electron donor and 
could therefore be responsible for the stabilization of the FelV-oxo group [111]. In 
peroxidases the histidyl imidazole may deprotonate to form an imidazolate bond with the 
iron [112], or may be strongly hydrogen-bonded to the protein [113], thus serving a 
similar stabilizing function for the FelV-oxo compounds. Compared to the cysteine 
ligand of the cytochrome P-450 system, however, histidine is certainly a weaker electron 
donor, which possibly effects a shift of the radical density from the iron-oxo compound 
to the porphyrin n system, as opposed to a shift to the sulfur of the cysteine ligand [114]. 
This difference in derealization of valence electrons may contribute to the different 
reactivities for these enzymes [115]. But also the protein environments must be respon-
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Figure 9 
Catalytic mechanisms of microperoxidases and cytochrome P-450. A: Formation of com-
pounds I and II and substrate oxidation in peroxidases. B: formation of the FelV-oxo compound 
and substrate oxidation in cytochrome P-450. G-addition occurs with aromatic substrates, but 
cytochrome P-450 can also catalyze other reactions. Note that the configuration of the FelV-oxo 
compound in cytochrome P-450 is speculative, since it has not yet been fully characterized. 
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sible for such different reactivities: in cytochrome P-450 oxygen is transferred directly 
from the heme-iron to the substrate ('cage reaction'), while in peroxidases the protein 
environment does not allow the substrate to approach the heme-iron and electrons are 
abstracted from the substrate at the hcme-edge. The substrate then reacts further in a 
non-catalyzed fashion with, for instance, solvent molecules, which may lead to the typical 
'escape' of free radicals [101, 116]. 
Microperoxidases have both cytochrome P-450 features (the heme-iron is acces-
sible to the substrate) and peroxidase features (the fifth ligand is histidine). The micro-
peroxidase-catalyzed para-hydroxylation of aniline proceeds through a cytochrome 
P-450-type of a-addition mechanism [117]. This mechanism involves the formation of a 
reaction intermediate in which the oxygen of compound I, formed as in peroxidases, is 
bound to the substrate, as in cytochrome P-450; upon dissociation of this intermediate, 
oxygen is transferred to aniline to form the hydroxylated product and the enzyme returns 
to its Felll resting state (Fig. 9). Typical peroxidase reactions, which involve formation 
of compound II through electron abstraction, can also be catalyzed by microperoxidases 
(e.g. [54, 118]). However, the reactive FelV-oxo compounds I or II can not be stabilized 
by a cysteine ligand, as was suggested for cytochrome P-450. Furthermore, the absence 
of the protein environment in microperoxidases, excludes the stabilization of the histidine 
ligand by hydrogen bonds, as in peroxidases, or any other form of control of the reaction. 
This may account for the rapid inactivation of these enzymes. 
The hemes in myoglobin and hemoglobin are structurally comparable to those of 
peroxidases and cytochromes P-450. However, iron is present as Fell in the deoxy-form 
and to some degree as Felll (in a semi Felll-superoxo complex) in the oxy-form 
(proposed in [119]). In all cytochrome hemes the iron can alternate only between the 
reduced Fell and oxidized Felll states and reactive FelV-containing hemes are not found 
[120]. The catalytic properties of these proteins in the presence of hydrogen peroxide, 
however, indicate that under these conditions FelV-oxo compounds can be formed; 
literature provides evidence for this [121-124]. This may explain why hydrogen peroxide 
causes oxidative damage to cytochromes, hemoglobins and myoglobins. In the presence 
of dioxygen formation of an FelV-oxo compound from the FeIII-02 heme in hemo-
globins and myoglobins is possible, but requires the presence of an external reductant, 
capable of donating an additional electron to the system to enable O-O bond cleavage, as 
for cytochrome P-450 [95]. Absence of such a reductant may be an important reason for 
the in vitro stability of hemoglobins and myoglobins in the presence of oxygen. 
Cytochromes are also capable of accepting electrons from external reductants; the 
shielding of the heme-iron from solvent and oxygen, by the hydrophobic pocket and / or 
its two axial amino acid ligands, may be the key to the stability of these proteins: when 
oxygen cannot bind to the heme-iron a reactive FelV-oxo complex can not be formed. 
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Oxidative Inactivation of heme proteins. 
Although the formation of FelV-oxo compounds during catalytic activity seems 
to play an important role in the inactivation of heme proteins, the mechanisms of inacti-
vation are largely unidentified. Several possible mechanisms are mentioned in literature: 
I Oxidation of the fifth ligand (histidine), to form arginine, may occur, as 
has been observed for copper-histidinyl complexes [125]. Although oxidation of 
histidine, that is not coordinated to the heme-iron, has been reported in peroxide-treated 
myoglobin [126, 127], there is no conclusive evidence for the involvement of this process 
in inactivation. 
II There is kinetic evidence for a 'substrate-involved' inactivation during the 
oxidation of various substrates by H202, using microperoxidase 8 as a catalyst [54]. 
Bleaching of the catalyst during substrate-involved inactivation is observed [54], and it 
has been suggested that the process proceeds through disintegration of the heme moiety 
of the microperoxidase [128], but other than that the mechanism remains unexplained. 
III Metelitza et al. [129] report that microperoxidases can tolerate much 
higher concentration of hydrogen peroxide when equimolar amounts of human serum 
albumin or monoclonal antibodies against porphyrin are added to the reaction mixture. 
The authors ascribe this stabilization to the protection of the heme against destruction by 
free radicals. 
IV The meso positions of the porphyrin ring play a central role in some of the 
proposed mechanisms for the degradation of hemes: oxidation at these positions and 
subsequent hydrolysis results in cleavage of the porphyrin (Fig. 10). For hemin the 
preferred site of oxidative attack appears to be the a-double bond [103], causing open-
ing of the ring and loss of iron [99]. It has been proposed that H202 attack on 
cytochrome c also leads to opening of the porphyrin a-double bond [130]. Porphyrins 
are, as stated before, relatively resistant to oxidative damage and, like oxygen, hydrogen 
peroxide itself is not a sufficiently strong oxidant to cause cleavage of the a-methene 
bridge. The heme group must activate H202 to an oxygen species which is a much more 
powerful oxidant [98, 131]. Singlet oxygen, superoxide anion or free HO» radicals do 
not seem to be involved in the degradation of the heme of cytochrome c, since scaven-
gers of these activated oxygen species have no effect on the degradation rate [130]. This 
points at a role for the FelV-oxo compound in this degradation mechanism. A bound, 
reactive oxygen of this type could be shielded from large scavenger molecules, and could 
thus, unimpeded, carry out its attack on the porphyrin ring. 
Microperoxidases lack such a shielding protein environment. Still, no effect of 
scavengers on the catalytic activity of microperoxidase 8 has been observed [117]. The 
P-450-type of o-addition in the hydroxylation of aniline, mentioned above, was observed 
for microperoxidase 8 in the presence of ascorbic acid; this scavenger inhibits the 
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Figure 10 
Degradation of heme. Left: Heme. a,ß,y and S indicate the positions of the meso H-atoms. 
Right: The product of oxidative cleavage of heme at the a position: Biliverdin IX a. [103] 
peroxidative pathway (electron abstraction, see Fig. 9) by reducing the oxidized 
substrate, rather than by scavenging compound II [117]. Therefore both compounds I 
and II are formed in the absence as well as in the presence of ascorbic acid. Possibly the 
oxidative attack on the a-methene bridge in the porphyrin, mediated by these FelV-oxo 
compounds, proceeds very fast, and may thus escape reduction by scavengers. 
V The meso positions in the porphyrin ring are also believed to be the sites 
where cross-linking can occur between peroxide-treated myoglobins [122]. The cross-
links are probably formed by tyrosine residues, which has also been reported for the 
formation of cross-links in peroxide-treated leghemoglobin [132]. It is suggested that 
oxidation of a histidine yields a radical that is eventually transferred to a tyrosine residue. 
The tyrosine radical may next form a meso adduct with the porphyrin by a mechanism 
analogous to that for meso addition of radicals to the heme of horse-radish peroxidase 
[105, 133]: the radicals bind to a meso carbon of compound II with concomitant reduc-
tion of the iron from the ferryl to the ferric state. Elimination of a proton yields the meso 
adduct. The resulting oxidized Felll heme has spectral properties that differ markedly 
from normal Felll hemes and can not be reduced by dithionite or ascorbic acid, preclud-
ing any role for this adduct in redox reactions [122, 132]. 
Since the microperoxidases investigated in this thesis do not contain tyrosine 
residues, inactivation of these enzymes in this way can be ruled out. In earlier publica-
tions, however, it has been suggested that also the oxidized histidine can bind covalently 
to the heme [126, 127]. In the microperoxidases discussed here the only histidine is the 
fifth ligand, which is of vital importance for catalysis. Oxidation and subsequent meso 
adduction of this ligand to the porphyrin ring would undoubtedly result in inactivation of 
the enzyme. 
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VI An inactivation mechanism that specifically depends on the absence of a 
protective environment of the heme, and also involves the formation of FelV-oxo 
compounds, is the formation of p:-oxo dimers (Fig. 11). Simple Fell-porphyrin 
complexes can react with O2 to form Felll-CV complexes. These complexes can react 
rapidly with other Fell porphyrins, unless sterically prevented by the protein environ-
ment, to form binuclear peroxo-bridged complexes. These peroxo complexes are stable 
at low temperature, but when the temperature is raised the O-O bond cleaves and two 
equivalents of an FelV-oxo compound II homologue are formed. Subsequent reactions 
between the FelV-oxo complex and the Fell porphyrin complex produce the binuclear 
(l-oxo porphyrin dimer [134]. However, the formation of |A-oxo dimers probably does 
not play an important role in the inactivation of microperoxidases: amino acid residues of 
other microperoxidase molecules, or added substrate, may occupy the sixth coordination 
site and thus hinder the dimerization mechanism. Furthermore, the aerobically prepared 
microperoxidases contain predominantly Felll heme, whereas n-oxo dimerization 
requires Fell heme. Finally, the fact that it has been demonstrated that, at least at micro-
molar concentrations, microperoxidase 8 is essentially monomeric in aerobic aqueous 
solution [135] also argues against |J.-oxo dimerization of microperoxidases. 
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Formation of |x-oxo dimers from Fell porphyrin complexes. Ovals indicate the porphyrin ring; 
the 5th ligand is histidine in microperoxidases. [18] 
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1.5 Outline of this thesis. 
The original goal set at the beginning of the research resulting in this thesis was 
the elucidation of the mechanism of biosynthesis of iron-sulfur clusters in iron-sulfur 
proteins. As a subject the nitrogenase Fe protein from Azotobacter vinelandii was 
chosen because the genes involved in the maturation of this protein, and possibly in the 
biosynthesis of the [4Fe-4S] clusters, had been identified previously (nifM, nifS, nifU) 
[136]. Soon after the start of the project the role of NifS as a cysteine desulfurase in the 
biosynthesis of the [4Fe-4S] clusters was elucidated by the group of Dr. D.R. Dean 
(Virginia Tech) [137, 138]. Also the investigation of NifU turned out to be in an ad-
vanced stage [139]. Our investigation of NifM is presented in chapter 5. The research did 
not result in a clue to the function of this protein, but did confirm the role of NifM in the 
maturation of the nitrogenase Fe protein. For the subsequent research a new goal was 
chosen, which is reflected in the title of this thesis. 
Microperoxidases are so-called mini-enzymes, prepared by proteolytic digestion 
of cytochromes c [53]. Lack of a specific substrate-binding site enables these mini-
enzymes to use a wide variety of substrates. They are able to catalyze peroxidase-like 
reactions [54, 118], as well as cytochrome P-450-like reactions, [55, 56]. A major 
drawback for the application of microperoxidases, for instance in industrial conversions, 
is their limited stability under reaction conditions: these enzymes are rapidly inactivated 
by hydrogen peroxide. Chapter 2 describes the preparation of microperoxidases, with 
increasing lengths of the peptide attached to the heme-moiety, by proteolytic digestion of 
horse-heart cytochrome c (microperoxidase 6, 8 and 11) and of cytochrome aso from 
Thiobacillus versutus (microperoxidase 17). The kinetic properties of the different 
microperoxidases were analyzed with respect to their capability to catalyze the hydrogen 
peroxide-dependent para-hydroxylation of aniline, as well as the influence of the 
attached peptide chain on the stability. 
Nitrogenase proteins are inactivated when they are exposed to oxygen (section 
1.4) [59-61]. Azotobacter vinelandii produces a small protein, the FeSII protein, that can 
bind to nitrogenase, rendering it temporarily oxygen resistant [140]. In chapter 3 the 
mechanism by which the FeSII protein offers protection for the nitrogenase Fe protein 
against inactivation by oxygen is investigated. Based on the results a model that 
describes the reactions that are involved in this process, and a possible spatial organi-
zation of the nitrogenase-FeSII complex, that plays a key role in the protection of nitro-
genase, are presented. 
Nitrogenase catalyzed reduction of N2 to NH3 requires the association of the 
nitrogenase Fe protein with the nitrogenase MoFe protein, MgATP dependent electron 
transfer from the Fe protein to the MoFe protein and on-enzyme MgATP hydrolysis 
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followed by dissociation of the Fe-MoFe complex [141]. Aluminum fluoride plus 
MgATP or MgADP inhibits nitrogenase by stabilizing the protein-protein complex of an 
intermediate of the on-enzyme MgATP hydrolysis reaction [142]. Chapter 4 reports on 
the redox properties, obtained by redox titration and electron paramagnetic resonance 
(EPR) spectroscopy of the AlF-MgADP stabilized transition state complex of Azoto-
bacter vinelandii nitrogenase. A possible mechanism of MgATP hydrolysis-driven elec-
tron transport within the nitrogenase protein complex, based on the results, is discussed. 
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Abstract 
Microperoxidases with increasing lengths of the peptide attached to the heme 
moiety have been isolated after proteolytic digestion of horse-heart cytochrome c 
(microperoxidases 6, 8 and 11) and of cytochrome C550 from Thiobacillus versutus 
(microperoxidase 17). The different microperoxidases catalyze the hydrogen peroxide-
dependent para-hydroxylation of aniline relatively efficiently but are rapidly inactivated 
under turnover conditions. The horse-heart cytochrome c derived microperoxidases have 
identical values for VW but showed a decrease of the KM for aniline and a higher stability 
when the attached peptide is longer. The kinetic constants obtained for microperoxidase 
17 differ markedly from the microperoxidases derived from horse-heart cytochrome c. 
Possible factors underlying the observed differences are discussed. 
Introduction 
Microperoxidases are so-called mini-enzymes, prepared by proteolytic digestion 
of cytochromes c [1]. They consist of a protoporphyrin IX covalently bound to a short 
residual peptide chain that contains the motif Cys-(Xaa)2-Cys-His. The protoporphyrin is 
covalently bound through thioether links to the cysteine side chains. The histidine, which 
is usually referred to as the fifth ligand, is axially coordinated to the heme-iron. The 
amino acid that serves as a sixth ligand for the heme-iron in the cytochromes (His or 
Met) is absent as a result of the proteolytic digestion. 
Lack of a specific substrate-binding site enables these mini-enzymes to use a wide 
variety of substrates. They are able to catalyze peroxidase-like reactions, such as the oxi-
dation of o-dianisidine [2-5] as well as cytochrome P-450-like reactions, such as the 
para-hydroxylation of aniline [6] and the demethylation of N-methylaniline [7]. A major 
drawback for the application of microperoxidases in, for instance, industrial conversions, 
is their limited stability under turnover conditions: these enzymes are rapidly inactivated 
by hydrogen peroxide. 
Up to now, only microperoxidases derived from horse-heart cytochrome c, 
namely microperoxidase 8, 9, 11 and 50, with polypeptide chains of 8,9, 11 and 50 
amino acids, respectively, have been described [6-8]. The present study was designed to 
investigate whether the composition of the peptide chain of the microperoxidases plays a 
role in the catalytic efficiency. For this purpose microperoxidases with different chain 
lengths were prepared from horse-heart cytochrome c, namely microperoxidase 8, 
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microperoxidase 11 and the novel microperoxidase 6. Furthermore, also a novel micro-
peroxidase 17, which has an essentially different amino acid composition around the 
heme site, was prepared from cytochrome csso from Thiobacillus versutus produced in 
Escherichia coli. 
Microperoxidases 6, 8, 11 and 17 were investigated and compared with respect 
to the para-hydroxylation of aniline. The results demonstrate significant differences in 
kinetic properties and stability. 
Materials and methods 
Preparation of microperoxidases. 
Microperoxidase 11 was prepared by digestion of horse-heart cytochrome c 
(Boehringer Mannheim) with pepsin (Sigma) essentially as described in the literature [9]. 
Microperoxidase 8 was prepared by digestion of the purified microperoxidase 11 with 
trypsin (Sigma) [9]. 
Microperoxidase 6 was prepared by digestion of microperoxidase 8 with car-
boxypeptidase Y (Boehringer Mannheim). To microperoxidase 8 (3.5 ml 225 |xM 
enzyme in 75 mM sodium acetate, pH 5.0), carboxypeptidase Y (0.5 mg in 0.5 ml H20) 
was added and the mixture was incubated at 25°C for 7 h. 
Microperoxidase 17 was prepared by digestion of cytochrome csso from T. 
versutus with trypsin. Cytochrome C530 from T. versutus was produced in E. coli, from 
the cloned gene under semi-anaerobic conditions and purified essentially as described 
previously [10]. Cytochrome csso (9 mg in 375 u.1 100 mM Tris/HCl, pH 8.0) was diges-
ted for 20 h at 37°C with 9 mg trypsin. 
To follow the course of the protease digestions, samples of 20 or 50 (i.1 were 
taken at different time-points. After inactivation of the proteases by addition of phenyl-
methylsulfonyl fluoride (PMSF) to a final concentration of 5 mM, the samples were ana-
lyzed by reverse-phase chromatography as described in the next section. Digestions were 
continued to completion, i.e. until no further changes were detected in the elution pattern 
of the peptides. 
Purification and analysis of microperoxidase preparations. 
Microperoxidases 6 and 17 were purified from the digestion-mixtures using an 18 
mm x 350 mm Biogel P6-Fine (Bio-Rad) column, equilibrated with 50 mM KPi, pH 7.5, 
at a flow rate of 0.25 ml min'. 2-ml portions of the digestion mixture were applied to the 
column and the microperoxidases were eluted at 0.15 ml min'. The eluate was moni-
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tored for the absorbance at 395 nm to detect heme-containing peptides. Microper-
oxidases 8 and 11 were purified likewise on a larger scale. Peak fractions were collected 
and the purity of the microperoxidases was checked by HPLC analysis, as described 
below. The heme content of the final preparations was determined, in duplicate, essen-
tially as described previously [9]. The A423 / A28o ratio of the preparations was above 3.0. 
For HPLC analysis, a Baker Bond WPC4 (250 mm x 4.6 mm) reverse-phase 
column was used in combination with a Waters TM 600 HPLC controller. Peptides were 
eluted at a flow rate of 1 ml min"1 with a 50-ml linear gradient from 0% to 50% aceto-
nitrile in 0.1% trifluoroacetic acid. Elution was continued for another 5 min with 50% 
acetonitrile in 0.1% trifluoroacetic acid. The eluate was monitored at 214 nm (using an 
Isco V4 detector) for detection of peptides and at 395 nm (using an Applied Biosystems 
757 detector) for the detection of porphyrin. 
Characterization of microperoxidases. 
Microperoxidases 8 and 11 have been characterized previously [9]. Microper-
oxidase 6 was characterized by determination of the amino acids that were removed from 
microperoxidase 8 by proteolytic digestion using a Biotronic LC 6000E analyzer. At the 
end of the incubation period, 20 \L\ 30 % (mass / vol.) sulfosalicylic acid and 100 ju.1 1 M 
acetic acid were added to 100 \l\ digestion mixture. After centrifugation (1 min, 23000 g) 
the supernatant fluid was used for quantitative determination of the free amino acids. 
Microperoxidase 17 was characterized by sequence analysis and mass spectro-
metry. Sequence analysis was performed on the model 476A pulsed liquid phase 
sequenator, with on-line Pth-Xaa analysis, on a 120A analyzer (Applied Biosystems). 
Sequencing reagents and solvents were obtained from the same firm. For mass spectro-
metry, the peptides were subjected to matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) analysis. Samples of 1 ul were mixed with 1 \i\ 50 mM oc-cyano-
4-hydroxycinnamic acid (Sigma) in water/acetonitrile/trifluoroacetic acid (60 : 39.9 : 0.1, 
by vol.) and applied onto the multi-sample target. The samples were analyzed on a VG 
Tofspec (Fisons) equipped with a Nitrogen laser. 
Assay for the para -hydroxy lation of aniline. 
Assays of the H202-dependent hydroxylation of aniline were according to a 
modification of the standard procedure of Brodie and Axelrod [11]. KPj buffer (274 ul, 
0.2 M, pH 7.6) was preincubated in glass tubes in a 37°C water bath. After 5 min, ascor-
bic acid (35 jLtl of a 3.5 mg ml'1 stock; final concentration 1.8 mM), aniline (3.5 (0.1 20-120 
mM aniline in DMSO; final concentration 0.2-12 mM) and the appropriate microperoxi-
dase (20 ju.1 of a 87.5 uM stock; final concentration 5 \iM) were added. 30 s later, the 
hydroxylation reaction was started with H2O2 (17.5 |il of a 50 mM stock; final concen-
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tration 2.5 mM.). The incubations were always kept in a 37°C water bath and constantly 
stirred; these conditions were also maintained during the additions. After the required 
incubation time (5-60 s), the reactions were stopped by adding 100 |i.l 20% (mass / vol.) 
trichloroacetic acid. After 15 min at room temperature, precipitated protein was removed 
by centrifugation (1 min, 23000 g). The para-hydroxylated aniline produced in the assay 
was determined after quantitative conversion to the colored indophenol. To this end, 45 
(J,l of phenol reagent [5% (mass / vol.) phenol in 2.5 M NaOH] and 90 ul 2.5 M Na2C03 
were added to the supernatant containing the hydroxylated aniline. The test-tubes were 
shaken at 250 rpm at room temperature for 1-3 h, until the maximum absorbance at 630 
nm was observed. Concentrations were calculated using a molar extinction coefficient of 
£63o = 30.5mM"1cm"1. 
The addition of ascorbic acid to the incubation mixture is an important modifica-
tion of the standard assay described by Brodie and Axelrod [11]: it efficiently blocks all 
peroxidase-type of reactions catalyzed by the microperoxidases, but does not affect the 
hydroxylation of aniline [12]. 
Stopped-flow spectroscopy. 
For the analysis of the degradation of microperoxidase 8 by H2O2 on a 10 s time-
scale a Hi-Tech SF-51 stopped-flow spectrophotometer (Salisbury, Wiltshire, UK) 
equipped with a data acquisition and analysis system was used. One syringe contained 5 
mM H2O2 in 0.2 M KPu pH 7.6; the other syringe contained 3.6 mM ascorbic acid, 0.8 
or 24 mM aniline and 10 11M microperoxidase 8 in the same buffer. The mixing ratio was 
1:1. For each of four separately prepared mixtures, four traces were recorded observing 
the disappearance of the Soret band. These traces could be analyzed by fitting the data to 
a single-exponential curve. 
MP6 * C - A - Q - C - H - T * 
MP8 * C - A - Q - C - H - T - V - E * 
MP11 * V - Q - K - C - A - Q - C - H - T - V - E * 
MP17 * C - K * A - C - H - M - V - Q - A - P - D - G - T - D - I - V - K * 
Figure 1 
Amino acid sequences of the microperoxidases. * indicate cleavage sites after proteolytic diges-
tion. Note that microperoxidase 17 has a cleavage site between the heme-binding cysteines. 
Microperoxidases 41 
Results and discussion 
Preparation and characterization of microperoxidases. 
Microperoxidase 17. Cytochrome C550 from T. versutus was purified from a re-
combinant E. coli strain, which contained the cloned gene [10], to greater than 95% 
purity. The A525/A280 ratio was 0.41. After digestion with trypsin for 24 h almost all of 
the cytochrome csso had been digested, but several different heme-containing products 
could still be observed (Fig. 2A). The fraction with the highest absorbance at 395 nm 
was isolated by means of gel-filtration on an 18 mm x 350 mm Biogel P6-Fine (Bio-Rad) 
column. Based on HPLC analysis, the final preparation was estimated to be over 95% 
pure (Fig. 2B). The purified heme-containing microperoxidase was subjected to N-termi-
nal sequence analysis yielding the sequence {(Cys) / Ala} {(Cys) + Lys} His Met Val Gin. 
This indicates that the microperoxidase contains two peptide chains: a dipeptide and a 
larger peptide. Apparently proteolytic cleavage has occurred between lysine-36 and 
alanine-37, but both peptides remain covalently bound to the heme by the liganding cys-
teine residues. 
The mass of the microperoxidase was determined by matrix-assisted laser 
desorption mass spectrometry. The experimentally obtained mass, 2451.3 Da, closely 
corresponds to the sum of the masses of peptides Cys35 - Lys36 and Ala37 - Lys51 
(1834.2 Da total), plus the mass of the heme group (616.5 Da). An additional mass of 
2487.8 Da that was found can be attributed to the potassium salt of the microperoxidase. 
This novel microperoxidase has been designated microperoxidase 17. 
Microperoxidase 6. HPLC analysis of samples taken during the digestion of 
microperoxidase 8 with carboxypeptidase Y clearly shows the disappearance of micro-
peroxidase 8 and the formation of one intermediate and one final product (Fig. 3A). 
Analysis of the free amino acids present in the digestion mixture indicates that this is the 
result of the consecutive removal of the two C-terminal amino acids of microperoxidase 
8, glutamate and valine, which make up the C-terminus of microperoxidase 8 (Fig. 1). 
Together these two amino acids constituted over 95 % of the total amount of amino 
acids detected in the digestion mixture after completion of the digestion. Digestion of 10 
nmole of microperoxidase 8 yielded 9.3 nmole glutamate and 9.5 nmole valine. Since no 
other (intermediate) products were observed after completion of the digestion (Fig. 3A) 
and since no significant amounts of threonine or histidine (respectively the third and 
fourth C-terminal amino acid in microperoxidase 8) were found in the mixture, the final 
product can be identified as microperoxidase 6 (Fig. 1). Fig. 3B shows the HPLC 
analysis of the final preparation, i.e. after gel-filtration. Based on these results, the purity 
was estimated to be over 95%. 
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Preparation of microperoxidase 17. Analysis by HPLC of peptides obtained after a 24-h diges-
tion of T. versutus cytochrome csso with trypsin (A) and of the final preparation of MP 17 after 
purification on Biogel P6 (B). 
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Preparation of microperoxidase 6. Analysis by HPLC of peptides at several time-points during 
the digestion of microperoxidase 8 with carboxypeptidase Y (A) and of the final preparation of 
microperoxidase 6 obtained after purification by gel-filtration (B). 
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Catalytic activities of the different microperoxidases. 
Figs. 4 and 5 compare the yields of p-hydroxyaniline obtained with the different 
microperoxidases in the hydroxylation assay of aniline at varying concentrations of H202 
and aniline, respectively. The reaction time in the experiments in Figs. 4 and 5 was 60 s. 
In the experiment in Fig. 4, the H2O2 concentration was varied at a saturating 
concentration of the second substrate, aniline (12 mM). It is immediately obvious from 
visual inspection of the data in Fig. 4 that the reaction does not follow Michaelis-Menten 
kinetics. With all microperoxidases, optimal product yields are obtained at a H2O2 con-
centration of 2.5 - 3.5 mM; at higher concentrations, product yields decrease again. The 
major reason for deviation of Michaelis-Menten kinetics lies in the rapid inactivation of 
the microperoxidases during the time-course of the reaction (compare Figs. 6A and 6B) 
due to oxidative damage. Fig. 4 indicates that inactivation is faster at higher H202 con-
centrations. 
Product yields obtained with the different microperoxidases under conditions of 
varying aniline concentrations at a fixed concentration of H202 (2.5 mM) are shown in 
Fig. 5. Although the data can be fitted perfectly with the Michaelis-Menten equation, it 
O MP6 
Figure 4 
Hydroxylation of aniline with the different microperoxidases as a function of the H202 con-
centration. Reaction time 60 s ; 12 mM aniline; 5 uM microperoxidase. In order to demonstrate 
the deviation of Michaelis-Menten kinetics, data-points obtained for the four lowest peroxide 
concentrations were fitted with the Michaelis-Menten equation. 
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should be emphasized that this equation may not be used to calculate apparent KM and 
Vmax values. This is obvious from inspection of Figs. 6A and 6B, which demonstrate the 
time-course of the hydroxylation reaction at high (12 mM) and low (0.4 mM) aniline 
concentrations, respectively. It is apparent from Fig. 6 that the reaction rates are not 
constant but decrease rapidly due to inactivation of the peroxidases. 
Although the experiments in Figs. 4 and 5 do not allow a kinetic description of 
the hydroxylation of aniline by the different microperoxidases, they do show that the size 
of the attached polypeptide influences the yield of the hydroxylated product. Comparing 
the three microperoxidases derived from horse-heart cytochrome c shows increasing 
product yields in the order MP6 -> MP8 -» MP11. This effect is most pronounced at 
low substrate concentrations: at 0.4 mM aniline, microperoxidase 11 yields almost 3 
times more hydroxylated product than microperoxidase 6 (Fig. 6B). 
The activity of microperoxidase 17 from T. versutus cytochrome aso is similar to 
that of microperoxidase 8. This indicates that not only the size of the attached peptide, 
but also its amino acid composition influences the efficiency of the reaction. 
o MP6 MP8 MP11 
12 14 
[Aniline] (mM) 
• MP17 
Figure 5 
Hydroxylation of aniline with the different microperoxidases as a function of the aniline con-
centration. Reaction time 60 s; 2.5 mM H202; 5 uM microperoxidase. Data-points were fitted 
with the Michaelis-Menten equation; see the text for the validity of this fitting. 
46 Chapter 2 
O MP6 MP11 
O MP6 MP11 
Figure 6 
Time-course of the hydroxylation of aniline with the different microperoxidases. A: 12 mM 
aniline. B: 0.4 mM aniline. All samples: 2.5 mM H202 and 5 |lM microperoxidase. Data in (A) 
and (B) were fitted with equations (1) and (3) in the Results section, respectively. 
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A full kinetic description of the microperoxidase-catalyzed hydroxylation of 
aniline should not only include kinetics for two-substrate reactions, but also the kinetics 
of inactivation. In a first approach to calculate apparent KM and V„nX values we used the 
data in Figs. 6A and 6B, that show the time-course of the hydroxylation catalyzed by the 
respective microperoxidases at high (12 mM) and low (0.4 mM) aniline concentrations 
and a fixed H202 concentration (2.5 mM). At 12 mM aniline (well above the ATM), the 
initial rate of the reactions approaches V^. It is obvious from Fig. 6A that the three 
microperoxidases from horse-heart cytochrome c have similar initial rates under these 
conditions; the initial rate of the reaction catalyzed by microperoxidase 17 from T. 
versutus cytochrome csso, however, is approximately two times faster. 
The data in Fig. 6A ([aniline] » KM) were fitted assuming: 
\r -kt 
with v being the actual rate at time t after the start of the incubation, and k the apparent 
first-order rate constant for inactivation of the microperoxidase. After integration we get: 
[P]t=(Vmax/k)(l-e-k') (1) 
with [P], being the concentration of the formed product at time t and Vmax / k = [P] max, 
the maximal product concentration at infinite time. Using equation (1) to fit the data 
resulted in values for k and [P]
 max, from which Vmax was then calculated. 
It should be emphasized that this equation does not imply that the inactivation of 
the microperoxidases is a first-order process. The rate of inactivation is dependent on the 
concentrations of both H2O2 (which causes the inactivation) and aniline (which protects 
against inactivation; see below), according to a mechanism not yet fully understood. 
Therefore, equation (1) gives only a first approximation of the kinetics of the inacti-
vation; it can be expected to be dependent on both the H202 and aniline concentrations 
and should therefore only be used to compare different microperoxidases under similar 
conditions. Application of equation (1) to fit the data-points in Fig. 6A results in the 
values for V^ and k given in Table I. The three microperoxidases derived from horse-
heart cytochrome c have similar Vmax values for the hydroxylation of aniline, but the 
apparent rate constant for inactivation increases slightly from microperoxidase 11 to 
microperoxidase 6. Microperoxidase 17, which is derived from T. versutus cytochrome 
csso, has a twofold higher VmaX for the reaction, but also a much higher rate constant for 
inactivation. 
Fig. 6B shows the para-hydroxylation of aniline by the different microper-
oxidases at low aniline concentration (0.4 mM). The data-points in Fig. 6B were fitted 
with the use of the Michaelis-Menten equation, again corrected for single exponential 
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decrease of the enzyme activity: 
v={(Vmax[S])/(KM + [S])}e-kt 
After integration we get: 
[P]t= {[S]/ (KM + [S])} (VmaJ k)(l - e-kl) 
which can also be written as: 
[P ] r= [P]max( l - e -* ' ) 
(2) 
(3) 
Fitting the data to equation (3) gave the values for the apparent rate constant for inacti-
vation at this aniline concentration (Table I) and for the maximal product concentration, 
[P] max- With these data and the values for VW obtained from Fig. 6A. the KM values 
were then calculated from equation (2). 
Inspection of the results, summarized in Table I, leads to the following conclu-
sions: for the microperoxidases derived from horse-heart cytochrome c, an increase in 
the size of the attached polypeptide results in a decrease of the apparent KM for aniline, 
together with an increase in stability, microperoxidase 11 has a twofold lower ATM for 
aniline and a 35% lower apparent rate constant for inactivation compared to microper-
oxidase 6. The microperoxidase derived from the T. versutus cytochrome has a higher 
KM than those derived from horse-heart cytochrome and a rate constant for inactivation 
comparable to microperoxidase 6. 
MP6 
MP8 
MP11 
MP17 
Table I 
Incubation time variable 
[aniline] = 12 mM. 
Vo (VU) j 
( uM s'1 ) | 
2.28 
±0.04 
2.35 
± 0.03 
2.28 
± 0.04 
4.47 
± 0.04 
k 
(s"1) 
0.079 
± 0.004 
0.069 
±0.002 
0.056 
± 0.002 
0.132 
±0.004 
Incubation time variable 
[aniline] = 0.4 mM. 
(mM) 
0.82 
±0.04 
0.63 
±0.04 
0.41 
±0.05 
1.33 
±0.03 
Vo 
| ( M-M s"1 ) 
0.75 
± 0.02 
0.89 
± 0.02 
1.14 
± 0.03 
1.14 
± 0.02 
k 
(s"1) 
0.141 
±0.007 
0.115 
± 0.005 
0.091 
±0.004 
0.141 
±0.006 
Kinetic parameters of the microperoxidases, with 95% confidence intervals. 
k indicates a pseudo first-order rate of inactivation at 2.5 mM hydrogen peroxide. 
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The apparent rate constants for inactivation of the microperoxidases at low sub-
strate concentration are always higher than those at high substrate concentration, which 
indicates that the substrate protects the microperoxidase against inactivation (Table I). 
An explanation of this observation is that hydroxylation of the substrate competes with 
side reactions of the intermediate iron-(per)oxo complex that inactivate the microper-
oxidase (such as the production of highly oxidative hydroxyl or superoxide radicals, the 
irreversible oxidation of the catalyst to (0,-oxo dimers or the abstraction of H-atoms from 
the meso-positions of the porphyrin). Although equations (1) and (2) serve our purposes 
well for the moment, a more accurate description of the kinetics of inactivation should 
also account for the dependence on the concentration of both substrates. When obser-
ving the horse-heart cytochrome c-derived microperoxidases, the influence of the aniline 
concentration on protection against inactivation (the ratio of the k values at 0.4 mM and 
at 12 mM aniline in Table I) decreases with the length of the peptide chain, i.e. in terms 
of stability, microperoxidases with a longer peptide chain benefit less from a higher 
aniline concentration. Of all microperoxidases investigated here the stability of microper-
oxidase 17 is least dependent on the aniline concentration. 
Stopped-flow analysis of the degradation of microperoxidase 8 by H202 in the 
presence of aniline and ascorbic acid on a 10 s time-scale yielded k values of 0.118 s'1 
(±0.008) at 0.4 mM aniline and 0.080 s~' (±0.005) at 12 mM aniline. These k values for 
the degradation of microperoxidase 8 are consistent with the k values for the inhibition of 
microperoxidase 8 as determined on a 1-min time-scale by the kinetic experiments, also 
with respect to the dependence of these processes on the aniline concentration (Table I). 
From this it can be concluded that investigation of the inactivation of microperoxidases 
on a seconds time-scale would not result in a better understanding of this process. 
Conclusions. 
The present study indicates that microperoxidases are relatively efficient cata-
lysts. Specificity constants for the hydroxylation of aniline (kcM / KM), for the microper-
oxidases used in this study, vary in the range 550 - 1200 M'1 s ' . 
The kinetic parameters for the microperoxidases derived from horse-heart cyto-
chrome c (microperoxidases 6, 8 and 11) show that the increase of the size of the peptide 
chain attached to the heme moiety has no effect on the V^ for the hydroxylation of 
aniline, but does result in 50% decrease of the KM- Obviously, a larger size of the 
attached peptide chain in these microperoxidases creates an environment around the 
heme-iron that is more suitable for the fairly hydrophobic substrate, but does not in-
fluence the actual rate of hydroxylation. Microperoxidase 17, which is derived from T. 
versutus cytochrome csso, has a twofold higher Vmax in this reaction, but the KM is lower 
than that of the microperoxidases derived from horse-heart cytochrome c. 
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A major drawback for the application of microperoxidases is their limited stability 
under turnover conditions. Comparing the rate constants for inactivation of the three 
microperoxidases derived from horse-heart cytochrome c indicates that the size of the 
attached peptide protects against inactivation, but a much higher stability under turnover 
conditions is required to make microperoxidases attractive for industrial application. To 
understand the mechanism of protection of the microperoxidase by the peptide, it is 
necessary to obtain information on the mechanism of inactivation. This work is currently 
in progress. One possibility is that the peptide chain serves as scavenger for hydroxyl or 
superoxide radicals produced during the reaction; another is that the peptide chain forms 
a physical barrier for the irreversible dimerization to the inactive |l-oxo dimer. The pep-
tide chain could also act as an alternative source of H-atoms and thus reduce the inacti-
vation of the enzyme by H-atom abstraction from the mejo-positions of the porphyrin by 
the iron-oxo species. 
The kinetic constants derived for the reaction catalyzed by microperoxidase 17, 
the microperoxidase derived from T. versutus cytochrome csso, are remarkably different 
from those of the microperoxidases derived from horse-heart cytochrome c. Values for 
Vmax, KM and the rate constant for inactivation are approximately 2-, 3-, and 1.5-fold 
higher than those for the largest cytochrome c-derived microperoxidases, microper-
oxidase 11. One of the reasons for the higher catalytic rate constant of microperoxidase 
17 may be the nick in the peptide chain, between the two cysteine residues, which form 
the thioether bonds with the porphyrin, caused by the digestion with trypsin. This may 
allow the ligating histidine, which is proximal to the second cysteine (Fig. 1), to take a 
slightly altered position towards the heme-iron, changing its electronic configuration and 
reactivity. Further research will have to provide conclusive evidence for this, possibly by 
means of site-directed mutagenesis of the cleavage site. The fact that microperoxidase 17 
was prepared from a cloned bacterial cytochrome c makes this approach possible. 
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Protection of the nitrogenase Fe protein from 
Azotobacter vinelandii against oxygen-inactivation 
by complex formation with the MoFe protein. 
Johan H. SPEE, Hans WASSINK, Walter M.A.M. VAN DONGEN and Huub 
HAAKER 
Protection of the nitrogenase Fe protein 53 
Abstract 
Nitrogenase consists of two metalloproteins, the Fe protein and the MoFe 
protein. The purified Fe protein is extremely susceptible to inactivation by oxygen. In a 
solution exposed to air its half-live of inactivation is about 30 seconds. In crude extracts 
prepared from Azotobacter species, the Fe protein is more resistant to oxygen-inacti-
vation as a result of complex formation with the MoFe protein and a [2Fe-2S] protein, 
called the FeSII protein. The mechanism by which these proteins offer protection against 
inactivation by oxygen was investigated. It is shown that binding of the Fe protein to the 
MoFe protein decreases its oxygen sensitivity. A further decrease of the oxygen sensiti-
vity was brought about by stabilization of the Fe protein-MoFe protein complex by the 
FeSII protein or by aluminum fluoride and MgADP. 
Kinetic evidence is presented that the three-component protein complex, formed 
by the Fe protein, the MoFe protein and the FeSII protein, can exist in at least two 
stoichiometrics : one FeSII protein binds one or two MoFe protein-Fe protein complexes. 
A model which quantitatively describes the experimental data is presented. This 
model takes into account 1 : the protection against oxygen-inactivation of the Fe protein 
offered by the MoFe protein; 2: the stabilization of the MoFe protein-Fe protein complex 
by the FeSII protein; 3: the different stoichiometrics of the three-component protein 
complexes and 4: the kinetics of reduction and dissociation of these complexes. In the 
present study evidence is obtained supporting the model in which the specific protein 
environment of the [4Fe-4S] cluster of the Fe protein in the Fe protein-MoFe protein 
complex is the basis for the preservation of the integrity of the cluster under oxidative 
conditions. 
Introduction 
Nitrogenase catalyzes the MgATP-dependent reduction of N2 to NH3. The 
enzyme consists of two component proteins. The homodimeric (72) iron protein (Fe 
protein) contains a single [4Fe-4S] cluster which is coordinated by two cysteine residues 
from each subunit [1]. The heterotetrameric (0^2) molybdenum-iron protein (MoFe 
protein), contains two unique iron-molybdenum-sulfur-homocitrate cofactors (FeMoco) 
[2] that are the proposed sites for binding and reduction of N2 [3, 4] plus two unique 
[8Fe-7S] clusters (P-clusters) [5, 6] which are believed to accept an electron from the Fe 
protein before transferring it to the FeMoco substrate binding-site. 
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A kinetic mechanism for nitrogenase catalysis has been described by Lowe and 
Thorneley [7] and has recently been extended by Duyvis et al. [8-10] and by Lowe et al. 
[11]. The model consists of two coupled cycles: the Fe protein cycle and the MoFe 
protein cycle. In the Fe protein cycle, the reduced Fe protein associates with the MoFe 
protein forming a two-component protein complex. The MoFe protein has two indepen-
dent binding sites for the Fe protein, one per ocß-dimer. Binding of MgATP to the Fe 
protein induces electron transfer from the Fe protein to the MoFe protein followed by 
on-enzyme hydrolysis of MgATP. Next the oxidized Fe protein, with MgADP bound, 
dissociates from the MoFe protein. With dithionite as the reductant, this dissociation is 
the rate-limiting step [12]. Finally, the free Fe protein is reduced and MgADP is replaced 
by MgATP. The MoFe protein cycle describes the stepwise reduction of the MoFe 
protein by eight consecutive electron transfer steps from the Fe protein, followed by the 
reduction of N2 to NH3, which requires six electrons, and the production of H2 from two 
protons and two electrons. 
Both nitrogenase .proteins are inactivated when they are exposed to oxygen. In 
vitro studies with Azotobacter nitrogenase proteins indicated that especially the Fe 
protein is prone to inactivation by oxygen [13-15]. Wang and colleagues [14] demon-
strated that the MoFe protein from A. vinelandii still retained about 90% of its activity 
after a 1 min exposure to 20% oxygen in argon, whereas under the same conditions the 
activity of the Fe protein was reduced to less than 20%. The authors noticed loss of Fe 
from the Fe protein which indicates that its [4Fe-4S] clusters are destroyed in the inacti-
vation process. 
Consequently, aerobic diazotrophic bacteria have to protect their nitrogenases 
from rapid and irreversible inactivation by oxygen but at the same time require oxygen to 
provide sufficient ATP to sustain nitrogen fixation. This requirement of ATP, produced 
by means of oxygen-dependent respiratory metabolism, on the one side and the oxygen 
instability of nitrogenases on the other side is known as the 'oxygen problem' [16, 17]. 
The nitrogen fixing soil bacterium A. vinelandii deals with this problem in two different 
ways. At high oxygen concentrations it produces a terminal oxidase, cytochrome d, with 
a high Vmax. Cytochrome d effectively prevents the accumulation of intracellular oxygen 
and subsequent inactivation of nitrogenase [18]. In addition to this so called respiratory 
protection A. vinelandii has a second strategy known as conformational protection. The 
bacterium produces a small iron-sulfur protein, known as the FeSII- or Shethna protein 
[19]. The FeSII protein has been isolated as a homodimeric (82) protein containing one 
[2Fe-2S] cluster per subunit. Under non-reducing conditions and in the presence of Mg2+ 
the FeSII protein associates with the Fe protein and MoFe protein, thus forming a three-
component protein complex in which the Fe protein is protected against oxygen-
inactivation [13, 14, 20, 21]. The stoichiometry of the three-component protein complex 
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as isolated from A. vinelandii is approximately one FeSII protein (82), one MoFe protein 
(0t2p2) and two Fe proteins (y2) [20]. The oxygen tolerant three-component protein 
complex can be reconstituted in vitro by mixing the anaerobically oxidized forms of the 
MoFe protein, the Fe protein and the FeSII protein in the presence of MgCl2 [14, 22]. 
This reconstituted complex dissociates upon reduction with dithionite making the nitro-
genase proteins again sensitive to oxygen-inactivation [22]. 
It has been demonstrated recently [23, 24] that the Fe protein-MoFe protein 
complex can be stabilized with aluminum fluoride and MgADP, resulting in a very stable 
nitrogenase complex which has been proposed to represent the transition state for ATP-
hydrolysis and subsequent electron transfer. The structure of this AlF-MgADP stabilized 
complex has been solved recently [25]: it has the subunit composition (0^72)2; one Fe 
protein y2 dimer per ocß-subunit pair of the MoFe protein, i.e. two Fe protein dimers are 
bound to one MoFe protein heterotetramer. 
In the present study we investigated the kinetics of oxygen-inactivation of the Fe 
protein under different conditions (all in the presence of MgADP and MgCk). 1: without 
addition of the MoFe or FeSII proteins; 2: in the presence of only the MoFe protein, i.e. 
the Fe protein mainly bound to the MoFe protein; 3: in the AlF-MgADP stabilized two-
component protein complex and 4: in the presence of the MoFe protein plus different 
amounts of FeSII protein, i.e. the Fe protein mainly in a three-component protein 
complex. The kinetics of the reduction of the three-component protein complex was 
investigated by means of stopped flow spectrophotometry. Based on the results obtained 
with these experiments a model is proposed in which stabilization of the Fe protein-
MoFe protein complex by the FeSII protein prevents the oxidative degradation of the 
[4Fe-4S] cluster of the Fe protein. 
Materials and methods 
Purification of the FeSII protein. 
The A. vinelandii FeSII protein was overexpressed in E. coli W3110 harboring 
the plasmid pAVFeSII and purified, essentially as described by Moshiri et al. [26]. In all 
purification steps a temperature of 4°C was maintained; no precautions were made to 
exclude 02. The final preparation was analyzed by means of PAGE and found to be over 
95% pure. The A280/A344 ratio was 0.90. Molar concentrations of the FeSII protein were 
determined from the absorbance at 344 nm, using £344 = 33.2 mM"1 cm"1 for the two 
[2Fe-2S] clusters in the dimeric protein [27]. The protein concentration was determined 
with the micro biuret method [28] after precipitation with deoxycholic acid and trichloro-
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acetic acid [29], using a molecular mass of 26.28 kDa per dimeric FeSII protein. The 
results indicated that the purified FeSII protein contained 1.8 [2Fe-2S] clusters per 
dimer. Earlier preparations of the recombinant FeSII protein yielded 1.9 clusters per 
dimer [26]. All concentrations of the FeSII protein are expressed here as concentrations 
of the dimeric protein calculated from the absorbance at 433 nm, i.e. based on the 
content of two [2Fe-2S] clusters per protein. 
Purification of nitrogenase proteins. 
A. vinelandii ATCC strain 478 was grown and the nitrogenase MoFe and Fe 
proteins were isolated as described by Duyvis et al. [9]. Protein concentrations were 
determined with the micro biuret method, as described above. The molar concentrations 
of the MoFe and Fe proteins were calculated from their molecular masses of 230 kDa 
and 63 kDa, respectively. The activities of the purified MoFe and Fe proteins were 
determined on the basis of the acetylene reduction activity at 30 °C, as described by 
Braaksma et al. [30]. The specific activity of each of the purified nitrogenase proteins 
was calculated from the maximum acetylene reduction rate at the optimal MoFe protein : 
Fe protein ratios, which were 1 liM MoFe protein plus 20 uM Fe protein for the measu-
rement of the specific activity of the MoFe protein and 2 (J.M MoFe protein plus 1 nM 
Fe protein for the measurement of the specific activity of the Fe protein. The specific 
activities for the purified MoFe and Fe proteins were at least 8 and 2 mol ethylene s'1 
(mol enzyme)"1 respectively. 
Previous studies have indicated that the FeSII protein does not function as an 
electron donor to nitrogenase [13, 20, 21]. However, to rule out any effect of the FeSII 
protein on the nitrogenase activity the activities of the MoFe protein (8 moles Fe protein 
per mole MoFe protein) and the Fe protein (1 mole Fe protein per mole MoFe protein) 
were assessed in the presence of FeSII protein concentrations ranging from 1 to 16 
moles FeSII protein per mole MoFe protein. No effects of the FeSII protein on the 
activities were observed (data not shown). 
Preparation of the protein mixtures. 
In vivo, the Fe protein is not reduced under conditions of oxygen-stress and is 
predominantly present in the oxidized form with MgADP bound (discussed below). 
Complex formation between the FeSII protein, the MoFe protein and the Fe protein 
requires the presence of Mg2+ [22]. All protein mixtures were prepared with the same 
anaerobic standard buffer: 50 mM TES/NaOH, pH 7.4, 5 mM MgCl2, 1 mM MgADP. 
At the given concentration, MgADP saturates the nucleotide binding sites of the Fe 
protein. The MoFe and Fe proteins were made dithionite-free by passage through a 1 cm 
x 10 cm Biogel P6-Fine (Bio-Rad) column, equilibrated with standard buffer, containing 
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also 150 mM NaCl in the case of the MoFe protein. The Fe protein was oxidized with 
PMS, while passing through the column, as described earlier [22]. The FeSII protein was 
purified aerobically; the oxidized FeSII protein was transferred to anaerobic standard 
buffer, also by passage through a 1 cm x 10 cm Biogel P6-Fine column. Next, protein 
concentrations were determined as described above. 
Samples containing free Fe protein or free FeSII protein were subsequently 
prepared by dilution with standard buffer to a final protein concentration of 10 U.M. The 
two-component protein mixture was prepared by mixing of the reductant-free MoFe 
protein and oxidized Fe protein, both in standard buffer, in a fixed molar ratio of 1 : 2. 
Three-component protein mixtures were prepared by mixing of the reductant-free MoFe 
protein and oxidized Fe protein in a fixed molar ratio of 1 : 2, followed by addition of the 
oxidized FeSII protein, all in standard buffer. The molar ratio of FeSII protein : MoFe 
protein was varied from 0.2 : 1 to 1 : 1 in the different experiments. For determination of 
the oxygen stability of Av2 in the two-component and three-component protein mix-
tures, these mixtures were diluted with standard buffer to a final MoFe protein concen-
tration of 5 (J.M. Three-component protein mixtures used for stopped-flow experiments 
were diluted similarly to a final MoFe protein concentration of 10 uM. All manipulations 
during the preparation of the mixtures were done under strictly anaerobic conditions, but 
without addition of dithionite. 
Preparation of the AlF-MgADP stabilized nitrogenase complex. 
The AlF-MgADP stabilized nitrogenase complex was prepared by incubating the 
purified, i.e. dithionite reduced, MoFe and Fe proteins with aluminum fluoride and 
MgADP essentially as described by Duyvis et al. [24]. Na2S204 and excess Fe protein 
were removed by applying the complex preparation onto a 1 x 10 cm DEAE Sephacel 
ion-exchange column, equilibrated with standard buffer also containing 0.9 mM A1F3 and 
9 mM NaF. The complex was eluted with the same buffer with 250 mM NaCl and next 
diluted with standard buffer to a final concentration of 5 uM with respect to the MoFe 
protein. Aluminum and fluoride form compounds of the general composition AlFx(OH")y. 
In the pH range 5 - 8 and with millimolar fluoride concentrations at least five different 
mixed OH" and F complexes of Al3+ are present [31]. For this reason we use 'A1F' as the 
general abbreviation for all forms of aluminum, fluoride and OH" coordination. 
Oxygen-inactivation of the protein mixtures. 
The two- and three-component protein mixtures (FeSII protein variable from 0 to 
5 uM; 5 uM MoFe protein; 10 uM Fe protein; in standard buffer) were incubated under 
argon in a 7.5 ml closed vial at room temperature. A 100 (i.1 sample (t = 0 min) was taken 
and added to 400 ul assay mixture containing 25 mM Na2S204 to assess the nitrogenase 
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activity with the acetylene reduction assay at 30 °C, as described by Braaksma et al. [30]. 
Next the vial was opened and air was blown in while stirring the solution gently. This 
procedure allows exposure of the proteins to a constant 02 concentration of 240 u.M. 
Further 100 fil samples were taken and tested for nitrogenase activity at 3, 6 and 10 min 
after the start of the exposure to oxygen. The oxygen-inactivation of 10 |J.M free Fe 
protein, in standard buffer, was determined similarly. To assess the activity of the free Fe 
protein, two molar equivalents of MoFe protein were added to the assay mixture. 
To determine the oxygen-inactivation of the AlF-MgADP stabilized nitrogenase 
complex 500 ul of the mixture (5 uM with respect to the MoFe protein, in standard 
buffer) was exposed to air as described above. Samples of 200 ul, taken at 0, 3, 6 and 10 
min, were injected into an anaerobic vial containing 20 ul 200 mM Na2S204 in standard 
buffer. After flushing the vial with argon for 2 min, 20 ul of 500 mM KPi, pH 7.4, was 
added and the complex was reactivated by incubating the mixture anaerobically for 45 
min at 50 °C. When incubated at this temperature the phosphate replaces the aluminum 
fluoride, allowing the dissociation of the complex [24]. The nitrogenase activity was 
determined, as described above, using 100 u.1 of the reactivated nitrogenase. 
Reduction of the protein mixtures. 
The kinetics of the reduction of the three-component protein mixtures was 
determined by rapid mixing of the samples with Na2S204 in a Hi-Tech SF-51 stopped-
flow spectrophotometer (Salisbury, Wiltshire, UK) equipped with an anaerobic kit and a 
data acquisition and analysis system. One syringe contained mixtures of 5 or 10 uM 
FeSII protein, 10 uM MoFe protein and 20 uM Fe protein, in standard buffer. The other 
syringe of the stopped-flow spectrophotometer contained 16 mM Na2S204 in the same 
buffer. The mixing ratio was 1 : 1 . Absorbance changes at 430 and 550 nm were 
recorded on different time-scales. The reduction of free FeSII protein was investigated 
similarly, with in the one syringe 10 uM of the oxidized protein, and in the other syringe 
16 mM Na2S204, both in standard buffer. 
The change in molar extinction upon reduction of the three-component protein 
mixtures, required for the simulations, were derived directly from the experimental 
stopped-flow traces: Ae430 = 10.6 and Aesso = 4.2 mM"1 cm' for the free FeSII protein; 
Ae430 = 11.2 and Aesso = 3.3 mM"1 cm"1 for MoFe protein plus Fe protein (with MgADP 
bound) in a 1 : 2 ratio. Reduction of the FeSII protein showed a lower molar extinction 
change than calculated from the spectra determined previously [20]. This is a result of 
the bandwidth of the spectrophotometer used in the stopped-flow experiments. The 
values for the incubations of Fe protein plus MoFe protein include a minor effect of the 
MoFe protein in molar extinction change upon reduction (about 10%). 
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Terminology of proteins, complexes and kinetic species. 
The MoFe and Fe proteins from A. vinelandii are generally abbreviated as Avl 
and Av2, respectively. Hereafter the heterotetrameric (a2ß2) MoFe protein and the 
homodimeric (82) FeSII protein will be referred to as 'Avl' and 'FeSII', respectively. In 
vivo, Av2 is not reduced under conditions of oxygen-stress and MgADP, bound to the 
oxidized Fe protein, is only very slowly replaced by MgATP [32]. As a consequence Av2 
is predominantly present as oxidized Av2(MgADP)2. To approximate to the physiologi-
cal conditions all experiments were performed in the presence of saturating MgADP 
concentrations. As a shorthand notation, 'Av2' will be used hereafter to refer to the 
dimeric (y2) Fe protein with MgADP bound. At the cellular protein concentrations in 
vivo (Avl=50 (iM, Av2=80 (iM, FeSII=50 (AM [33]) and with a dissociation constant of 
about 1 |i.M [10] almost all Av2 is bound to Avl. The complex formed by one Avl and 
two Av2, with MgADP bound, will be indicated as the Avl-[Av2]2 complex. It must be 
noted, however, that the presence of a nucleotide (MgADP or MgATP) is not required 
for the formation of a three-component complex by FeSII, Avl and Av2 [22]. The 
oxygen-inactivated form of Av2 will be indicated as Av2jnaCt- The suffix 'red' is used for 
the dithionite reduced form of a protein or species (e.g. FeSIIred, Av2red). The kinetic 
species Avlocß, FeSIlS and Av2 are used to describe the kinetics of inactivation, 
complex formation and reduction of the proteins in the various experiments. It is gener-
ally accepted that the two Av2 binding sites on Avl are independent. Such an indepen-
dent functioning ocß-subunit pair of Avl is referred to as the Avlocß species. We 
assumed that the 8 subunits of FeSII each have two different binding sites for Avl aß; 
the independently functioning half of FeSII is referred to as the FeSIlS species. 
Shorthand notations are used in the Results section only. 
Results 
Avl protects Av2 from inactivation by oxygen. 
The residual activity of free Av2 after exposure to oxygen is shown in Fig. 1 
(trace 'Av2'). The inactivation of Av2 is rapid and can be described by single exponential 
decay with feobs = 2 x 10"2 s"1 (pseudo first-order reaction at 240 \iM 02). However, when 
Avl is present during exposure to oxygen the decay is considerably slower (Fig. 1, trace 
'Av2 + Avl'), indicating that Avl protects Av2 against oxygen-inactivation. When 
approximated by single exponential decay the 'overall' rate constant for inactivation of 
Av2 in the presence of Avl is 5 x 10"3 s', i.e. four times slower than for free Av2. From 
the rate constants for the reversible association of Avl with Av2 (k2 and k.2, Table I) it 
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Figure 1 
Inactivation of nitrogenase by oxygen. Relative residual activity as a function of the time of 
exposure to 240 uM oxygen. 'Av2': 10 |iM free Av2. 'Av2 + Avl': 10 uM Av2, 5 liM Avl. 
'AlF-MgADP Stabilized': 5 |xM of the AlF-MgADP stabilized two-component nitrogenase 
complex. All in standard buffer. The lines drawn through the data-points are single-exponential 
decay curves with rate constants t = 2x 10" s"1 for free Av2, k = 5 x 10"3 s"1 for Av2 in the 
presence of Avl and k = 2 x 10 s"1 for the AlF-MgADP stabilized complex. 
follows that, at the given concentrations of Avl and Av2, approximately 75% of Av2 is 
bound to Avl, in an Avl[Av2]2 complex, at the start of the exposure to oxygen. The 
fourfold decrease in the rate of inactivation that is observed when Avl is added to Av2 
indicates that free Av2 is inactivated much more rapidly than Av2 associated with Avl. 
Apparently, the rate of inactivation of Av2 in the presence of Avl depends on the 
dissociation constant of the Avl-[Av2]2 complex. 
A stable, but enzymatically inactive protein complex can be prepared by incu-
bating the Fe and MoFe proteins with MgADP, AIF3 and NaF. This stabilized two-
component protein complex was isolated and also exposed to oxygen. After exposure the 
complex was dissociated at 50°C in the presence of phosphate to restore the activity, as 
described before [24]. As shown in Fig. 1 (trace 'AlF-MgADP stabilized'), this sample 
retained 95% of its activity after a 10 min exposure to oxygen. This result confirms the 
conclusion, drawn above, that the association with Avl protects Av2 against inactivation 
by oxygen. 
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Protection against oxygen-inactivation by the FeSII protein. 
Oxidized A. vinelandii nitrogenase proteins associate with FeSII to form a three-
component protein complex in which nitrogenase is protected from inactivation by 
oxygen. This FeSII-mediated protection was investigated in vitro with incubations con-
taining FeSII (0-5 |0.M), reductant-free Avl (5 |iM) and oxidized Av2 (10 |J.M) in the 
presence of MgADP and MgCl2. 
Fig. 2A shows the residual nitrogenase activity of the three-component protein 
mixtures after exposure to oxygen for 0, 3, 6 and 10 min (fitted curves are discussed 
below). As is obvious from this figure, increasing the FeSII : Avl ratio from 0 to 1 
results in a considerable increase of the residual nitrogenase activity, which indicates that 
FeSII offers protection against oxygen-inactivation. At the highest FeSII : Avl ratio over 
80% of the nitrogenase was still active after 10 min of exposure to oxygen, whereas, at 
that time, the activity of the sample that did not contain FeSII (ratio = 0) was reduced to 
less than 10% of the initial activity. 
Fig. 2B shows the protection, caused by FeSII (defined in the legend), as a func-
tion of the molar FeSII : Avl ratio (for simplicity, only the data-points for exposure 
times of 3 and 6 min are shown). This figure indicates that the protection increases 
linearly with the FeSII : Avl ratio until this ratio is about 0.5 FeSII molecule per Avl 
molecule. At higher FeSII : Avl ratios the protection increases only slightly. Since pre-
vious studies have shown that FeSII is a homo-dimer both in vitro and in vivo [26], the 
conclusion that can be drawn from these results is that one FeSII dimer suffices for the 
almost optimal protection of two Avl and four Av2 molecules. 
The stoichiometry of the three-component protein complex as isolated from A. 
vinelandii [20], or prepared in vitro from purified proteins [22] has been analyzed before 
and revealed a FeSII : Avl : Av2 molar ratio of approximately 1 : 1 : 2 , i.e. a twofold 
higher FeSII content than required for the almost optimal protection against oxygen-
inactivation. This suggests that, depending on the available amount FeSII, two forms of 
the three-component protein complex, with different stoichiometries, can exist that both 
offer protection for the nitrogenase Fe protein against oxygen-inactivation. Evidence for 
the existence of both types of three-component protein complexes is given below. 
Figure 2 
Inactivation of nitrogenase in the three-component protein mixtures. A: relative residual 
nitrogenase activity as a function of the time of exposure to 240 uM oxygen. 5 uM Avl, 10 uM 
Av2; FeSII : Avl molar ratios as indicated in the figure (ratios 0.3 and 0.75, shown in Fig. B, are 
omitted in Fig. A). All in standard buffer. The simulated curves are based on the model in Fig. 4 
and the kinetic constants from Table I. B: relative protection against inactivation of the samples 
in A as a function of the FeSII : Avl ratio after 3 (•) or 6 (o) min exposure to oxygen. 100% 
protection corresponds to the activity before exposure to oxygen. 0% protection corresponds to 
the activity of the sample without FeSII ('0') observed after either 3 or 6 min exposure to oxygen. 
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Figs. 2A and 2B show that in the three-component protein mixtures, even at the 
highest FeSII : Avl ratios, nitrogenase is slowly inactivated by oxygen. Also, previous 
investigations showed that the three-component protein complex is by no means totally 
stable [14, 21, 22]. In the presence of only Avl, Av2 is inactivated quite rapidly (appr. 
90% inactivation after 10 min exposure to oxygen). This inactivation was ascribed to the 
dissociation of Av2 from Avl. On the other hand, the Fe protein in the AlF-MgADP 
stabilized protein complex (Fig.l) is very resistant to oxygen-inactivation (appr. 5% 
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inactivation after 10 min exposure to oxygen). Since Av2 can not dissociate from this 
AlF-MgADP stabilized complex, this slow inactivation must take place while Av2 is 
bound to Avl. The rate of inactivation of the three-component protein mixtures at the 
highest FeSII : Avl ratios is intermediate between these extremes (appr. 20% inactiva-
tion after 10 min exposure to oxygen). It is possible that the rate of inactivation observed 
for the three-component protein mixtures is determined by the rate of dissociation of 
FeSII from the three-component protein complex and subsequent dissociation of Av2 
from Avl-[Av2]2, and that, similar to the AlF-MgADP stabilized complex, also in the 
three-component protein complex protection against oxygen-inactivation is based on 
stabilization of the Avl [Av2]2 complex. 
Reduction of free FeSII and the three-component protein mixtures. 
Fig. 3 shows the reduction with 8 mM Na2S204 (actual reductant 3.35 |iM S02"~) 
of protein mixtures containing FeSII, Avl and Av2 in a 1 : 1 : 2 ratio (I) and a 0.5 : 1 : 2 
ratio (II), respectively. Reduction of these mixtures by Na2S204 was followed in a 
stopped-flow spectrophotometer observing the decrease in absorbance at 430 and 550 
nm. The data of both traces I and II can be approximated by single exponential decay 
with kobs = 0.13 s"1 (not shown; the fitted curves in Fig. 3 are discussed below). Free Av2 
is reduced, under exactly the same conditions, with &0bS = 6.8 s"1 [10]. In the presence of 
excess Avl reduction of Av2 takes place with fc0bs = 1-5 s'; this observed rate is a 
combination of the rate of dissociation (2.8 (J.M1 s~') and association (3.3 |XM"' s"1) of the 
AvlaßAv2 species, reduction of free Av2 (£obs = 6.8 s') and reduction of Av2 in the 
AvlaßAv2 species (koils = 0.5 s') [10]. The inset in Fig. 3 shows the reduction of puri-
fied, free FeSII. The observed rate constant for this process is &0bs = 0.39 s"1. 
The rate constant observed for the reduction of both the three-component protein 
mixtures is significantly slower than those observed for the reduction of free FeSII, of 
free Av2 and of Av2 in the presence of Avl. This means that no significant amounts of 
free FeSII, free Av2, or Av2 in a Avl-[Av2]2 complex, are present in either of these 
mixtures. Consequently, when FeSII, Avl and Av2 are present in a 1 : 1 : 2 ratio (I) 
practically all of the proteins must be incorporated into a three-component protein com-
plex. This is consistent with the stoichiometry (1.1 : 1 : 2) that was found by Scherings et 
al. [22]. Apparently, under these conditions one FeSII binds one Avl plus two Av2 
molecules, presumably as one Avl[Av2]2 complex. Also when FeSII, Avl and Av2 are 
present in a 0.5 : 1 : 2 ratio (II) practically all of the proteins must be incorporated into a 
three-component protein complex. This is in agreement with the data shown in Fig. 2: at 
the protein ratios used here nitrogenase was almost optimally protected against oxygen-
inactivation. Apparently, at relatively low FeSII concentrations, one FeSII is capable of 
binding two Avl plus four Av2 molecules, presumably as two Avl [Av2]2 complexes. 
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Figure 3 
Reduction of free FeSII and the three-component protein mixtures. Stopped-flow traces, 
recorded at 430 nm, of the reduction, with 8 mM Na2S204, of the three-component protein 
mixtures. I: 5 uM FeSII; 5 uM Avl; 10 iiM Av2. II: 2.5 uM FeSII; 5uM Avl; 10 uM Av2. 
Inset: 5 ixM FeSII. All in standard buffer. The simulated curves for traces I and II (»marks), are 
based on the model presented in Fig. 4, the kinetic constants from Table I and the molar 
extinction coefficients from Materials and Methods. 
Computer simulation and fitting of the experimental data. 
The proposed mechanism, based on the results described above, is that one FeSII 
can bind one or two Avl[Av2]2 complexes, which suppresses the dissociation of Av2 
from Avl. If this hypothesis is true, reduction of oxidized Av2 in these complexes must 
be slow compared to the reduction of the free protein: it is known that the Fe protein 
from K. pneumoniae is not [11] and Av2 only slowly [10] reduced by dithionite when it 
is bound to the MoFe protein. A kinetic analysis of the reduction of the different mix-
tures can therefore provide evidence for complex formation as a mechanism of protec-
tion against oxygen-inactivation. 
Based on the experiments a model (Fig. 4) was set up to describe the reactions 
involved in the oxygen-inactivation, reduction and complex formation of the proteins in 
the different mixtures. The possible association of FeSIIô with AvlaßAv2jnac t (oxygen 
inactivated Av2 bound to Avl) is not considered in this model. The simulation program 
Fitsim [34, 35] was used to obtain kinetic constants. The reactions involved, with the 
values for the rate constants obtained in the present study and by Duyvis et al. [10], are 
also presented in Table I. 
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Simulation of the oxygen-inactivation data (Fig. 2A shows the simulated curves 
together with the corresponding experimental data), which will be discussed first, was 
done in consecutive steps. An initial value for the rate of inactivation of free Av2 could 
be determined directly from the data presented in Fig. 1 (trace 'Av2')- The same £obs for 
the inactivation of Av2 thus obtained and the rate constants for the reversible association 
Avlaß.Av2inact 
*_2x[Avlaß]J *2 
Av2mact 
Av2 
*2 1 *-2x[Avlaß] 
Avlaß«Av2 
k5 
Av2 r ed 
*io *-10x[Avlaß] 
*6 
Avlaß-Av2red 
FeSIlS 
*7 
Kd3 I + Avlaß-Av2 
FeSIIO.Avlaß-Av2 
KM I + Avlaß-Av2 
FeSIlSred 
*ii A-11 x[Avlaß-Av2] 
FeSH6red-Avlaß.Av2 
*12 Jt_12x[Avlaß-Av2] 
FeSH5-[Avlaß.Av2]2 kg FeSIIo r ed-[Avlaß.Av2]2 
Figure 4 
Reactions involved in the model proposed for the oxidative inactivation, complex formation 
and reduction of FeSII, Avl, Av2. The reactions are also presented, with values for the kinetic 
parameters, in table I. Reactions 1 and 5-9 are pseudo first-order reactions. Avl aß represents 
one of two independently functioning halves of the tetrameric (a2ß2) MoFe protein. Each Avl aß 
species is assumed to have one binding site for Av2 (y2) and one binding site for FeSII8. FeSII8 
represents one independently functioning half of the dimeric (82) FeSII protein. Each FeSIIS 
species is assumed to have two different binding sites for Avlaß Av2. 
66 Chapter 3 
of Av2 with Avlaß [10] have been used to describe the inactivation of Av2 in the pres-
ence of Avl (Fig. 2A, trace '0'). The experimental data could be simulated best when 
both the oxidized and inactivated forms of Av2 were allowed to associate with Avlaß, 
thus forming AvlaßAv2 and Avlaß-Av2i„act species, respectively, and the rate con-
stants for both interactions were identical. The value for the rate of inactivation of free 
Av2 by oxygen that resulted from these simulations was k\ = 1.8 x 10"2 s'. As is obvious 
from Fig. 2A the inactivation of Av2 in the presence of Avl can be simulated quite accu-
rately with this simple and logical model. 
Finally, using the values mentioned for the different rate constants, the oxygen-
inactivation of the mixtures containing Avl, Av2 and various concentrations FeSII were 
analyzed. The experimental data obtained for all the FeSII : Avl ratios used in the 
oxygen-inactivation assays were fitted simultaneously (only fits and experimental data for 
the FeSII : Avl ratios 0, 0.2, 0.4, 0.5 and 1 are shown in Fig. 2A; ratios 0.3 and 0.75 
were also investigated and consistent with the presented data). The simulations were 
relatively insensitive to the actual fc-values for the rate of association and dissociation of 
the FeSIIoAvlocßAv2 and FeSIlS[AvlaßAv2]2 species, but did depend on the KA 
values. The best fit of the dissociation constant of the FeSIIoAvlaßAv2 species was 
found to be KAi = 95 ± 44 nM. Only a minimum value could be determined for the 
dissociation constant of the FeSIlS[AvlaßAv2]2 species, since in the simulations the 
rate constant for association of the complex (&_4) inclined towards zero. Setting a limit of 
k.4 - 10"3 s', resulted in KM > 2 |iM. Although these are only rough approximations of 
the dissociation constants of these complexes, the results do suggest that the species 
FeSIlS[AvlaßAv2]2 is not very stable, i.e. the second AvlaßAv2 is not bound very 
firmly to FeSIlS. When AvlaßAv2inact was allowed to participate in the formation of the 
three-component complexes, the second Avlotß-Av2 or Avlaß-Av2jnact was bound more 
firmly than the first one, but the fitting of the experimental data was worse. Also a model 
that did not take the formation of a FeSH5[Avlaß-Av2]2 species into account resulted 
in simulations that deviated much from the experimental data: both parameters that are 
indicative for the quality of the fit (the R-squared value and the mean-squared error [35]) 
become worse. Therefore, the FeSIl8[Avlocß-Av2]2 species, whether unstable or not, 
plays an important role in the mechanism by which FeSII protects nitrogenase against 
oxygen-inactivation. This importance is even more significant in vivo since nitrogenase 
concentrations in A. vinelandii cells are over 50 |iM [33], i.e. more than ten times higher 
than in the in vitro experiments discussed here. Fig. 2 shows that, allowing both the 
formation of the FeSIIoAvlaßAv2 and the FeSIl8[AvlaßAv2]2 species, and using 
the obtained kinetic parameters, also the experimental data for the inactivation of the 
three-component protein mixtures can be simulated quite accurately. 
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Rate 
constants 
Ar, = 1.8 102 s"1 
* a = 2.8 s'1 
k .2i = 3.3 uM"1 s'1 
k
 2 = 2.8 s-1 
t .2 = 3.3 uM"1 s'1 
ATd3 = 95 nM 
tfd4 > 2 uM 
k 5 = 6.8 s"1 
*:
 6 = 0.5 s ' 
k
 7 = 0.39 s"1 
k
 8 = 9.8 10"2 s"1 
* 9 = 14.8 10'2 s'1 
*
 10 = 25 s'1 
fc .10 = 26 itM-1 s'1 
Source 
Present 
work 
Present 
work 
Duyvis 
[10] 
Present 
work 
Present 
work 
Duyvis 
[10] 
Duyvis 
[10] 
Present 
work 
Present 
work 
Present 
work 
Duyvis 
[10] 
Rate constants could not be 
determined from experimental 
data. 
Rate constants could not be 
determined from experimental 
data. 
Table I 
Reactions involved in the oxidative inactivation, reduction and complex formation of 
nitrogenase from A. vinelandii. These reactions are also shown in a scheme in Fig. 4. The rate 
constants related to oxygen-inactivation (reaction 1) and reduction (reactions 5 to 9) are pseudo 
first-order rate constants measured with 240 |XM oxygen and 8 mM Na2S204 (actual reductant 
3.3 |J.M S02') respectively. Shorthand notations are explained in the legend of Fig. 4 and in the 
Materials and Methods section. 
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Further kinetic parameters were obtained by simulating the reduction of the 
three-component protein mixtures, using the kinetic parameters determined so far. The 
relevant reactions are shown in Fig. 4. The rate of reduction of free FeSII was deter-
mined experimentally: this process could be analyzed directly, i.e. without data simula-
tion, by fitting a single exponential decay curve with fcobs = 0.38 s"1 to the experimental 
trace (Fig. 3, inset). This curve fitted the experimental data closely, both at 430 nm and 
at 550 nm. The rates of reduction of free Av2 and of Av2 in the presence of Avl are 
known from literature; a detailed kinetic analysis of the rate of reduction of the 
Avlaß-Av2 species, of the dissociation of this species, both in the reduced and oxidized 
form, and of the reduction of free Av2 will be published elsewhere [10]. 
Using all the kinetic parameters and extinction coefficients thus obtained, curves 
based on the kinetic model shown in Fig. 4 were fitted, simultaneously, to the experi-
mental data obtained for the reduction of the three-component protein mixtures at both 
430 and 550 nm. This yielded the pseudo first-order rate constants for the reduction of 
FeSIIô in the FeSIIo-AvlaßAv2 species (Jt8 = 9.8 (± 0.1) 10"2 s') and for the reduction 
of FeSIIÔ in the FeSIIO[AvlocßAv2]2 species (fc, = 14.8 (± 0.03) 10"2 s"1). The standard 
errors for the rate constants for the dissociation and association of the reduced 
FeSIIoredAvlaßAv2 species and for the reduced FeSIIôred[Avlo$Av2]2 species were 
relatively large, indicating that the simulation is not very dependent on these parameters. 
This is a consequence of the fact that the rate of dissociation of these reduced species is 
relatively fast compared to the rate of reduction of FeSIlS in the FeSIIÔ- AvlaßAv2 and 
FeSIIÔ-[Avl aß-Av2]2 species. The kinetic parameters for dissociation and association of 
these reduced species were therefore left out of further consideration. Experimental data 
for the reduction of the three-component protein mixtures, at 430 nm, are compared with 
the simulations in fig. 3. As is obvious from this figure the experimental data can be 
explained adequately with the presented model. 
Discussion 
The [4Fe-4S] cluster in the Fe protein is located at the surface of the dimeric 
protein, exposed to the solvent [1]. Although the three dimensional structure of the Fe 
protein-MoFe protein complex has not yet been solved, results obtained by the study of 
altered proteins prepared by site-directed mutagenesis have indicated that amino acid 
residues surrounding the [4Fe-4S] cluster in the Fe protein interact with the MoFe 
protein when these proteins are associated [36-38]. A docking model based on the 
crystal structures of the Fe and MoFe proteins and these amino-acid substitution studies 
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[39-41], suggests that when the Fe protein is bound to the MoFe protein its [4Fe-4S] 
cluster is no longer exposed to the solvent, but is buried in the Fe protein-MoFe protein 
interface. The crystal structure of the AlF-MgADP stabilized nitrogenase complex shows 
that also in this complex the [4Fe-4S] clusters are buried in the Fe protein-MoFe protein 
interface [25]. We propose that this buried position prevents the disintegration of the 
cluster upon oxidation. 
Some interesting similarities exist between the AlF-MgADP stabilized two-
component protein complex and the FeSII stabilized three-component protein complex. 
Formation of the three-component protein complex requires that the Fe and FeSII 
proteins involved are oxidized; the [4Fe-4S] cluster of the Fe protein in this complex is in 
the oxidized state [22, 42]. Duyvis et al. [8] demonstrated that in the AlF-MgADP stabi-
lized complex the [4Fe-4S] cluster of the Fe protein is also in the oxidized state, even 
though this complex was prepared in the presence of the reducing agent dithionite. In 
addition, both these complexes are relatively resistant to oxygen-inactivation. These 
similarities suggest that protection against oxygen-inactivation by these protein 
complexes is based on the same principle: stabilization of the Fe protein-MoFe protein 
complex. 
Since no structure is available for the three-component protein complex one can 
only speculate on its configuration and spatial organization. The FeSII protein may link 
Fe protein-MoFe protein complexes to form polymers, in which case the observed 
stoichiometry of one FeSII protein per Fe protein-MoFe protein complex would allow 
interaction of the FeSII protein with either the Fe protein or the MoFe protein. It is very 
unlikely, however, that the FeSII protein interacts directly with the Fe protein in a 
complex in which the FeSII protein binds only one or two Fe protein-MoFe protein 
complexes. First, the minimal stoichiometry of the three-component protein complex 
determined in this study (one dimeric FeSII protein per two Fe protein-MoFe protein 
complexes, i.e. per four Fe proteins) makes direct interaction of the FeSII protein with 
the Fe protein improbable. Furthermore, earlier studies have indicated that the FeSII 
protein has only a small effect on the stability of the Fe protein in the absence of the 
MoFe protein; also no fixed Fe protein : FeSII protein stoichiometry was found in the 
absence of the MoFe protein [13]. We therefore propose that the FeSII protein interacts 
with the MoFe protein in the Fe protein-MoFe protein complex, resulting in stabilization 
of the Fe protein-MoFe protein complex. 
The kinetics of the reduction of the three-component protein mixtures indicate 
that the FeSII and Fe proteins, at both stoichiometrics investigated, are incorporated in a 
three-component protein complex, which points at the existence of two different forms 
of three-component protein complexes. Size-exclusion chromatography and analytical 
ultracentrifugation of the in vitro prepared three-component protein complex already 
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demonstrated that this complex exists in more than one form [22]. In the model presen-
ted here one form has a stoichiometry of one dimeric FeSII protein per Fe protein-MoFe 
protein complex, which is in agreement with the stoichiometry of the complex as isolated 
from A. vinelandii [20], the other form has a stoichiometry of one dimeric FeSII protein 
per two Fe protein-MoFe protein complexes, which is in agreement with the minimal 
stoichiometry that is required to obtain almost optimal protection against oxygen-inacti-
vation. The simulations of the oxygen-inactivation assays showed that complex 
formation of the FeSII protein with two Fe-protein-MoFe protein complexes plays an 
important role in the protection against oxygen-inactivation. 
Fig. 5 shows a schematic drawing of one of the possible spatial organizations of 
the three-component protein complexes, taking into account the considerations about the 
interaction of the FeSII protein with the MoFe protein and the model that was used to 
simulate the experimental data. 
Figure 5 
Schematic representation of one of the possible spatial organizations of the three-component 
protein complexes. FeSII binds Avl perpendicular to both the Avl[Av2]2 complexes, i.e. these 
complexes must be considered to be rotated, facing FeSII. Black dots indicate the [4Fe-4S] 
cluster in the Fe protein. Kinetic species, used for data simulation, are the top or bottom halves of 
the physical complexes depicted here. Arrows indicate sites on the independent AvlaßAv2 
species where the independent FeSIIÔ species can bind. Such binding sites may be located on one 
a or ß subunit or on both the subunits. 
Protection of the nitrogenase Fe protein 71 
Acknowledgments 
We thank F. Moshiri and R. Maier from the John Hopkins University in Baltimore, USA, 
for providing us with the plasmid pAVFeSII, harboring the structural gene for the FeSII 
protein, and professor C. Veeger for his continuous support and interest. This investiga-
tion was supported by the Netherlands Foundation for Chemical Research (SON) with 
financial aid from the Netherlands Organization for Scientific Research (NWO). 
References 
1 Georgiades, M.M., Komiya, H., Chakrabarti, P., Woo, D., Kornuc, J.J. and Rees, D.C. 
(1992) Science 257, 1653 - 1859 
2 Kim, J. and Rees, D.C. (1992) Nature 360, 553 - 560 
3 Shah, V.K. and Brill, W.J. (1977) Proc. Natl. Acad. Sei. USA 74, 3249 - 3253 
4 Hawkes, T.R., McLean, P.A. and Smith, B.E. (1984) Biochem. J. 217, 317 - 321 
5 Bolin, J.T., Ronco, A., Morgan, T.V., Morteson, L.E. and Xuong, N.H. (1993) Proc. 
Natl. Acad. Sei. USA 90, 1078 - 1082 
6 Peters, J.W., Stowell, M.H.B., Soltis, M., Finnegan, M.G., Johnson, M.K. and Rees, 
D.C. (1997) Biochemistry 36, 1181 - 1187 
7 Lowe, D.J. and Thorneley, R.N.F. (1984) Biochem. J. 224, 877 - 886 
8 Duyvis, M.G., Wassink, H. and Haaker, H. (1994) Eur. J. Biochem 225, 881 - 890. 
9 Duyvis, M.G., Wassink, H. and Haaker, H. (1996) J. Biol. Chem. 47, 29632 - 29636. 
10 Duyvis, M.G., Wassink, H. and Haaker, H. (1997) Biochemistry, submitted 
11 Lowe, D.J., Ashby, G.A., Brune, M., Knights, H., Webb, M.R. and Thorneley, R.N.F. 
(1995) in: Nitrogen fixation: fundamentals and applications (Tikhonovich I.A., 
Romanov V.F. and Provorov N.A., Eds.) pp. 103 - 108, Kluwer Academic Publications, 
Dordrecht. 
12 Thorneley, R.N.F. and Lowe, D.J. (1983) Biochem. J. 215, 393 - 403 
13 Veeger, C , Laane, G., Scherings, G., Matz, L, Haaker, H. and Van Zeeland-Wolbers, L. 
(1980) in: Nitrogen Fixation (Newton W.E. and Orme-Johnson W.H. Eds.) vol. I, pp. 
111 - 137, University Park Press, Baltimore. 
14 Wang, Z.C., Burns, A. and Watt, G.D. (1985) Biochemistry 24, 214 - 221. 
15 Robson, R.L. (1979) Biochem. J. 181, 569 - 575. 
16 Yates, M.G. (1988) in: The Nitrogen and Sulphur Cycles (Cole J.A. and Ferguson S.J.. 
Eds.) pp. 383 - 416, Cambridge University Press, Cambridge. 
17 Gallon, J.R. (1992) New Phytol. 122, 571 - 609. 
18 Kelly, M.J.S., Poole, R.K., Yates, M.G. and Kennedy, G. (1990) J. Bacteriol. 172, 
6010-6019. 
19 Shethna, Y.I, DerVartanian, D.V. and Beinert, H. (1968) Biochem. Biophys. Res. 
Comm. 31, 862 -867. 
20 Scherings, G., Haaker, H. and Veeger, C. (1977) Eur. J. Biochem. 77, 621 - 630. 
21 Moshiri, F, Kim, J.W., Fu, C. and Maier, R.J. (1994) Mol. Microbiol. 14, 101 - 114. 
72 Chapter 3 
22 Scherings, G., Haaker, H., Wassink, H. and Veeger, C. (1983) Eur. J. Biochem. 135, 
591 - 599. 
23 Renner, K.A. and Howard, J.B. (1996) Biochemistry 35, 5353 - 5358. 
24 Duyvis, M.G., Wassink, H. and Haaker, H. (1996) FEBS Lett. 380, 233 - 236. 
25 Schindelin, H., Kisker, C , Schlessman, J.L., Howard, J.B. and Rees, D.C. (1997) 
Nature 387, 370 - 376 
26 Moshiri, F., Course, B. R., Johnson, M.K. and Maier, R.J. (1995) Biochemistry 34, 
12973 - 12982. 
27 DerVartanian, D.V., Shethna, Y.I. and Beinert, H. (1969) Biochim. Biophys. Acta 194, 
548 - 563. 
28 Goa, J. (1953) Scand. J. Clin. Lab. Invest. 5, 218 - 222. 
29 Bensadoun, A., and Weinstein, D. (1976) Anal. Biochem. 70, 241 - 250. 
30 Braaksma, A., Haaker, H., Grande, H.J. and Veeger, C. (1982) Eur. J. Biochem. 121, 
483-491. 
31 Martin, R.B. (1988) Biochem. Biophys. Res. Com. 155, 1194 - 1280 
32 Ashby, G.A. and Thorneley, R.N.F. (1987) Biochem. J. 246, 455 - 465 
33 Klugkist, J., Haaker, H., Wassink, H. and Veeger, C. (1985) Eur. J. Biochem. 146, 509 
-515 
34 Barshop, B.A., Wrenn, R.F. and Frieden, C. (1983) Anal. Biochem. 130, 134 - 145. 
35 Zimmerte, CT. and Frieden, C. (1989) Biochem. J. 258, 381 - 387 
36 Lowery, R.G., Chang, CL., Davis, L.C., McKenna, M.C, Stephens, P.J. and Ludden, 
P.W. (1989) Biochemistry 28, 1206 - 1212. 
37 Seefeldt, L.C (1994) Protein Sei. 3, 2073 - 2081. 
38 Wolle, D., Kim, C.H., Dean, D.R. and Howard, J.B. (1992) J. Biol. Chem. 267, 3667 -
3673. 
39 Howard, J.B. and Rees, D.C. (1994) Annu. Rev. Biochem. 63, 235 - 264. 
40 Howard, J.B. (1993) in: Molybdenum enzymes (Stiefel E.L., Coucouvanis D. and 
Newton W.E., Eds.) pp. 271 - 289, Chapman and Hall, New York. 
41 Peters, J.W., Fisher, K. and Dean, D.R. (1995) Annu. Rev. Microbiol. 49, 335 - 366. 
42 Simpson, F. and Burns, R.H. (1984) in: Advances in nitrogen fixation research 
(Veeger C. and Newton W.E., eds.) p. 243, Nijhoff and Junk Publishers, The Hague, The 
Netherlands. 
Protection of the nitrogenase Fe protein 73 
Chapter 4 
Redox properties and electron paramagnetic resonance 
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Abstract 
Substrate reduction catalyzed by nitrogenase requires the association of the iron 
(Fe) protein and the molybdenum-iron (MoFe) protein, MgATP-dependent electron 
transfer from the Fe protein to the MoFe protein, and on-enzyme MgATP hydrolysis, 
followed by protein-protein complex dissociation. Aluminum fluoride (A1F) plus MgATP 
or MgADP inhibit nitrogenase by stabilizing the protein-protein complex of an inter-
mediate of the on-enzyme MgATP hydrolysis reaction. We report here the redox 
properties and electron paramagnetic resonance (EPR) signals of the AlF-MgADP stabi-
lized transition state complex of Azotobacter vinelandii nitrogenase. The midpoint 
potential of the iron-molybdenum-sulfur-homocitrate cluster in the MoFe protein remains 
unchanged, but that of the [4Fe-4S] cluster in the Fe protein, and of the unique [8Fe-7S] 
cluster in the MoFe protein are both lowered. Furthermore a change in spin-state of the 
EPR signal of the two electrons oxidized [8Fe-7S] cluster was observed. The present 
results reveal a possible mechanism of MgATP hydrolysis driven electron transport 
within the nitrogenase protein complex: conformational changes of the protein complex 
during the on-enzyme MgATP hydrolysis lower the potential of [4Fe-4S] cluster of Fe 
protein and that of the [8Fe-7S] cluster of MoFe protein. This process turns both clusters 
into effective reductants for substrate reduction at the iron-molybdenum-sulfur-
homocitrate cluster, the putative substrate-binding site of nitrogenase. 
Introduction 
Nitrogenase catalyzes the biological reduction of N2 to NH3. The enzyme 
complex consists of two dissociable metalloproteins: the molybdenum-iron (MoFe) 
protein, an 0^2 tetramer which contains two unique [8Fe-7S] clusters (P-cluster) plus 
two iron-molybdenum-sulfur-homocitrate clusters (FeMoco) [1], and the Fe protein, a Y2 
dimer that contains a single [4Fe-4S] cluster [9]. Substrate-binding, activation and reduc-
tion take place on the MoFe protein, presumably on FeMoco. The Fe protein provides 
the MoFe protein with the required electrons and couples ATP-hydrolysis to the 
substrate reduction (see [2] for a review). A kinetic mechanism for nitrogenase catalysis 
has been described by Lowe and Thorneley [3] and was recently modified [4-6]. The Fe 
protein associates with the MoFe protein; each aß-half of the MoFe protein has an 
independent binding site for one Fe protein. Binding of MgATP to the Fe protein induces 
a conformational change in the Fe protein-MoFe protein complex that is necessary for 
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electron transfer from the Fe protein to the MoFe protein; this reaction is followed by 
hydrolysis of MgATP after which the oxidized Fe protein, with MgADP bound, 
dissociates from MoFe protein [4]. With dithionite as the reductant, this dissociation is 
the rate-limiting step [7, 8]. Next, the oxidized Fe protein is reduced and two MgADP 
molecules are replaced by two MgATP molecules preparing the Fe protein for a second 
round of docking to the MoFe protein and subsequent electron transfer. This cycle is 
repeated until sufficient electrons have accumulated to reduce N2 bound to FeMoco. 
The association of the MoFe protein with the Fe protein and the interaction with 
MgATP has a central role in this process. A clue to how the hydrolysis of MgATP 
facilitates electron transfer within nitrogenase came from the crystal structure of the Fe 
protein. A close structural similarity was observed between the nucleotide-binding sites 
of the Fe protein from A. vinelandii and the molecular switch protooncogenic ras protein 
p21 [9]. This similarity suggested that MgATP-binding and hydrolysis might switch 
nitrogenase between different conformations. Evidence for this hypothesis was presented 
by Lanzilotta et al. [10]. By using the altered Fe protein, L127A, that resembles the Fe 
protein in the MgATP-bound conformation without MgATP bound, Lanzilotta et al. 
showed that only the ATP-bound conformation is necessary for electron transfer from 
the Fe- to the MoFe protein and that the two proteins form a tight complex in this 
conformation. By using an other altered Fe protein (D39N), it was shown that after 
electron transfer and MgATP hydrolysis, the protein-protein complex could not change 
to its MgADP-bound conformation, which completely prevented dissociation of the 
protein-protein complex [11]. Additional evidence for the MgATP hydrolysis driven 
conformational changes of the protein-protein complex came from inhibition of nitro-
genase by aluminum fluoride. It was shown that aluminum fluoride in the presence of 
MgATP or MgADP inhibits nitrogenase by stabilization of the protein-protein complex 
[12, 13]. From solution X-ray scattering, a low resolution structure of the Klebsiella 
pneumoniae AlF-inhibited nitrogenase was obtained [14]. The agreement between the 
docking model constructed from the crystal structures of the separate proteins [2] and 
the solution X-ray scattering structure is good except for flexible, solvent exposed loop 
sections of the MoFe protein and parts of the Fe protein. The data suggest that the 
conformation of the AlF-MgADP stabilized nitrogenase is more compact than that of the 
separate proteins. Nitrogenase and protooncogenic ras proteins have similar aluminum 
fluoride-binding characteristics. The Fe protein and Ras alone do not bind or become 
(in)activated by aluminum fluoride alone; only in the presence of the nucleotide 
diphosphate and their physiological partner (the MoFe protein or the guanosine 
triphosphatase activating protein, respectively) a stable complex was formed [12, 13, 
15]. Crystal structures of GDP or ADP and aluminum fluoride-binding proteins revealed 
that aluminum fluoride binds with a geometry resembling that of the putative transition 
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State of the G(A)TPase mechanism: an octahedrally coordinated Al ion with four F 
ligands, one O from the ß phosphate of G(A)DP and one from a water molecule [16-18]. 
It is therefore very likely that the AlF-MgADP inhibited nitrogenase represent the transi-
tion state for the SN2 on-enzyme ATPase reaction of nitrogenase. The redox properties 
and the EPR signals of both the purified Fe- and the MoFe proteins have been investi-
gated extensively. In the present paper we report on the redox properties and EPR 
signals of the putative transition state analogue of the on-enzyme ATPase reaction of 
nitrogenase. The mechanistic significance of the data is discussed. 
Materials and methods 
Preparation of the aluminum fluoride-MgADP inhibited nitrogenase. 
Azotobacter vinelandii ATCC strain 478 was grown and the nitrogenase MoFe-
and Fe proteins were isolated and characterized as described elsewhere [4]. The molar 
concentrations of the MoFe- and Fe protein were calculated from their molecular masses 
of 230 kDa and 63 kDa, respectively. Aluminum fluoride MgADP inhibited nitrogenase 
(transition state complex) was prepared as described by Duyvis et al. [12]. The specific 
activity of this complex, as detected by the acetylene reduction assay, was less than 0.06 
mol ethylene s ' (mol MoFe)"1, (less than 1% of the maximal MoFe protein activity). 
Aluminum and fluoride form compounds of the general composition AlFx(OH")y. In the 
pH range 5 - 8 and with millimolar fluoride concentrations at least five different mixed 
OH" and F complexes of Al3+ are present [19]. Consequently we use 'aluminum fluoride' 
or 'A1F' as the general abbreviation for all forms of aluminum, fluoride and OH" coor-
dination. 
Redox titration and EPR spectroscopy of the transition state complex. 
Dye mediated redox titrations of the transition state complex of nitrogenase were 
done in an anaerobic cell under purified argon. The protein / mediator mixture was in 50 
mM Tris/HCl, pH 8.0. The final complex concentration was 56 uM with respect to the 
MoFe protein. Methyl- and benzyl-viologen, 2,2'-Bipyridinium-N,N'-di-propylsulfonate, 
neutral red, safranin-O, phenosafranin, anthraquinone-2-sulfonate, phenazine ethosulfate, 
2,6 dichlorophenol-indophenol, resorufin, tetramethyl-p-phenylenediamine, 2-hydroxy 
1,4-napthoquinone, indigo disulfonate and methylene blue mediators were used at a final 
concentration of 40 uM. The redox potential was adjusted with freshly prepared 
Na2S204, and potassium ferricyanide solutions in 0.5 M Tris/HCl, pH 8.0. Potentials 
reported in this paper are relative to the normal hydrogen electrode (NHE) and were 
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obtained by using a potential of + 246 mV (vs. NHE) for the saturated calomel electrode 
at 22 °C [20]. EPR spectra were taken on a Bruker ER 200D spectrometer with 
peripheral equipment, as described in [21]. Parallel mode spectra were taken with the 
ER4116 dual-mode resonator. Spectra were simulated as multicomponent effective 
S=l/2 powder patterns broadened by g-strain collinear with the Zeeman interaction [22]. 
Stopped-flow analysis of the formation of the transition state complex. 
The kinetics of the formation of the AlF-MgADP stabilized transition state 
complex was analyzed by rapid mixing of the nitrogenase proteins with MgATP and 
aluminum fluoride in a Hi-Tech SF-51 stopped-flow spectrophotometer (Salisbury, 
Wilts, UK) equipped with an anaerobic kit and a data acquisition and analysis system. 
One syringe of the stopped-flow spectrophotometer contained 20 \iM MoFe protein, 120 
UM Fe protein and 10 mM Na2S204 in 50 mM TES/NaOH, pH 7.4 and 5 mM MgCl2. 
The other syringe contained 10 mM MgATP, 0.8 mM A1F3-H20, 8.0 mM KF and 10 mM 
Na2S204 in the same buffer. The mixing ratio was 1:1. Absorbance changes, for detection 
of oxidation and reduction of the Fe protein, were recorded at 430 nm. 
Results and discussion 
Stopped-flow analysis of the formation of the transition state complex. 
Fig. 1 shows the changes in absorbance (AA430) of the dithionite-reduced Fe 
protein upon addition of aluminum fluoride and / or MgATP. The observations can be 
explained with the current model for the interaction of the nitrogenase proteins, descri-
bed in the Introduction. In the presence of dithionite the Fe protein is reduced and under 
the experimental conditions both binding sites on the MoFe protein will be occupied by 
Fe protein with MgATP bound within the the mixing time of the stopped-flow apparatus 
[3]. Within 0.1 s after mixing with MgATP the bound Fe protein is oxidized (Fig 1, 
inset): binding of MgATP induces a structural change in the protein-protein complex that 
allows the transfer of one electron from the Fe protein to the MoFe protein. Oxidation of 
the Fe protein is followed by on-enzyme ATP hydrolysis and dissociation of the oxidized 
Fe protein from the MoFe protein. With dithionite as the reductant, this dissociation is 
the rate limiting step in the catalytic cycle (2.8 s ' at 20 °C); after dissociation, the Fe 
protein is reduced at 6.8 s~' [34]. Since the Fe protein is present in excess, the docking 
sites on the MoFe protein are rapidly reoccupied by reduced Fe protein. These kinetics 
result in the oxidation of 30% of Fe protein, mainly bound to the MoFe protein (the inset 
of Fig. 1 shows a ÀA430 of about 0.1, which corresponds to oxidation of approximately 
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20 uM Fe protein, whereas 60 \iM was present in the sample). After a few seconds, the 
MgADP concentration increases and, consequently, increasing amounts of reduced Fe 
protein with MgADP bound will occupy the Fe protein-binding sites on the MoFe 
protein. This is observed as a decrease of the absorbance at 430 nm: the Fe protein is not 
oxidized since MgADP inhibits electron transfer to the MoFe protein. Because dithionite 
is present in excess, MgADP inhibition results in a steady increase of the amount of 
reduced Fe protein. When no aluminum fluoride is added (trace 'ATP') the ADP inhibi-
tion and reduction of the Fe protein are completed within 50 s. 
When aluminum fluoride is present, however, the system does not reach this 
redox state (trace 'ATP + A1F'). Initially there is no significant difference between the 
two samples (Fig. 1, inset): the maximal amount of Fe protein is oxidized upon the 
addition of ATP, resulting in a rapid increase of the absorbance, and the subsequent re-
reduction of the protein results in a decrease. In time, however, the absorbance increases 
again, suggesting oxidation of Fe-S clusters. After 250 s this oxidation reaches its 
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Figure 1 
Stopped-flow spectroscopy of the formation of the AlF-MgADP stabilized transition state 
complex. Changes in absorbance were measured at 430 nm. At this wavelength, the absorbance 
is largely determined by the oxidation state of the [4Fe-4S] clusters of the Fe protein; contri-
butions of the clusters of the MoFe protein are negligible. 'ATP': dithionite reduced MoFe 
protein and Fe protein were mixed with MgATP. 'ATP + A1F': dithionite reduced MoFe protein 
and Fe protein were mixed with MgATP and A1F. Inset: the 'ATP' and 'ATP + A1F' traces, as 
defined above, during the first 0.4 s. Final concentrations: MoFe protein 10 uM; Fe protein 60 
uM; Na2S204 10 mM; A1F3 0.4 mM; KF 4 mM; MgATP 5 mM. 
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maximal value. Complex formation with A1F and MgADP was confirmed by parallel 
experiments: samples of the incubations were taken and after dilution the activity of the 
MoFe protein was tested. It was found that after an incubation time of 250 s all MoFe 
protein activity was inhibited by complex formation (data not shown). The redox changes 
occurring during the formation of the AlF-MgADP stabilized transition state complex 
were confirmed by redox titration and EPR spectroscopy. 
Redox titration and EPR spectroscopy: the [4Fe-4S] cluster. 
The [4Fe-4S] cluster of the Fe protein is a one-electron donor that operates 
between the +1 and +2 oxidation levels. There has been one report that the hydroquinone 
form of methylviologen can reduce the [4Fe-4S] cluster to its all ferrous state [23]. The 
cluster is diamagnetic in the oxidized state. Reduced by dithionite, in a one-electron 
process with Em = -473 mV for the Fe protein with MgADP bound, or Em = -435 mV for 
the Fe protein with MgATP bound [24], the cluster exhibits EPR spectra from non-
interacting mixtures of S=3/2 and S=l/2 spin states [25]. However, no significant S=3/2 
or S=l/2 EPR signals with g-values characteristic for the Fe protein could be detected in 
the samples containing the AlF-MgADP stabilized transition state complex at redox 
potentials between -500 and +100 mV. The very weak signal that is observed is probably 
caused by a small amount of free Fe protein. This suggests that the Fe protein in the AlF-
MgADP stabilized transition state complex is diamagnetic, and therefore oxidized, within 
this potential range. We do not think that the absence of an EPR signal of the Fe protein 
is caused by the formation of the all ferrous state of the [4Fe-4S] cluster. If this is the 
case, the cluster must stay in its all ferrous state from -500 to +100 mV, which is very 
unlikely. In addition to this, we found that, under the conditions used, the free Fe protein 
could not be reduced to its all ferrous state: the intensity of the S=3/2 and S=l/2 signals 
did not change when the protein was incubated with 10 mM dithionite at pH values 
between 7.5 and 10 (under these conditions the Eh changes from approximately -550 to 
-700 mV, respectively). The conclusion must be that the specific conformation of the 
transition state complex lowers the midpoint potential of the Fe protein to a value 
significantly less than -500 mV, thus inducing the transfer of one electron to the MoFe 
protein and disabling the re-reduction of the Fe protein by dithionite. 
Redox titration and EPR spectroscopy: FeMoco. 
Previous studies have shown that the purified, dithionite-reduced MoFe protein 
exhibits only an S=3/2 EPR signal that is assigned to the iron-molybdenum-sulfur-
homocitrate cofactor (FeMoco) [26]. Under turnover conditions, i.e. in the presence of 
reduced Fe protein and MgATP, the S=3/2 FeMoco signal disappears, presumably 
because of so-called super-reduction of the cofactor: the Fe protein transfers at least one 
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electron to the dithionite-reduced FeMoco [27, 28]. The dithionite-reduced FeMoco can 
also be oxidized to a diamagnetic redox state [29]. For this one-electron process, 
midpoint potentials of-100 mV [30] and -42 mV [31] have been reported. Fig. 2. shows 
that the EPR spectrum observed for the AlF-MgADP stabilized transition state complex 
is in good agreement with this. At low redox potentials an S=3/2 signal is observed with 
g - 3.7 that changes into S=0 (diamagnetic) with a midpoint potential of about -100 mV. 
Super-reduction of FeMoco was not observed within the given potential range (-500 to 
+100 mV ). In conclusion, redox properties and EPR spectra of the FeMoco in the AlF-
MgADP stabilized transition state complex are not different from those observed for the 
purified MoFe protein. 
Redox titration and EPR spectroscopy: the P-cluster. 
Different from FeMoco, the P-cluster is diamagnetic in the presence of dithionite [26, 
31]. This situation has been proposed by Miinck et al. [26] to correspond to the all-
ferrous, uncharged cluster, which is therefore designated P°. Upon oxidation of P°, in a 
two-electron process with Em = -307 mV, an S=3 signal appears in the EPR spectrum 
[31]. However, the existence of a one-electron oxidized P-cluster, P1+, has also been 
125 
P-cluster (S = 5/2) 
FeMoco (S = 3/2) 
-200 -100 0 100 
E vs NHE (mV) 
Figure 2 
Redox titration of the AlF-MgADP stabilized transition state complex. 
The solid lines are least-squares fits to the n = 1 Nernst equation with Em = -90 mV for the iron-
molybdenum cofactor (S=3/2) and Era = -430 mV for the P-cluster (S=5/2) of the MoFe protein. 
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proposed and is associated with a physical, i.e. non-interacting, mixture of S=5/2 and 
S=l/2 signals [32]. The midpoint-potential for abstraction of the first electron, P° —» P1+, 
is believed to be close to that for abstraction of the second electron, P1+ —» P2+. The P2+ 
clusters can be oxidized further to form P3+ clusters in a one-electron process with a 
midpoint potential of +90 mV, resulting in S=7/2 and S=l/2 signals [31]. As for the 
purified protein, the S=5/2 signal is difficult to detect in the AlF-MgADP stabilized tran-
sition state complex because the coefficient D of the zero-field interaction is negative: 
the S=5/2 multiplet is inverted and the EPR detected l±l/2> doublet is an excited state. 
At low temperatures the signals are too weak for detection by depopulation of the l±l/2> 
doublet, at higher temperatures the signals are broadened by spin-lattice relaxation. 
Fig. 3 shows the S=5/2 P-cluster signal and S=3/2 FeMoco signal at 23 K. At 
low temperature (4.2 K) the S=5/2 signal disappears and the two samples (A and B) give 
identical FeMoco S=3/2 spectra (not shown). 
190 240 
B (mT) 
Figure 3 
Low-field EPR spectra of the AlF-MgADP stabilized transition state complex poised at 
different redox potentials. The samples were 56 uM with respect to the MoFe protein in 50 mM 
Tris/HCl, pH 8.0. Trace A: complex poised at -287 mV (FeMoco S=3/2 signal). Trace B: 
complex poised at -462 mV (FeMoco S=3/2 and P-cluster S=5/2 signals). Trace C: simulation of 
trace B (see Table I). EPR conditions: microwave frequency, 9.41 GHz; microwave power, 200 
mW; modulation frequency, 100 kHz; modulation amplitude, 0.8 mT; temperature 23 K. 
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Fig. 4 shows the dependence of the S=5/2 signal intensity on temperature, both 
experimental and theoretical. The dependence of the S=5/2 signal on the redox potential 
is shown in Fig. 2. Not only the negative zero-field interaction, but also the fact that the 
midpoint-potential for the transition of P° to P1+ is close to that for Pl+ to P2+, makes the 
S=5/2 signal difficult to detect in the free MoFe protein. In the AlF-MgADP stabilized 
transition state complex, however, these potentials are further apart and the S=5/2 signal 
can be discerned more easily. The signal appears (upon oxidation of P° to P1+) at a 
potential < -500 mV, out of the range of these experiments. The midpoint potential asso-
ciated with the disappearance of the S=5/2 signal at increasing redox potentials, i.e. the 
oxidation of P1+ to P2+, is about -430 mV. Since, in the purified MoFe protein, this value 
is about -310 mV [31] the midpoint potential for abstraction of the second electron from 
the P-cluster is lowered in the transition state complex. The S=3 signal, that is exhibited 
by P2+ in the purified MoFe protein [31, 32], was hardly detectable in the AlF-MgADP 
stabilized transition state complex. Possibly S=0 for P2+ in this complex; the weak S=3 
signal that was detectable at Eh = -250 mV may be caused by a small amount of free 
MoFe protein in the sample. Whatever the spin-state of P2+ in the transition state 
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Figure 4 
Thermal (de)population of the highest doublet (ms = ± 1/2) of the inverted (D<0) S=5/2 mul-
tiplet from the P1+ clusters in the AlF-MgADP stabilized transition state complex. The data-
points are the amplitude at g = 5.27 multiplied by the detection temperature (i.e. corrected for 
Curie-law temperature dependence). The solid line is a fit of the data to a Boltzmann distribution 
over the sub-levels of an S=5/2 system with D = -8.11 cm'. The deviation above T = 25 K 
reflects lifetime broadening. 
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complex may be, it is different from that found for the purified protein. Apparently, the 
exchange-coupling is different in the AlF-MgADP stabilized transition state complex, 
which points at a different conformation of the P-cluster. 
In the simulation of trace C, Fig. 3, the ratio of S=3/2 (FeMoco) over S=5/2 (Pl+) 
is 1 : 0.14. In Fig. 4 it is shown that the population of the measured doublet is 0.085 at 
T=23 K. For FeMoco the population of the measured doublet is 0.65 at this temperature. 
This can be calculated from D « 5 cm' [26]. Thus, for equal amounts of S=3/2 
(FeMoco) and S=5/2 (P1+), the ratio should be 0.085 : 0.65 =0.13. The value of 0.14 
found in the simulation is very close to this, so the two signals are essentially stoichio-
metric, i.e. the S=5/2 signal accounts for 100% of the P-clusters in the sample. Conse-
quently this is not a matter of a physical mixture of S=5/2 and S=l/2 spin states, as was 
previously observed for the purified MoFe protein. Fig. 5 shows the S=l/2 spectra from 
the AlF-MgADP stabilized transition state complex. At Eh = -462 mV (trace A) only a 
weak S=l/2 signal from Fe protein is detected. At Eh = -287 mV (trace B) two S=l/2 
species are present in equal amounts (a and ß in the simulation parameters in Table I). 
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Figure 5 
S=l/2 spectra from the AlF-MgADP stabilized transition state complex poised at different 
redox potentials. Trace A: complex at -462 mV. Trace B: complex at -287 mV. Trace C: simu-
lation of trace B (see Table I). The (partially) truncated radical signal in traces A and B is from 
the redox mediators. EPR conditions: microwave frequency, 9.416 GHz; microwave power, 0.8 
mW; modulation frequency, 100 kHz; modulation amplitude, 0.8 mT; temperature, 13 K. 
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One peak in trace B (the second one from low field) is deformed by the radical and by 
the negative gz peak (g = 2.0) of the S=3/2 signal from FeMoco. 
These results show that the S=l/2 and S=5/2 signals do not have a parallel redox 
behavior, which is in contradiction with what was found previously for free MoFe 
protein [32], but it does agree with the observation above that the S=5/2 signal accounts 
for aU of the P-clusters in the sample. Possibly this condition is specific for the A1F-
MgADP stabilized transition state complex. The nature of these two S=l/2 signals 
present in the AlF-MgADP stabilized transition state complex and in the purified MoFe 
protein, remains to be established. 
Mechanistic implications. 
Our data suggest a possible mechanism for the electron-transfer from the Fe 
protein to the FeMoco in the MoFe protein, the putative substrate-binding site of nitro-
genase. After binding and on-enzyme hydrolysis of MgATP, the protein-protein complex 
changes its conformation to the MgADP-bound conformation. The AIF-MgADP stabi-
lized protein-protein complex is suggested to be part of this reaction coordinate. In this 
transition state the redox potentials of the [4Fe-4S] cluster of the Fe protein and of the 
P-cluster of the MoFe protein are lowered and both clusters become one electron 
oxidized. The electron acceptor is FeMoco. Changes in redox properties are probably 
caused by conformational changes of the protein-protein complex. The disappearance of 
the S=3 signal of the P-clusters, in the range between -500 and +50 mV, shows that such 
conformational changes indeed take place in the MoFe protein when the protein-protein 
complex assumes the transition state. Furthermore, the recent publication of the crystal 
structure of the AIF-MgADP stabilized complex reveals that also the dimeric Fe protein 
has undergone substantial conformational changes in this complex [33]. 
Table 1 Parameters used for the simulation of EPR spectra. 
Low-field spectra (Fig. 3) 
S=3/2 S=5/2 
High-field spectra (Fig. 5) 
S=l/2 (a) S=l/2 (ß) 
gx 
gy 
gz 
Axx 
A y y 
Azz 
ratio 
4.35 
3.65 
2 
0.11 
0.11 
0.11 
1 
6.64 
5.27 
2 
0.4 
0.08 
0.1 
0.14 
1.808 
1.941 
2.016 
0.010 
0.007 
0.009 
1 
1.887 
1.887 
2.050 
0.012 
0.012 
0.007 
1 
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The role of NifM in the maturation of the nitrogenase 
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Abstract 
The nifM gene in the Azotobacter vinelandii nif-gem cluster encodes a 30 kDa 
protein. The role of NifM in the maturation of the nitrogenase Fe protein was investi-
gated. Comparison of the nucleotide- and derived amino acid sequence of nifM with 
sequences in several nucleotide- and protein sequence databases reveals a high homology 
between NifM and proteins involved in protein folding, especially E. coli parvulin, a 
peptidylprolyl cis-trans isomerase (PPIase). Deletion of nifM from the A. vinelandii 
genome resulted in accumulation of inactive, precipitated nitrogenase Fe protein, indi-
cating that NifM might be required for proper folding of the Fe protein. 
The NifM protein was purified from an E. coli clone containing the A. vinelandii 
ntfM gene on a plasmid under control of the T7-(|>10 promoter and tested for PPIase 
activity with two artificial substrates. Although activity was observed with one of the 
substrates, this activity was found to be due to a contamination of the NifM preparation 
with a small amount of an E. coli PPIase. 
Introduction 
Nitrogenase, the enzyme that catalyzes the reduction of dinitrogen to ammonia 
(nitrogen fixation) consists of two proteins. The MoFe protein, or Avl, is an o ^ tetra-
mer containing two [8Fe-7S] clusters (P-clusters) and two [Mo-7Fe-9S-homocitrate] 
clusters (FeMoco) [1]. The iron-molybdenum clusters probably form the active site of 
the enzyme. The Fe protein, or Av2, donates the electrons required for nitrogen reduc-
tion to the MoFe protein. The Fe protein is a homodimer containing a single [4Fe-4S] 
cluster between the subunits [2]. 
Biosynthesis of the Fe protein. Biosynthesis of the nitrogenase proteins requires 
the concerted activity of the proteins encoded by approximately 20 genes. In Azotobacter 
vinelandii, these ntf genes are located in 2 clusters [3, 4]. Indications about the functions 
of these genes in the biosynthesis of nitrogenase have been obtained by investigating A. 
vinelandii mutants in which specific nif genes were deleted. These studies indicated that 
for biosynthesis of active Fe protein an intact copy of the nifM gene was absolutely re-
quired: no Fe protein activity was detectable in AnifM mutants [5]. Deletion of two other 
genes, nifS and nifU resulted in a considerable decrease of Fe protein activity in Azoto-
bacter cells. The nifS gene encodes a pyridoxalphosphate-dependent cysteine desulfu-
rase, which catalyzes, under reducing conditions, the conversion of cysteine into alanine 
and sulfide [6, 7]. The sulfide produced in this reaction can be used for the biosynthesis 
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of iron-sulfur clusters: in the presence of Fe-ions and cysteine NifS catalyzes the biosyn-
thesis of the [4Fe-4S] cluster in the apoprotein of the nitrogenase Fe protein [8]. Genes 
encoding proteins with high sequence similarity to A. vinelandii nifS have been found 
recently in several non-diazotrophic organisms, including E. coli and B. subtilis [9, 10], 
suggesting that the role of this protein in biosynthesis of Fe-S clusters is not limited to 
the nitrogenase Fe protein; indeed, in vitro NifS catalyzed biosynthesis of Fe-S clusters in 
several other apo-Fe-S proteins has been demonstrated now [10, 11, 12]. The role of 
NifU, a protein with a [2Fe-2S] cluster [13], in the biosynthesis of the nitrogenase Fe 
protein is not yet clear. Also the Fe protein of Klebsiella pneumoniae nitrogenase 
requires NifM for biosynthesis. Experiments in which K. pneumoniae nifli, the gene 
encoding the subunit of the Fe protein, was introduced in E. coli cells together with dif-
ferent sets of other nif genes indicated that coexpression of nifli and nifM was sufficient 
to produce active Fe protein [14]. 
Several functions for NifM have been suggested, among these insertion of the 
[4Fe-4S] cluster, conformational isomerization of the cluster in a post-insertional event 
and promotion of proper assembly of the two subunits of the Fe protein for appropriate 
positioning of the ligands of the Fe-S cluster (reviewed by Dean et al., [15]). Recently it 
was proposed that NifM might be a peptidylprolyl cis-trans isomerase (PPIase) [16]. 
Peptidylprolyl cis-trans isomerases. PPIases are enzymes found both in proka-
ryotes and in eukaryotes (see [17] and [18] for reviews). They catalyze the interconver-
sion of the frans-isomer of proline into the cw-isomer. During protein synthesis, peptide 
bonds formed by the proline residues are in the trans conformation, but in folded pro-
teins appr. 15% of the residues have a cis conformation. Although cis-trans isomeri-
zation occurs spontaneously, PPIases considerably increase the rate of this process. A 
mechanism involving stabilization of a transition state that is characterized by partial 
rotation around the C-N amide bond, for which the enzymes use free energy released 
from favorable noncovalent interactions with the substrate ('catalysis by distortion') has 
been proposed. [19, 20]. 
Together with the protein disulfide isomerases (which catalyze the formation of 
disulfide bridges), PPIases enhance the rate of one of the two slow steps in protein 
folding in vitro. Acceleration of in vitro refolding of a series of proteins by PPIases has 
been demonstrated (reviewed in [17]). Although definitive proof for their function in 
vivo is still lacking, it is generally believed now that these enzymes, together with the 
chaperone systems, are required for fast and accurate protein folding. PPIases are 
subdivided into three classes: FK506-binding proteins or FKBP's, which are inhibited by 
immunosuppressive macrolides (FK506, rapamycin), cyclophilins (inhibited by the 
immunosuppressive peptide cyclosporin A) and parvulins, which are neither inhibited by 
macrolides nor by cyclosporin. PPIases belonging to the different classes have a different 
specificity for the synthetic substrates that are used to test their activity [21, 22]. There is 
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no sequence similarity between FKBP's, cyclophilins and parvulins, but extensive 
sequence homology exists between different PPIases within each class. On the basis of 
this homology NifM is believed to be a parvulin-type PPIase. Besides the prototype 
PPIases (which usually consist of 90 - 170 residues) PPIase-like domains and PPIase 
activities are also found in larger proteins, which might have other functions as well. 
Materials and methods 
Plasmids. 
A summary of the plasmids and recombinant A. vinelandii strains used in this 
study is given in Table I. Plasmids pDB527, pDB559, pDB551 and pDB525 were gifts 
of Dr. D. Dean (Virginia Polytech and State University, Blacksburg, Virginia, USA). 
Plasmid pDB527 contains the A. vinelandii nifH gene, amplified with PCR from start- to 
stopcodon and inserted downstream of the strong T7-<f>10 promoter of expression vector 
pET-5a [23]. Plasmids pDB559, pDB551 and pDB525 contain the A. vinelandii nifM, 
nifô and nifU genes, respectively, downstream of the T7-<|)10 promoter of pT7-7 [24]. 
Expression of genes under control of the T7-<|)10 promoter was in E. coli BL21[DE3] 
[25]; E. coli TG2 [26] was used as a host-strain for the construction of plasmids. 
Plasmid pAV41 was constructed as follows: first, otf9 (the gene downstream of 
nifM and in the same operon) was isolated on a 2.0 kb SphUStul restriction fragment 
(see Jacobson, [3], for restriction sites used) and inserted into SphUHindlll digested 
pDB559. Next, the resulting plasmid, pAV40, was digested with Xbal and Gal. The 
resulting 2.2 kb fragment, i.e. the entire insert with nifM and orf9 downstream the vector 
encoded T7-(|)10 ribosome-binding site (RBS), was made blunt-ended with Klenow-
polymerase and SI-nuclease and inserted into ßamHI-digested pDB527 (the BamRl 
ends made blunt with Klenow-polymerase). The resulting plasmid, pAV41, contains, in 
this order, the T7-(|)10 promoter and RBS of vector pET5a, followed by the nifH gene, a 
second copy of the T7-(|>10 RBS and the nifM and orf9 genes; orf9 is preceded by its 
natural RBS. 
Plasmid pAV49 was made in the following way: first, a 3.1 kb Sphl fragment 
containing nifU, nifS and part of nifV was inserted into pUC19. The resulting plasmid, 
pAV13, was digested with Sstl and Hindlll. The 2.1 kb fragment containing the 3' end of 
nifU, the entire nifS and the 5' end of niJV was inserted into SsiUHindlll digested 
pDB525, placing nifU, nifS and the truncated nifW gene under control of the vector-
encoded T7-(j)10 promoter. Finally, the insert of the resulting plasmid (pAV48), including 
the vector encoded promoter and RBS, was isolated on a 3.1 kb BgKVSphl restriction 
fragment and inserted into BaniHVSphl digested pACYC184, resulting in recombinant 
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E. coli strains: 
E. coli TG2 thi, supE, hsdSK (rK\ mK ), recA::TnlO (TcR), A(lac-pro), 
F(traD36, proA+B+ lacfZAMIS) [26] 
E. coli BL21 [DE3] F, ompT, hsdS„ (rB\ mB"), dem, gal, (DE3) [25] 
A. vinelandii strains: 
A. vin. ATCC478 wild-type A. vinelandii 
A. vin. DJ67 AnifZM strain of A. vinelandii OP (in-frame deletion); nif ' [5] 
A. vin. DJ136 AnifM strain of A. vinelandii OP (frameshift deletion); nif ' [5] 
A. vi«. BB 1 nißi revenant of A. vinelandii DJ 136, containing the modified 
nifM gene with a 6 x His-tag from pAV42; nif + (this study) 
Vectors / plasmids: 
pUC18/19 general cloning vectors, ApR, pMBl origin [39] 
pACYC184 general cloning vector, CmR, TcR, p 15A origin [40] 
pT7-7 expression vector: T7-(|)10 promoter and RBS, ApR, pMBl origin [24] 
pET-5a expression vector: T7-(j)10 promoter and RBS, ApR, pMBl origin [23] 
pDB525 nifU gene of A. vinelandii OP, amplified from start- to stopcodon with 
PCR and inserted into pT7-7 (gift of Dr. D. Dean) 
pDB527 nifH gene of A. vinelandii OP (encoding the Fe protein), amplified from 
start- to stopcodon with PCR and inserted into pET-5a (gift of Dr. Dean) 
pDB551 nifS gene of A. vinelandii OP, amplified from start- to stopcodon with 
PCR and inserted into pT7-7 (gift of Dr. D. Dean) 
pDB559 nifM gene of A. vinelandii OP, amplified from start- to stopcodon with 
PCR and inserted into pT7-7 (gift of Dr. D. Dean) 
pAV 13 3.2 kb Sphl fragment with A. vinelandii ATCC478 nifU, niß and the 5'-
end of nifV inserted into the Sphl site of pUC19 (this study) 
pAV40 2.0 kb SphVStul fragment with A. vinelandii ATCC478 nifM (3'-end) and 
orf9 inserted into SphVHindlll digested pBD559 (-> T7-(|)10 promoter + 
RBS - nifM - orf9 (this study)) 
pAV41 2.2 kb XbaUClal fragment of pAV40 (made blunt with Klenow 
polymerase and S1 nuclease) inserted into BamHl digested pBD527 (—» 
T7-<|>10 promoter + RBS - nifH -T7-(|>10 RBS- nifM - orß (this study)) 
pAV42 2.2 kb HincIVKpnl fragment with A. vinelandii ATCC478 nifM and orß, 
inserted into HinclUKpnl digested pUC19, with the sequence GCA CAT 
CAC CAT CAC CAT CAC, encoding Ala-6xHis, inserted into the Ncol 
site of nifM (this study) 
pAV48 2.1 kb SstVHindlll fragment of pAV 13 inserted into SstUHindUl digested 
pDB525 (-> T7-(|)10 promoter + RBS - nifU - niß - nifV (5'-end) (this 
study)) 
pAV49 3.1 kb BglWSphl fragment of pAV48 inserted into BamYQJSphl digested 
pACYC184 (-> T7-(|>10 promoter + RBS - nifU - niß - nifV (5'-end) (this 
study)) 
Table I Bacterial strains and plasmids. 
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plasmid pAV49. pAV49 contains the T7-(|>10 promoter and RBS, followed by nifU, nifS 
and the truncated niJV. The vector of pAV49 (pACYC184) is compatible with the pET-
vector in pDB527 and pAV41, allowing coexpression of nifH, nifM, nifU, nifS and orß 
in different combinations of the respective plasmids. 
A nifM gene with 6 extra codons for a C-terminal histidine-tag was constructed 
as follows: A 2.0 kb HincWJKpnl fragment containing the nifM and orß genes was in-
serted into Hincll/Kpnl digested pUC19. The resulting plasmid contains a single Ncol 
site overlapping with the codons for the three C-terminal amino acids of NifM. After 
digestion of this plasmid with Ncol, the following synthetic double stranded DNA frag-
ment was ligated into the Ncol site: 
5' CAT GCA CAT CAC CAT CAC CAT CAC GGA TAA TCGAT 3' 
3' GT GTA GTG GTA GTG GTA GTG CCT ATT AGCTAGTAC 5' 
His Ala His His His His His His Gly *** 
This insertion places an extra Ala-residue and a 6 x His-tag in the correct reading 
frame in-between the two C-terminal amino acids of wild-type NifM. The Ncol site is 
removed by the mutation. A plasmid (pAV42) with the insertion in the proper orientation 
was selected by double-stranded plasmid sequencing. pAV42 was introduced into the 
AntfM, nif' strain A. vinelandii DJ136 by transformation (Dr. D. Dean). 130 transfor-
mants showing restoration of diazotrophic growth on plates containing Burk's agar with-
out added nitrogen source were selected. In order to check if the mutated nifM gene was 
properly inserted into the bacterial chromosome by double cross-over, chromosomal 
DNA of 12 of these transformants was isolated after growth in liquid Burk's medium and 
digested with Ncol. After electrophoresis in a 0.6% agarose gel and transfer to nitro-
cellulose membrane, the digested DNA was hybridized with the insert of pAV40, labeled 
by nick-translation with [a32P]dATP as a radioactive precursor. Hybridizing bands of 2.9 
and 2.1 kb were detected in the chromosomal DNA of 11 of 12 transformants (2.9, 1.7 
and 0.4 kb in the DNA of wild-type A. vinelandii). This indicates, that a: proper double 
cross-over has occurred in these transformants and b: the Ncol site at the 3'-end of wild-
type nifM is lost, as expected for the mutated gene. One of the transformants, A. 
vinelandii BB1, was used for further study. 
Bacterial strains and growth conditions. 
Wild-type A. vinelandii ATCC 478 and A. vinelandii BB1 were grown under 
nitrogen-fixing conditions in a 200 1 fermentor containing Burk's medium without added 
ammonium salts, essentially as described before [27]. The A. vinelandii AnifM mutant 
DJ67 [5] was grown in a 200 1 fermentor containing Burk's medium limited in ammonia 
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[(NH4)2S04, 5.7 mM]. This allowed this nif' mutant to grow to mid-exponential phase 
on the added nitrogen source. After depletion of the added nitrogen source, the culture 
was incubated for a further 2 hours at 30 °C in the fermentor causing derepression of the 
nif genes and resulting in expression of the Nif proteins. 
E. coli TG2 strains containing recombinant plasmids were grown in TY medium 
containing the appropriate antibiotics in a thermostatted gyrotory shaker (37 °C, 200 
rpm). E. coli BL21[DE3] strains containing plasmids used for expression of mj-genes 
from T7-(j)10 promoters were grown in TY medium, containing 0.2 % sucrose and 100 
mg ml"1 ampicillin, to mid-exponential phase (OD60o = 0.6 - 0.7) in a gyrotory shaker at 
37 °C, after which expression was induced by the addition of isopropyl-ß-D-thiogalac-
topyranoside (IPTG; 0.2 mM final concentration). Different culture conditions were: a: 
induction at 20 °C (in this case cultures were cooled to 20 °C one hour prior to addition 
of IPTG), b: induction under anaerobic conditions (in this case culture was in screw-
capped bottles which were made anaerobic by tightly closing the screw-caps one hour 
before induction) and c: combination of a and b. 
Purification of NifM from E. coli BL21[DE3](pDB559). 
A. vinelandii NifM was purified from E. coli BL21[DE3] strain harboring 
recombinant plasmid pDB559. A 6 1 culture of E. coli BL21[DE3](pDB559) was grown 
in TY medium containing 100 mg ml"1 ampicillin in a thermostatted shaker at 37°C until 
mid-exponential phase. Induction of expression of nifM was either at 37 °C or at 20 °C. 
For expression at 37 °C, IPTG (0.2 mM final concentration) was added to the 
culture when an ODÔOO of 0.6 - 0.7 was reached. Three hours after induction, cells were 
harvested by centrifugation and broken by passing the cells, resuspended in 100 mM 
Tris/HCl, 1 mM DTT, pH 8.5, twice through a French pressure cell at 10,000 pounds 
per square inch. After centrifugation (30 min at 30.000 g), almost all (> 90%) NifM 
produced after induction at 37 °C was found as inclusion bodies in the pelleted cell 
debris. This pellet was washed twice with 100 mM Tris/HCl, 2% sodium deoxycholate, 
10 mM DTT, pH 8.5 and inclusion bodies were solubilized in the same buffer containing 
8 M urea. After removal of insoluble material (30 min, 30.000 g) the dissolved protein 
was diluted to appr. 0.15 mg ml'1 with urea containing buffer. Next the concentration of 
urea was first gradually and slowly decreased to 1.8 M by consecutive dialysis steps 
against equal volumes of 100 mM Tris/HCl, pH 8.5. The remaining urea was removed by 
3 consecutive dialysis steps against 5-fold excess 100 mM Tris/HCl, pH 8.5, followed by 
concentration of the protein by ultra-filtration on an Amicon YM 10 membrane. After 
removal of precipitated material by centrifugation appr. 20 mg soluble and essentially 
pure NifM was obtained. 
For expression of nifM at 20 °C, the mid-exponential phase culture was trans-
ferred to a shaker kept at 20 °C. After one hour equilibration at this temperature, IPTG 
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was added (0.2 mM final concentration). Cells were harvested by centrifugation 7 h later, 
when the NifM content reached its maximal level. Appr. 75% of NifM accumulates as 
soluble protein in cells grown at 20°C. The pellet (42 g) was resuspended in 50 ml 100 
mM Tris/HCl, pH 8.0, 1 mM DTT. After addition of DNasel and RNase A, cells were 
broken by two passages through a French pressure cell at 10,000 psi. Large cell debris 
was removed by centrifugation at 20,000 g for 20 min. This and following steps were 
performed at 4°C. After dialysis against 2 liters of 100 mM Tris/HCl, pH 7.6, 1 mM 
DTT (buffer A), the supernatant was loaded onto a DEAE-Sephacel column (25 x 2.6 
cm). After application of a linear gradient of 0 - 0.5 M NaCl in buffer A, NifM was found 
to elute at appr. 0.23 M NaCl. Pooled fractions containing NifM were concentrated by 
ultra-filtration on an Amicon YM-10 membrane, centrifuged to remove precipitates and 
applied onto a Superdex 200 gel-filtration column (88 x 2.6 cm) in buffer A + 150 mM 
NaCl. Pooled fractions from this column were again concentrated by ultra-filtration and 
centrifuged, followed by a second ion-exchange purification step on Q-Sepharose (15 x 
2.6 cm) developed with 0.1 - 0.5 M NaCl in buffer A. Finally, NifM-containing fractions 
were desalted and applied (without further addition of salt) onto a hydrophobic interac-
tion column (Phenyl-Sepharose, 20 x 2.6 cm). Bound NifM was eluted from this column 
with a gradient of 0 - 50% (vol./vol.) ethyleneglycol in buffer A. Fractions containing 
NifM were again concentrated by ultra-filtration and stored in liquid nitrogen. 
Assay for measuring PPIase activity of NifM. 
The assay for PPIase activity makes use of the selectivity of chymotrypsin for 
digestion of /7-nitroaniline esters of tetrapeptides that contain proline in the P_2 position 
[28]. In watery solutions, an equilibrium exists between peptide molecules with proline in 
the cis and trans conformations, respectively. Using an excess chymotrypsin, the trans 
conformers are digested very rapidly, while the rate of digestion of the cis conformers is 
dependent on the rate of the cis-trans isomerization. Addition of a PPIase to the diges-
tion mixture increases the rate of cis-trans isomerization and, therefore, also the rate of 
digestion of the peptide. 
Two peptide substrates were used in this study: N-succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide (suc-AAPF-pNA, Sigma) and N-succinyl-Ala-Phe-Pro-Phe-p-nitroanilide 
(suc-AFPF-pNA, Bachem, Switzerland). The assay was performed in a Hi-Tech SF-51 
stopped-flow apparatus (Salisbury, Wiltshire, UK). One syringe contained the peptide 
substrate (6 - 2240 (i.M, diluted from 1.5 or 50 mg ml"1 stock solutions in DMSO) and 
NifM (0 - 7.2 uM) in 50 mM Hepes/NaOH, 100 mM NaCl, pH 7.5. Prolonged incuba-
tion of NifM with the peptide substrate did not influence the ratio of cis to trans confor-
mers of the peptide. The second syringe contained chymotrypsin (Boehringer), 3.6 mg 
ml"1, diluted from a 60 mg ml'1 stock solution in 1 mM HCl, in 50 mM Hepes/NaOH, 
100 mM NaCl, pH 7.5. Both syringes were kept at 20 °C. Directly after filling the syrin-
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ges the reaction was started by shooting 0.15 ml of the substrate / NifM mixture against 
0.15 ml of the protease solution. The reaction was followed by measuring the increase of 
the absorbance at 390 nm or at 445 nm (for substrate concentrations above 200 |iM.) 
due to formation of p-nitroanilide (e39o = 13,300 M"1 cm"1; £445 = 1250 M"1 cm', [29]). 
Under these conditions, the trans conformer of the substrate is digested by chymotrypsin 
within the first second after mixing, followed by a slower digestion of the cis conformer, 
the rate being dependent on the activity of PPIase. PPIase activity in NifM preparations 
was determined as the rate of p-nitroanilide production in the slow step of the reaction in 
the presence of NifM minus the rate in its absence due to spontaneous cis-trans conver-
sion. Substrate concentrations used for calculation of kinetic parameters were those of 
the cw-conformers; the percentages of cw-conformers in watery solutions of the sub-
strates suc-AAPF-pNA and suc-AFPF-pNA were 10% and 25%, respectively. 
For inhibition studies rapamycin (Sigma) was added in different concentrations 
(0-500 nM) to the syringe that contained the substrate and NifM. Use of a stopped-flow 
apparatus allowed monitoring of the progress of the reaction from 10 ms after mixing. 
Compared to a conventional spectrophotometer, use of a stopped-flow apparatus has the 
advantage that variations in mixing times are avoided, which is especially important at 
high substrate concentrations. 
Antibodies against NifM. 
Antibodies were raised against NifM purified from inclusion bodies isolated from 
E. coli BL21[DE3] (pDB559) grown at 37 °C. NifM (40 |ig in 100 ul buffer) was mixed 
with 100 JLLI Freunds complete adjuvans or 100 ul Specoll and injected subcutaneously 
into BALB/C mice, followed 4 weeks later by a boost with the same amount of NifM. 
Mice were Weeded one week after the boost. Serum was obtained after centrifugation 
(10 min, 10,000 g) of the clotted blood cells. 
Results and discussion 
NifM has homology with the peptidylprolyl cis-trans isomerase parvulin. 
Screening of several nucleotide- and protein sequence databases (EMBL, Gen-
bank, PIR, Swissprot), using a variety of homology search programs (FASTA, TFASTA, 
BLAST, Smith-Waterman), revealed, apart from NifM proteins from other diazotrophes, 
only a limited number of other proteins with relevant sequence homology to A. vine-
landii NifM ([16], our own observations). Among the proteins with homology to NifM 
(some of these are only putative, as they have not yet been purified, but have only been 
identified by nucleotide sequencing and other molecular genetic techniques) are the 
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PPIase parvulin from E. coli and proteins encoded by the prtM gene of Lactobacillus 
lactis [30, 31], the prsA gene of Bacillus subtilis [32] and the surA gene of E. coli [33]. 
Genetic and / or biochemical analysis of these genes and / or the proteins they encode 
suggests that they are all involved in protein folding / maturation. The only one of the 
proteins for which ample information is available on a genetic level and which has also 
been characterized biochemically is parvulin, encoded by the E. coli ppiC gene [22, 34]. 
Parvulin has been characterized as a small (10.1 kDa), highly active PPIase with a 
substrate specificity that is different from the FKBP- and cyclophilin-types of PPIases. 
Furthermore, its activity is not inhibited by cyclosporin A and FK506. 
Indications for involvement in protein folding of the other proteins with sequence 
similarity to NifM is indirect and stems primarily from genetic experiments: surA from E. 
coli was isolated as a locus which upon transposon mutagenesis induced accumulation of 
misfolded proteins in the periplasm [33]; deletion of prtM in Lactobacillus lactis results 
in excretion of the extracellular protease encoded by prtP in inactive form [30, 31]; prsA 
is required for biosynthesis of periplasmic a-amylase in Bacillus subtilis [32]. Like NifM, 
also the proteins encoded by surA, prtM and prsA have a 'domain' with sequence simi-
larity to parvulin (which occurs twice in surA) [16]. These proteins are much larger than 
parvulin (10.1 kDa): NifM, PrtM and PrsA are appr. 33 kDa, SurA 62 kDa. However, 
outside the region of appr. 100 amino acids with sequence similarity to parvulin and 
NifM, the sequences of these larger proteins are widely divergent. 
Fig. 1 shows a comparison of the amino acid sequence of A. vinelandii and 
Klebsiella pneumoniae NifM with parvulin. The sequences of the NifM proteins of A. 
vinelandii and K. pneumoniae, which obviously have a similar function in biosynthesis of 
the nitrogenase Fe proteins in respective species, have hardly any similarity to one 
another, except for the region where the homology with parvulin is found. Only 70 
amino acid residues (24%) of A. vinelandii NifM (292 amino acids total) are identical in 
K. pneumoniae NifM (266 amino acids). The conserved residues are primarily clustered 
in the C-terminal part of NifM: of the 120 N-terminal residues of A. vinelandii NifM, 
only 15 (12.5%) are identical in K. pneumoniae NifM, while 55 (32%) are conserved in 
the 172 C-terminal amino acids. 
Maximal conservation is found between residues 182 - 247 of the A. vinelandii 
sequence and residues 160 - 225 ofthat of K. pneumoniae nijM (29 identical residues, 
i.e. 45%). As shown in the alignment in Fig. 1, the primary structure of parvulin (93 
amino acids) is highly similar to the latter regions of both NifM sequences: of the 65 
amino acid residues in this region, 20 (19) are identical between parvulin and A. 
vinelandii (K. pneumoniae) NifM and another 14 (15) are replaced by residues which are 
considered to be functionally homologous. 
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NIFMVI 
PARVULIN 
NIFMKL 
MASERLADGDSRYYLLKVAHEQFGCAPGELSEDQLQQADRIIGRQRHIED 50 
MNPWQ RFARQRLARSRWNRDPAALDPADTPAFEQAWQRQCHMEQ 4 4 
NIFMVI 
PARVULIN 
NIFMKL 
AVLRSPDAIGWIPPSQLEEAWAHIASRYESPEALQQALDAQALDAAGMR 100 
TIVARVPEGDIPAALLE NIAASLAIWLDEGDFAPPERA 82 
NIFMVI 
PARVULIN 
NIFMKL 
AMLARELRVEAVLDCVCAGLPEISDTDVSLYYFNHAEQFKVPAQHK- -Hl 149 
MAKTAAALHI 10 
AIVRHHARLELAFADIARQAPQPDLSTVQAWYLRHQTQFMRPEQRLTRHL 132 
NIFMVI 
PARVULIN 
NIFMKL 
LVTINEDFPENTREAARTRIETILKRLRGKPERFAEQAMKHSECPTAMQG 199 
LV KEEKLALDLLEQIKNGAD-FGKIAKKHSICPSGKRG 47 
LLT VDNDREAVHQRILGLYRQINASRDAFAPLAQRHSHCPSALEE 177 
* * * * ** 
NIFMVI 
PARVULIN 
NIFMKL 
GLLGEWPGTLYPELDACLFQMARGELSPVLESPIGFHVLYCESVSPARQ 249 
GDLGEFRQGQMVPAFDKWFSCPVLEPTGPLHTQFGYHIIKVLYRN* 9 3 
GRLGWISRGLLYPQLETALFSLAENALSLPIASELGWHLLWCEAIRPAAP 227 
* * * * * * ** 
NIFMVI 
PARVULIN 
NIFMKL 
LTLEEILPRLRDRLQLRQRKAYQRKWLVCLLQQNATLENLAHG* 
MEPQQALESARDYLWQQSQQRHQRQWLEQMISRQPGLCG* 
292 
266 
Figure 1 
Alignment of the sequences of A. vinelandii and K. pneumoniae NifM (NIFMVI and 
NIFMKL, respectively) with E. coli parvulin. Amino acid sequences were aligned with the 
CLUSTAL V program [42] using the PAM250 protein-weight matrix [41]. Identical residues 
(asterisks) and homologous residues (dots) are only shown in the region where all three sequences 
overlap. Residues conserved in parvulin and in one or both NifM sequences are shown bold 
Deletion of the gene encoding NifM in A. vinelandii. 
The A. vinelandii strain DJ67, in which the nifM gene is deleted by genetic 
modification, was previously shown to accumulate normal amounts of Fe protein. 
However, the Fe protein was completely inactive in this mutant; also activity of the 
MoFe protein was very low [5]. We have been able to confirm the results obtained by 
Jacobson et al. [5] with this strain. 
In order to attempt purification of the inactive Fe protein from A. vinelandii 
DJ67, a 200 1 culture of this mutant strain was grown under ammonia-limiting condi-
tions. Under these conditions this nif ' strain grows to mid-exponential phase on the 
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added nitrogen source, followed by derepression of the nitrogenase proteins upon 
exhaustion of the nitrogen source. However, after anaerobic disruption of the A. vine-
landii DJ67 cells and after removing insoluble material by centrifugation, we noticed that 
the majority of the Fe protein and large part of the MoFe protein are found in the pellet 
after the centrifugation step. Fig. 2A shows a Coomassie-stained SDS-polyacrylamide 
gel containing broken cells of A. vinelandii DJ67, fractionated into soluble and insoluble 
fractions by centrifugation at 20,000 g for 30 min. It is apparent from Fig. 2A that, 
contrary to wild-type A. vinelandii, the àntfM strain DJ67 accumulates the majority of 
the Fe protein (and also part of the Mo-Fe protein) in the insoluble fraction. Fig. 2B 
shows an immunoblot of the same fractions of both wild-type and DJ67 A. vinelandii 
cellular proteins incubated with antibodies raised against the Fe protein. The experiment 
in Fig. 2B confirms the results in Fig. 2A. Further purification of the Fe protein produced 
by A. vinelandii DJ67 was not attempted. 
These experiments indicate that deletion of nifM results in the accumulation of 
aggregates of inactive Fe protein in A. vinelandii cells that can easily be pelleted by cen-
trifugation, suggesting that the protein is not properly folded. This, and the remarkable 
sequence homology of NifM with other proteins involved in protein folding / maturation, 
suggests involvement of NifM in the folding of the Fe protein to its native conformation. 
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Figure 2 
Separation of nitrogenase proteins of wild-
type and AnifllA. vinelandii (strain DJ67) 
into soluble and insoluble fractions. 
A. vinelandii wild-type and DJ67 cells were 
ruptured in a French-pressure cell, followed 
by separation of the broken cells into soluble 
and insoluble fractions by centrifugation. 
Equivalent amounts of these fractions were 
analyzed by SDS-PAGE, followed by either 
(A) staining with Coomassie Brilliant Blue or 
(B) by immunochemical staining applying 
antibodies against the nitrogenase Fe protein. 
A Lane 1: DJ67, soluble fraction. 
A Lane 2: DJ67, insoluble fraction. 
B Lane 1: wildtype, insoluble fraction. 
B Lane 2: wildtype, soluble fraction. 
B Lane 3: DJ67, insoluble fraction. 
B Lane 4: DJ67, soluble fraction. 
B Lane M: low-molecular-weight markers. 
Arrows: position of the Fe protein. 
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Production of Fe protein in E. coli. 
Deletion of specific genes in the A. vinelandii nif gene clusters gave indications 
for involvement of four genes in these clusters in the biosynthesis of the Fe protein [3, 5]. 
NifH (the structural gene for the Fe protein) and nifM appear absolutely required for 
synthesis of active Fe protein. Deletion of nifU and nifS results in mutant strains that 
accumulate a 15 - 20 fold lower amount of active Fe protein compared to the wild-type 
strain. This either suggests that nifU and nifS are not absolutely required for synthesis of 
active Fe protein, but affect only the efficiency of biosynthesis, or that proteins encoded 
by genes outside the nif gene clusters may (partially) replace nifU and nifS. In this 
respect it is interesting to note that the A. vinelandii genome contains, outside the nif 
gene clusters, two other copies of nifS (Dr. D. Dean, personal communication). 
In order to investigate what is the minimum amount of genes required for bio-
synthesis of active Fe protein, the nifH gene was expressed in E. coli, alone and in dif-
ferent combinations with nifM, nifU and nifS. Furthermore, the role of orf9, an open 
reading frame encoding a 48 kDa protein which is not required for biosynthesis of active 
Fe protein in A. vinelandii [3], but which is present in the same operon as nifM, was 
investigated. 
E. coli BL21[DE3] (pDB527) was used for expression of the nifH gene in E. 
coli. Under all conditions tested (induction at 20 °C or 37 °C; aerobic or anaerobic 
induction) large amounts of Fe protein were produced in E. coli BL21[DE3] (pDB527). 
However, no Fe protein activity was detectable in extracts of these cells. The Fe protein 
produced in these cells was not soluble and could be easily pelleted in extracts of these 
cells by low-speed centrifugation (not shown), indicating that it occurred in large aggre-
gates. 
Coexpression of nifH, nifU and nif S was done in E. coli BL21[DE3] containing 
both (compatible) plasmids pDB527 and pAV49. Also the Fe protein produced in this 
doubly transformed expression strain was inactive and insoluble, indicating that NifU and 
NifS are not sufficient for biosynthesis of active Fe protein. 
Also coexpression of nifH, nifM and orf9 in E. coli BL21[DE3] (pAV41) did not 
result in production of active and soluble Fe protein. Extracts of E. coli BL21[DE3] 
(pAV41) separated on 15% SDS-polyacrylamide gels clearly showed that the three 
proteins were produced in high amounts after induction with IPTG. This result does not 
agree with that obtained by Howard et al. [14]. These authors demonstrated that coex-
pression of K. pneumoniae nifH and nifM in E. coli was sufficient for production of fully 
active Fe protein, which was spectroscopically indistinguishable from the Fe protein pro-
duced in Klebsiella. A difference in the experimental setup between Howard's and our 
experiments was the use of different expression systems, which yielded high amounts of 
the recombinant proteins, synthesized in short periods of time, in our case, and only 
moderate amounts, synthesized over much longer periods of time, in the system used by 
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Howard. This may be relevant if proteins which are produced in low amounts by the E. 
coli strain itself are involved in maturation of the Fe protein. In this respect, it is inter-
esting that very recently a NifS protein has been purified that is produced in low amounts 
by E. coli (0.15 % of the total cellular protein) [10]. It cannot be excluded that E. coli 
NifS replaces NifS encoded by the nif gene cluster in the activation of the Fe protein, but 
is not able to cope with the high amounts of Fe protein made in the expression system 
used by us. 
Unfortunately, loss of plasmid pAV41 has prevented us till now to investigate if 
active Fe protein can be produced in E. coli by coexpression of all four genes, nifH, 
nißi, nifU and nifS. 
Purification of NUM. 
A. vinelandii NifM was isolated from an E. coli clone, E. coli BL21[DE3] 
(pDB559), that contained the cloned gene in expression vector pT7-7. Induction of gene 
expression at 37 °C caused NifM to accumulate largely in inclusion bodies. Isolation of 
the inclusion bodies and refolding from 8 M urea yielded soluble NifM which was puri-
fied to homogeneity. However, freezing and thawing caused aggregation of this refolded 
NifM protein. 
Induction at 20 °C resulted in production of NifM as a soluble protein. NifM was 
purified to high purity with the four-step procedure given in Materials and Methods. 
Although no purification table is given, as no activity was measured during subsequent 
steps, it was obvious that considerable loss occurred during purification: high amounts of 
NifM precipitated during dialysis and especially during the ultra-filtration steps. The final 
yield of NifM was 46 mg from 23 g of cells. The purified protein was colorless; the UV-
visible spectrum gave no evidence for the presence of a cofactor. 
Fig. 3 shows a SDS-polyacrylamide gel of four fractions from the final purifica-
tion step on Phenyl-Sepharose. NifM has an apparent molecular weight of 34 kDa on 
SDS-polyacrylamide gel, which is close to the molecular weight calculated from the 
amino acid composition (32.8 kDa, [3]) as derived from the sequence of the gene. The 
apparent molecular weight of the native protein was determined by chromatography on 
Superdex 200 with suitable marker proteins. Purified NifM had an apparent molecular 
weight of 42 kDa on this column; furthermore, a minor peak corresponding with an 
apparent molecular weight of 71 kDa was detected (Fig. 4). Analysis of the 42 kDa and 
71 kDa fractions on SDS-polyacrylamide gel indicated that both peaks contain NifM. 
Apparently, the majority of NifM is a monomer under these conditions, but a minor 
fraction runs as a dimer. When NifM is concentrated by ultracentrifugation before 
application on the Superdex column, a large fraction is present as aggregates with a very 
high apparent molecular weight. 
102 Chapter 5 
Figure 3 
SDS-polyacrylamide gel electrophoresis of NifM 
purified from E. coli BL21[DE3] (pDB559). 
Shown are NifM-containing fractions of the final Phenyl 
Sepharose column (lanes 1-5) and low-molecular-weight 
marker-proteins (Pharmacia). 
The behavior of NifM during hydrophobic interaction chromatography on Phenyl 
Sepharose, onto which the protein binds without added salts and from which it can only 
be eluted with high concentrations of ethylene glycol, suggests that NifM is very hydro-
phobic. We therefore considered the possibility that in A. vinelandii NifM is not present 
as a separate protein, but occurs as a subunit of a larger protein complex. Consequently, 
purification of NifM (or of the complex) was also attempted from A. vinelandii. As indi-
cated by incubation of Western blots of A. vinelandii cell extracts with antibodies against 
NifM, the amount of NifM is very low in Azotobacter. In order to allow purification of 
NifM from Azotobacter, 6 codons for His were incorporated into the nifM gene, enabling 
synthesis of NifM with a C-terminal His-tag, and this modified gene was crossed into the 
A. vinelandii AntfM mutant DJ67. The resulting strain, A. vinelandii BB1, was capable 
of normal diazotrophic growth, indicating that the His-tagged NifM was functional. 
Purification of the His-tagged NifM was attempted by anaerobic Immobilized Metal 
Affinity Chromatography of cell-free extract of A. vinelandii BB1, grown under diazo-
trophic conditions. Both zinc-activated iminodiacetic acid Sepharose 6B (Sigma) and 
nickel-activated nitrillotriacetic acid agarose (Quiagen) were used as chromatographic 
resin; elution of bound protein was done, subsequently, with increasing concentrations of 
imidazole (up to 250 mM), followed by EDTA (10 mM) and urea (8 M). Under none of 
these conditions specific binding and elution of NifM was detected, although cell-free 
extract of up to 40 g cells was applied to the columns. This suggests that the His-tag on 
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NifM is not available for binding to the immobilized metal ions, possibly as a result of 
specific folding or of proteolytic removal. 
We also considered the possibility that NifM forms a complex with the protein 
encoded by orf9, which is in the same Operon as nifM. Orf9 encodes a homologue of the 
E. coli protein ClpX, an ATP-binding protein which, like certain chaperones, can dis-
solve protein aggregates and occurs in E. coli as a component of the ATP-dependent 
protease ClpP, [35], However, coexpression of nifM and orf9 in E. coli and subsequent 
purification indicate that NifM and the protein encoded by orf9 eluted in different frac-
tions of an ion-exchange column. 
Is NifM a PPIase? 
Based on the homology between NifM and parvulin, we have looked for PPIase 
activity in NifM isolated from E. coli BL21[DE3] (pDB559). The Fe protein from A. 
vinelandii nitrogenase contains 8 proline residues per subunit [36], which are in the 
folded protein all in the ?ra/«-conformation ([2], Dr. D. Dean, personal communication), 
i.e. the same conformation that they have in the unfolded protein as it is synthesized. 
< 
Time 
Figure 4 
Gel-filtration of purified NifM on Superdex 200. Shown are the two peaks obtained by gel-
filtration of the purified NifM (arrows). The position of the following markers (obtained in 
separate runs) is indicated: 1: Blue dextran, 2: Human transferrin, 3: Bovine serum albumin, 4: 
Ovalbumin 5: Chymotrypsinogen 6: Cytochrome c j , 7: CuS04. The low-molecular-weight peak 
in the chromatogram is the result of DTT, present in the NifM-sample. 
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However, it cannot be excluded that some of these residues transiently assume a cis-
conformation during biosynthesis of the protein, a process which would be facilitated by 
a PPIase. Three of the prolines in each subunit are close to the Fe-cluster, two of them 
(Pro-91 and Pro-93) in loops, one from each subunit, that wrap around the [4Fe-4S] 
cluster and extend over the surface of the other subunit. These loops contain the Cys-97 
ligand for the Fe-S cluster. Change of the conformation of these prolines will result in a 
change of position of the loops (and the cysteine ligands) and may be involved in subunit 
assembly or cluster incorporation. The involvement of NifM as a PPIase in the matura-
tion of the Fe protein is therefore not inconceivable. 
PPIase activity of NifM was determined with two substrates: suc-AAPF-pNA 
and suc-AFPF-pNA. The side chain of the second amino acid determines the specificity 
of PPIases belonging to the different classes: cyclophilins have a much higher specificity 
for suc-AAPF-pNA than for suc-AFPF-pNA; FKBP's, on the other hand, prefer sub-
0.23 
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Figure 5 
PPIase activity of the purified NifM preparation. Hydrolysis of cis-suc-AFPF-pNA by 
chymotrypsin in the presence (upper curve, continuous line) or absence (lower curve, dotted line) 
of NifM as measured with a stopped-flow apparatus. 892 uM suc-AFPF-pNA; 3.6 uM NifM; 
1.8 mg ml'1 chymotrypsin; T = 20 °C. Formation of p-nitroaniline was recorded at 395 nm. Note: 
curves only show the slow step of the PPIase reactions, i.e. the chymotrypsin-catalyzed 
production of p-nitroaniline from the cw-conformer of suc-AFPF-pNA after spontaneous (lower 
curve) and NifM-catalyzed (upper curve) isomerization. Hydrolysis by chymotrypsin of the 
«rans-conformer of suc-AFPF-pNA (75% of the total concentration of suc-AFPF-pNA), which 
occurs within the first second of the reaction, is not shown in this Figure. 
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strates with a bulky hydrophobic side chain on the second amino acid. Only one parvulin-
type PPIase has been isolated until now; it has a slightly higher specificity for suc-AFPF-
pNA than for suc-AAPF-pNA [22]. 
NifM purified and refolded from inclusion bodies had no activity with either sub-
strate. Also NifM isolated as soluble protein had no activity with suc-AAPF-pNA as a 
substrate, but activity with suc-AFPF-pNA was readily detected (Fig. 5), although at 
rather high NifM concentrations. Kinetic parameters were determined by measuring the 
reaction rates at varying substrate concentrations (3 - 1120 \LM) and 3.6 (AM NifM (Fig. 
6). Data-points in Fig. 6 were fitted with the Michaelis-Menten equation, resulting in the 
following values for the kinetic parameters: kcàt = 1.17 s"1; KM = 0.24 mM; feu I KM = 4.8 
103 M"1 S"1. This feat / #M value is considerably lower than those measured for prototype 
PPIases: parvulin and cyclophilins, 1-2 107 M ' s"' [29, 22], FKBP's appr. 5 106 M"1 s"1 
[29]. Although the £M-value is in the same range as found for cyclophilins and FKBP's 
(0.5 - 1 mM), the k^t is 100-1000 fold lower, suggesting that a) NifM has a low activity 
(as found for some PPIase-domain proteins like FKBP25mem from Legionella 
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Figure 6 
Kinetics of hydrolysis of suc-AFPF-pNA by chymotrypsin in the presence of NifM. 
v represents the initial rate of hydrolysis of the «.y-conformer of suc-AFPF-pNA in the presence 
of NifM, corrected for the rate of spontaneous hydrolysis in the absence of NifM. Note: [S] is the 
total concentration of suc-AFPF-pNA in the reaction (cis- + trans-conformers); the concentration 
of the cis-conformer is 25% of the total concentration. 3.6 uM NifM; T = 20 °C. Data-points 
were fitted with the Michaelis-Menten equation. 
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pneumophila, [37] or b) only a small part of the NifM molecules is enzymatically active 
or c) NifM is contaminated with a small amount of a very active E. coli PPIase. 
In a first experiment to discriminate between these possibilities the influence of 
rapamycin on the PPIase activity of NifM was studied. Rapamycin is a competitive inhi-
bitor for FKBP's, but does not inhibit PPIase activity of cyclophilins or parvulin. Fig. 7 
shows that 50% of the PPIase activity associated with NifM (concentration NifM in the 
assay 3.7 |0.M) was inhibited at a rapamycin concentration of 22 nM. The PPIase activity 
associated with NifM must therfore be caused by contamination of the NifM preparation 
with a low amount of a FKBP-type of PPIase. 
The conclusion from these experiments must be that, although PPIase activity 
was found in the NifM preparation, inhibition of this activity with a low concentration of 
rapamycin indicates that it results from a contamination with a very small amount of an 
E. coli FKBP. Although E. coli FKBP's were not known at the time of these 
experiments, very recently a dimeric FKBP has been isolated from E. coli (FKBP22) 
with similar size and behavior on ion-exchange and hydrophobic interaction columns as 
NifM [38]. PPIase activity of NifM has, therefore, not been demonstrated. 
200 
[rapamycin] (nM) 
Figure 7 
Inhibition of PPIase activity associated with NifM by rapamycin. 
Percentual decrease of the initial rate of hydrolysis of the c/s-conformer of suc-AFPF-pNA with 
purified NifM (corrected for spontaneous hydrolysis) in the presence of different concentrations 
of rapamycin. 20 uM suc-AFPF-pNA; 3.6 uM NifM; T = 20 °C. Note: rapamycin did not inhibit 
spontaneous hydrolysis. 
The role of NifM 107 
Acknowledgments 
Dr. D. Dean (Virginia Polytech and State University, Blacksburg, Virginia, USA) 
kindly provided us with plasmids pDB525, pDB527, pDB551 and pDB559 and the A. 
vinelandii mutant strain DJ67 and helped with construction of A. vinelandii BB1. Dr. J. 
Kay (University of Sussex, Brighton, UK) did the first PPIase tests with NifM and provi-
ded us with information on the assay conditions. Dr. G. Fischer (Max-Planck-Gesell-
schaft, Arbeitsgruppe 'Enzymologie der Peptidbindung', Halle, Germany) provided us 
with information about E. coli PPIases prior to publication. We thank professor C. 
Veeger for his continuous support and interest. This research was supported by the 
Netherlands Foundation for Chemical Research (SON) with financial aid from the 
Netherlands Organization for Scientific Research (NWO). 
References 
1 Kim, J. and Rees, D.C. (1992) Nature (London) 360, 553 - 560. 
2 Georgiadis, M.M., Komiya, H., Chakrabarti, P., Woo, D., Kornuc, J.J. and Rees, D.C. 
(1992) Science 257, 1653 - 1659. 
3 Jacobson, M.R., Brigle, K.E., Bennett, L.T., Setterquist, R.A., Wilson, M.S., Cash, 
V.L., Beynon, J., Newton, W.E. and Dean, D.R. (1989) J. Bacteriol. 171, 1017 - 1027. 
4 Joerger, R.D. and Bishop, P.E. (1988) J. Bacteriol. 170, 1475 - 1487. 
5 Jacobson, M.R., Cash, V.L., Weiss, M.C., Laird, N.F., Newton, W.E. and Dean, D.R. 
(1989) Mol. Gen. Genet. 219, 49 - 57. 
6 Zheng, L., White, R.H., Cash, V.L., Jack, R.F. and Dean, D.R. (1993) Proc. Natl. Acad. 
Sei. U.S. 90, 2754 - 2758. 
7 Zheng, L., White, R.H., Cash, V.L. and Dean, D.R. (1994) Biochemistry 33, 4714 -
4720. 
8 Zheng, L. and Dean, D.R. (1994) J. Biol. Chem. 269, 18723 - 18726. 
9 Sun, D. and Setlow, P. (1993) J. Bacteriol. 175, 1423 - 1432. 
10 Flint, D.H. (1996) J. Biol. Chem. 271, 16068 - 16074. 
11 Green, J., Bennett, B., Jordan, P., Ralph, E.T., Thomson, A.J. and Guest, J.R. (1996) 
Biochem. J. 316, 887 - 892. 
12 Hidalgo, E. and Demple, B. (1996) J. Biol. Chem. 271, 7269 - 7272. 
13 Fu, W., Jack, R.F., Morgan, T.V., Dean, D.R. and Johnson, M.K. (1994) Biochemistry 
33, 13455 - 13463. 
14 Howard, K.S., McLean, P.A., Hansen, F.B., Lemley, P.V., Kobaln, K.S. and Orme-
Johnson, W.H. (1986) J. Biol. Chem. 261, 772 - 778. 
15 Dean, D.R., Bolin, J.T. and Zheng, L. (1993) J. Bacteriol. 175, 6731 - 6744. 
16 Rudd, K.E., Sofia, H.J., Koonin, E.V., Plunkett III, G., Lazar, S. and Rouviere, P.E. 
(1995) Trends Biochem. Sei. 20, 12 - 14. 
17 Kay, J.E. (1996) Biochem. J. 314, 361 - 385. 
18 Galat, A. and Metcalfe, S.M. (1995) Prog. Biophys. Molec. Biol. 63, 67 - 118. 
108 Chapter 5 
19 Harrison, R.K. and Stein, R.L. (1990) Biochemistry 29, 1684 - 1689. 
20 Harrison, R.K. and Stein, R.L. (1992) J. Am. Chem. Soc. 114, 3464 - 3471. 
21 Harrison, R.K. and Stein, R.L. (1990) Biochemistry 29, 3813 - 3816. 
22 Rahfeld, J.U., Schlierhorn, A., Mann, K. and Fischer, G. (1994) FEBS Lett. 343, 65 -
69. 
23 Rosenberg, A.H., Lade, B.N., Chui, D., Lin, S.-W., Dunn, J.J. and Studier, F.W. (1987) 
Gene 56, 125-135. 
24 Tabor, S. (1990) in: Current protocols in molecular biology (F.A. Ausubel, R. Brent, 
R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith and K. Strahl, eds.) pp. 16.2.1 -
16.2.11, Greene Publishing and Wiley Interscience, New York, USA. 
25 Studier, F.W., Rosenberg, A.H., Dunn, J.J. and Dubendorff, J.W. (1990) Meth. 
Enzymol. 185, 60 - 89. 
26 Gibson, T.J. (1984) Studies of the Epstein-Barr virus genome. PhD-thesis, University of 
Cambridge, UK. 
27 Duyvis, M.G., Wassink, H. and Haaker, H. (1994) Eur. J. Biochem 225, 881 - 890. 
28 Fischer, G., Bang, H., Berger, E. and Schellenberger, A. (1984) Biochim. Biophys. Acta 
791, 87 - 97. 
29 Kofron, J.L., Kuzmic, P., Kishore, V., Colón-Bonilla, E. and Rich, D.H. (1991) 
Biochemistry 30, 6127-6134. 
30 Haandrikman, A.J., Kok, J., Laan, H., Soemitro, S., Ledeboer, A.M., Konings, W.N. and 
Venema, G. (1989) J. Bacteriol. 171, 2789 - 2794. 
31 Vos, P., Van Asseldonk, M., Van Jeveren, F., Siezen, R., Simons, G. and De Vos, W.M. 
(1989) J. Bacteriol. 171, 2795 - 2802. 
32 Kontinen, V.P., Saris, P. and Sarvas, M. (1991) Mol. Microbiol. 5, 1273 - 1283. 
33 Missiakas, D„ Betton, J.M. and Raina, S. (1996) Mol. Microbiol. 21, 871 - 884. 
34 Rahfeld, J.U., Rücknagel, K.P., Scheiben, B., Ludwig, B., Hacker, J., Mann, K. and 
Fischer, G. (1994) FEBS Lett. 352, 180 - 184. 
35 Wojtkowiak, D., Georgopoulos, C. and Zylicz, M. (1993) J. Biol. Chem. 268, 22609 -
22617. 
36 Brigle, K.E., Newton, W.E. and Dean, D.R. (1985) Gene 37, 37 - 44. 
37 Schmidt, B., Rahfeld, U., Schierhorn, A., Ludwig, B, Hacker, J. and Fischer, G. (1994) 
FEBS Lett. 352, 185-190. 
38 Rahfeld, J.U., Rücknagel, K.P., Stoller, G., Hörne, S.M., Schierhorn, A., Young, K.D. 
and Fischer, G. (1996) J. Biol. Chem. 271, 22130 - 22138. 
39 Yannisch-Perron, C., Vieira, J and Messing, J. (1985) Gene 33, 103 - 119. 
40 Chang, A.C.Y. and Cohen, S.N. (1978) J. Bacteriol. 134, 1141 - 1156. 
41 Dayhoff, M.O., Schwartz, R.M. and Orcutt, B.C. (1978) Atlas of Protein Sequence and 
Structure, Vol.5, Suppl. 3, (Dayhoff, M.O., Ed.) p. 345, NBRF, Washington. 
42 Higgins, D.G. and Sharp, P.M. (1988) Gene 73, 237 - 244. 
The role ofNifM 109 
Summary 
Microperoxidases: kinetics and stability. 
Microperoxidases are small enzymes prepared by proteolytic digestion of cyto-
chromes c. The proteolytic removal of most of the protein environment allows these 
enzymes to use a wide variety of substrates in peroxidase- and cytochrome .P-450-type 
reactions. A major drawback for the application of microperoxidases, however, is their 
rapid inactivation. The formation of high valent FelV-oxo compounds, formed during 
catalysis, probably plays a key role in this inactivation. Chapter 2 describes the hydrogen 
peroxide-dependent para-hydroxylation of aniline by microperoxidases which have 
peptides attached to the heme moiety with different chain lengths (microperoxidases 6, 8 
and 11, all prepared from horse-heart cytochrome c) and composition (microperoxidase 
17, prepared from cytochrome csso from Thiobacillus versutus). 
Investigation of MP6, MP8 and MPI 1 (with peptide chains of 6, 8 and 11 amino 
acids, respectively) showed that these microperoxidases have similar VW values, but that 
the rate of inactivation is dependent on the length of the peptide chain. Inactivation rates 
(at 0.4 mM aniline) range from 0.141 s"1 for MP6 to 0.091 s"1 for MPI 1. Although inac-
tivation is rapid in all cases, a longer peptide chain apparently offers more protection 
against inactivation. The KM is also dependent on the length of the peptide chain, ranging 
from 0.82 mM for MP6 to 0.41 mM for MPI 1. In addition, the rates of inactivation for 
these microperoxidases decreases by about 50% when the aniline concentration is 
increased from 0.4 to 12 mM. This points at a role for the substrate in the inactivation 
process; possibly binding of aniline to the heme moiety also offers some protection. 
MP 17 has kinetic properties that are not in line with those of the microper-
oxidases described above: contrary to what is to be expected on the basis of the length of 
the attached peptide chain (17 amino acids) the rate of inactivation as well as the KM and 
Vmax values are higher than for the other microperoxidases. Increasing the aniline 
concentration from 0.4 to 12 mM only decreases the rate of inactivation of MP 17 by 
about 10%. The observed correlation between VW and the rate of inactivation of the 
microperoxidases confirms the assumption that high valent heme compounds, formed 
during catalysis, are involved in inactivation. The different catalytic properties of MP 17 
must be caused by the specific properties of its peptide chain. MP17 does not bind a 
single peptide chain, as do the other microperoxidases, but two: a short chain (2 amino 
acids) and a longer chain (15 amino acids), which is the result of proteolytic cleavage 
between the heme-binding cysteines. Furthermore, the amino acid composition of the 
(broken) peptide chain is different from that of the other microperoxidases. 
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The FeSII protein: stabilization of nitrogenase. 
The nitrogen fixing soil bacterium A. vinelandii produces a small iron-sulfur 
protein, known as the FeSII protein, that can bind to nitrogenase rendering it temporarily 
oxygen resistant. In chapter 3 of this thesis evidence is given that FeSII protein offers 
protection for the nitrogenase Fe protein from A. vinelandii against oxygen-inactivation 
by stabilizing the association of the Fe protein (Av2) with the MoFe protein (Avl). 
Av2 was exposed to oxygen (air) in the presence of MgADP under several con-
ditions. Exposure of free Av2, i.e. without adding FeSII or Avl, to oxygen results in 
rapid inactivation: all activity is lost within 5 minutes. When Avl is added in a 1 : 2 ratio 
with Av2 the inactivation is about 4 times slower. Under the experimental conditions 
approximately 75% of Av2 is associated with Avl, as Avl[Av2(MgADP)2]2, at the start 
of the exposure to oxygen, which indicates that Av2 is protected against oxygen-inacti-
vation by association with Avl. Addition of both Avl and the FeSII protein results in a 
further decrease of the inactivation. When the FeSII protein, Avl and Av2 are present in 
a 1 : 1 : 2 ratio, the rate of inactivation is 8 times slower, as compared to the sample 
containing only Av2 and Avl. This indicates that the FeSII protein stabilizes the inter-
action between Av2 and Avl. In the presence of MgADP and aluminum fluoride Avl 
and Av2 form a stable Avl[Av2(AlF/MgADP)2]2 complex, from which Av2 can not 
dissociate. This nitrogenase complex proved to be the most stable of all investigated 
samples, which confirms the conclusion that the association of Av2 with Avl protects 
Av2 against inactivation by oxygen. 
Evidence for the existence of two types of three-component protein complexes, 
formed by Av2, Avl and the FeSII protein, was obtained from stopped-flow experi-
ments. It was shown that when Avl is present in a twofold excess with respect to the 
FeSII protein, the latter protein binds two Avl[Av2(MgADP)2]2 nitrogenase complexes, 
whereas when equimolar amounts of Avl and FeSII are present in the incubation only 
one Avl [Av2(MgADP)2]2 nitrogenase complex is bound by the FeSII protein. 
Based on these experiments a model was set up to describe the reactions involved 
in the oxygen-inactivation and the reduction of the nitrogenase proteins under the 
various experimental conditions. Using this model and the kinetic parameters obtained 
from the various experiments, the data could be simulated best when 1 : both the active 
and inactivated forms of Av2 were allowed to associate reversibly with Avl, 2: the rate 
constants for both interactions were identical and 3: the formation of both types of 
three-component complexes with the FeSII protein was taken into account. These simu-
lations indicated that the formation of complexes between the FeSII protein and the 
Avl[Av2(MgADP)2]2 nitrogenase complex is an adequate explanation for the protection 
against oxidative inactivation of nitrogenase by the FeSII protein. 
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The transition state complex of nitrogenase: redox regulation. 
Nitrogenase catalyzed reduction of N2 to NH3 requires the association of the 
nitrogenase Fe protein (Av2) with the nitrogenase MoFe protein (Avl), MgATP-
dependent electron transfer from Av2 to Avl and on-enzyme ATP hydrolysis followed 
by dissociation of Av2, with MgADP bound, from Avl. Aluminum fluoride and MgADP 
inhibit the dissociation of Av2 from Avl by stabilizing the protein-protein complex of an 
intermediate of the on-enzyme MgATP hydrolysis reaction. 
Redox titrations and EPR spectroscopy revealed that the redox properties of 
FeMoco in Avl remain unchanged in this complex, as compared to the purified, free 
MoFe protein. The redox properties of the [8Fe-7S] P-clusters in Avl, however, are 
markedly different. Upon oxidation, in a two-electron process, of the P-clusters in puri-
fied Avl an EPR-signal appears with Em = -307 mV. In the AlF/MgADP stabilized 
complex this signal was not observed. Another signal, exhibited by the one electron 
oxidized P-clusters, appears at a potential lower than -500 mV (out of the range of the 
experiments). This signal disappears again at Em = -430 mV, which indicates that in the 
AlF/MgADP stabilized complex the abstraction of the second electron takes place at this 
potential. These observations indicate that the P-clusters in the AlF/MgADP stabilized 
complex have a different conformation, as compared to the P-clusters in free Avl. 
The [4Fe-4S] clusters in Av2 operate between the +1 and +2 oxidation levels. 
Upon reduction of the clusters in purified Av2 EPR-signals appear at Em = -473 mV 
when MgADP is bound to the protein or at Em = -440 mV when MgATP is bound. For 
the AlF/MgADP stabilized complex, however, no EPR-signals characteristic for reduced 
Av2 were observed and it was concluded that in the AlF/MgADP stabilized nitrogenase 
complex the midpoint redox potential of the [4Fe-4S] clusters in Av2 is lowered to less 
than -500 mV, out of the range of the experiments. This change in redox potential indi-
cates that also the [4Fe-4S] clusters of Av2 in the AlF/MgADP stabilized complex have a 
different conformation, as compared to the clusters in free Av2. 
These results indicate that nitrogenase catalysis involves conformational redox 
regulation. Free Av2 has a relatively high redox potential which facilitates electron 
transfer to this protein from reductants (flavodoxin) in the cell. After binding of MgATP, 
Av2 changes its conformation. These changes in conformation lower the redox potential 
of the [4Fe-4S] cluster in Av2, thus inducing electron transfer to the P-clusters in Avl. 
The lowered redox potential of the P-clusters, resulting from conformational changes 
caused by binding of Av2 to Avl, facilitates electron transfer to FeMoco, the putative 
substrate-binding site, which has unchanged redox properties. The FeMoco clusters in 
turn transfer the electrons to the substrate, N2, to generate ammonia. After on-enzyme 
hydrolysis of ATP the Fe protein changes to the MgADP-bound conformation and 
dissociates from the MoFe protein to enter a new cycle of electron transfer. 
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NifM: its role in the biosynthesis of the Fe protein. 
Chapter 5 reports on the investigation of the possible role of NifM in the matu-
ration of the nitrogenase Fe protein from Azotobacter vinelandii. NifM was purified 
from E. coli harboring a recombinant plasmid that incorporated the nifM gene. The puri-
fied protein was colorless: the UV-visible spectrum gave no evidence for the presence of 
a cofactor. Comparison of the DNA and amino acid sequences of NifM with those of 
other proteins revealed that NifM has a relevant sequence homology to several proteins 
that are involved in protein folding / maturation, especially parvulin from E. coli. 
Parvulin is a peptidylprolyl cis-trans isomerase, or PPIase. PPIases catalyze the intercon-
version of the frans-isomer of proline into the cw-isomer. During protein synthesis, 
peptide bonds formed by the proline residues are in the trans conformation, but in folded 
proteins, appr. 15% of the residues have a cis conformation. In addition, the proper 
folding of a protein may require the temporary conversion of the trans conformation to 
the cis conformation. NifM could therefore be involved, as a PPIase, in the proper 
folding / maturation of the Fe apoprotein. PPIase activity of NifM could not be demon-
strated. The role of NifM in the maturation of the Fe protein, however, was positively 
demonstrated: deletion of the nifM gene from A. vinelandii results in the production of 
inactive, precipitated Fe protein. 
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IJzer bevattende enzymen en zuurstof. 
Enzymen zijn eiwitten die biochemische reacties katalyseren. Deze reacties 
vormen de basis van het functioneren van het organisme en zijn betrokken bij de afbraak, 
omzetting en opbouw van de componenten waaruit het organisme bestaat. Zonder enzy-
men zouden deze reacties niet plaats kunnen vinden en zou leven onmogelijk zijn. IJzer 
maakt onderdeel uit van veel van deze enzymen en is dan ook onmisbaar voor alle orga-
nismen. Het ijzer is meestal opgenomen in een cofactor: een niet door het eiwit gevormd 
deel van het enzym dat betrokken is bij de katalyse. Veel enzymen met ijzer bevattende 
cofactoren worden geïnactiveerd door zuurstof of door z.g. geactiveerd zuurstof in de 
vorm van o.a. waterstofperoxide, superoxide en hydroxyl radicalen. De cofactoren zijn 
meestal het doelwit van deze oxidatieve afbraak, maar de mechanismen die er aan ten 
grondslag liggen zijn nog grotendeels onbegrepen. De bestudering van de oxidatieve 
inactivering van microperoxidases en nitrogenase, met verschillende typen ijzer bevat-
tende cofactoren, vormt een belangrijk deel van dit proefschrift. 
Microperoxidases. 
In microperoxidases is het ijzer aanwezig in het centrum van de z.g. heem-groep: 
een cofactor die is opgebouwd uit een ringvormige structuur van, met name, koolstof-
atomen. De ring is aan de buitenzijde verbonden met twee aminozuren (cysteines) in het 
eiwit; een derde aminozuur (histidine) staat loodrecht op het vlak van de heem-groep en 
is verbonden met het centrale ijzer-ion. Microperoxidases worden verkregen door het 
grootste deel van het eiwit van een z.g. cytochroom c te verwijderen. Het aantal amino-
zuren in de resterende eiwitketen geeft het microperoxidase zijn naam. De invloed van de 
lengte en samenstelling van de eiwitketen van MP6, MP8, MP11 en MP17 voor de 
katalystische eigenschappen van deze microperoxidases wordt in dit proefschrift 
beschreven. Microperoxidases worden gebruikt in het biochemisch onderzoek als een 
modelsysteem voor enzymen die betrokken zijn bij detoxificatie processen, zoals peroxi-
dases en cytochroom P-450. Doordat de eiwitomgeving in microperoxidases grotendeels 
ontbreekt, zijn deze enzymen in staat om de verschillende biochemische reacties waar-
voor zij model staan te katalyseren; in de oorspronkelijke cytochromen bepaalt de eiwit-
omgeving van de heem-groep de reacties die daar plaats kunnen vinden. Een nadelig 
gevolg is echter dat microperoxidases niet kunnen profiteren van de bescherming tegen 
oxidatieve inactivering die de eiwitomgeving de heem-groep biedt. 
Samenvatting 115 
De waterstofperoxide afhankelijke para-hydroxylering van aniline door micro-
peroxidases vormt het onderwerp van hoofdstuk 2 van dit proefschrift. Het daar 
beschreven onderzoek laat zien dat microperoxidases efficiënte katalysatoren zijn, maar 
dat zij ook snel geïnactiveerd worden tijdens de reacties die zij katalyseren. De vorming 
van hoog geoxideerde vormen van de heem-groep, die een rol spelen bij de katalyse, ligt 
waarschijnlijk ten grondslag aan deze inactivering. Onderzoek aan MP6, MP8 en MP 11 
liet zien dat de V^ m, de maximale snelheid waarmee het substraat wordt omgezet, voor 
deze microperoxidases gelijk is, maar dat een langere eiwitketen resulteert in een lang-
zamere inactivering. Dit wijst erop dat inactivering een gevolg is van het grotendeels 
ontbreken van de eiwitomgeving. Een langere eiwitketen gaat ook gepaard met een 
lagere KM, d.w.z. met een hogere affiniteit voor het substraat. Alle onderzochte micro-
peroxidases zijn daarbij enigzins stabieler bij hogere substraat concentraties. Dit kan 
betekenen dat binding van het substraat aan de heem-groep ook enige bescherming tegen 
inactivering biedt. 
In tegenstelling tot de hiervoor besproken microperoxidases, die gemaakt zijn van 
paardehart cytochroom c, is MP 17 gemaakt van cytochroom csso uit de bacterie Thioba-
cillus versutus. MP 17 bleek sterk afwijkende eigenschappen te hebben: in tegenstelling 
tot wat de lengte van de eiwitketen doet vermoeden, verlopen de inactivering en de 
omzetting van het substraat (Vmax) sneller dan bij de andere microperoxidases; ook is de 
affiniteit voor het substraat geringer. De correlatie tussen Vmax en de snelheid van inacti-
vering bevestigt de veronderstelling dat hoog geoxideerde vormen van de heem-groep, 
die gevormd worden tijdens de katalyse, betrokken zijn bij de inactivering. MP 17 bevat 
niet één enkele eiwitketen, maar twee: een korte keten (2 aminozuren) en een langere (15 
aminozuren) zijn elk middels een cysteine aan de heem-groep gebonden. Ook de amino-
zuur samenstelling van deze onderbroken eiwitketen verschilt van die van de andere 
microperoxidases. De oorzaak van de afwijkende katalytische eigenschappen van MP 17 
moet dan ook gezocht worden in deze verschillen. 
De stabiliteit van nitrogenase. 
Nitrogenase speelt een centrale rol in de z.g. stikstof-cyclus: het zet moleculaire 
stikstof om in ammoniak, een proces dat bekend staat als stikstof-fixatie. Stikstof komt 
voor in de meeste componenten van de cel. De lucht om ons heen bestaat voor 78% uit 
moleculaire stikstof (N2). Dit molecuul is echter zeer stabiel en kan hierdoor niet door 
organismen gebruikt worden als voedingsbron. Ammoniak kan wel in het metabolisme 
worden opgenomen; de rol van nitrogenase is dan ook het beschikbaar maken van 
stikstof in de atmosfeer voor de biosynthese van bijvoorbeeld eiwitten en DNA. 
Nitrogenase is een enzym dat is samengesteld uit twee componenten die tesamen 
een complex kunnen vormen: het ijzer-eiwit (Fe-eiwit) en het molybdeen-ijzer-eiwit 
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(MoFe-eiwit). Beide delen bevatten z.g. ijzer-zwavel clusters: cofactoren die zijn 
samengesteld uit ijzer- en sulfide-ionen. Deze ijzer-zwavel clusters zitten vast aan de 
eiwitketen via bindingen tussen de ijzer-ionen en aminozuren in het eiwit, meestal 
cysteines. Met name het ijzer-zwavel cluster van het Fe-eiwit is erg gevoelig voor 
oxidatieve afbraak. Dit vormt een probleem voor stikstof-fixerende organismen: enerzijds 
hebben zij zuurstof nodig om, via biochemische omzetting van voedingsstoffen, energie 
vrij te maken die nodig is voor de stikstof-fixatie, anderzijds vormt de aanwezigheid van 
zuurstof een bedreiging voor het nitrogenase enzym dat deze reactie katalyseert. De 
stikstof-fixerende bodembacterie Azotobacter vinelandii heeft twee manieren om dit 
probleem aan te pakken: het bevat een enzym dat zuurstof in de cel kan omzetten, en het 
produceert een eiwit, het z.g. FeSII-eiwit, dat nitrogenase tijdelijk kan beschermen tegen 
inactivering door zuurstof. 
In hoofdstuk 3 wordt het onderzoek naar de werking van dit FeSII-eiwit 
beschreven. Het zuurstof gevoelige Fe-eiwit is hierbij blootgesteld aan zuurstof onder 
verschillende omstandigheden. In afwezigheid van zowel het MoFe-eiwit als het 
FeSII-eiwit werd het Fe-eiwit snel geïnactiveerd. Wanneer alleen het MoFe-eiwit aan het 
Fe-eiwit werd toegevoegd nam de snelheid van inactivering aanzienlijk af. Toevoeging 
van zowel het MoFe-eiwit als het FeSII-eiwit resulteerde in een nog verdere afname van 
de inactivering. Dit wordt toegeschreven aan het feit dat het FeSII-eiwit, door aan het 
Fe-MoFe nitrogenase complex te binden, het Fe-eiwit en MoFe-eiwit bijeen houdt. Twee 
vormen van het door het FeSII-eiwit gestabiliseerde complex zijn aangetoond: Het 
FeSII-eiwit bindt bij hogere concentraties een enkel Fe-MoFe nitrogenase complex, bij 
lagere concentraties kan het twee van deze complexen binden. In aanwezigheid van 
MgADP en aluminium-fluoride ontstaat een speciale vorm van het Fe-MoFe nitrogenase 
complex, waarin het Fe-eiwit zeer vast aan het MoFe-eiwit is gebonden; dit complex 
bleek het beste bestand te zijn tegen inactivering door zuurstof. Uit deze waarnemingen 
blijkt dat bescherming tegen inactivering van het Fe-eiwit in alle gevallen berust op 
stabilisatie van het ijzer-zwavel cluster in dit eiwit, of op afscherming van dit cluster van 
de oplossing en de daarin aanwezige zuurstof, wanneer het Fe-eiwit aan het MoFe-eiwit 
is gebonden. 
Redox regulatie van nitrogenase. 
De functie van ijzer in biologische systemen berust op het feit dat dit ijzer-ionen 
kan vormen met verschillende ladingen: ijzer bevattende cofactoren kunnen electronen 
opnemen en afstaan. We spreken dan van verschillende redox-toestanden van de cofac-
tor. Een overgang van de ene redox-toestand naar de andere vindt plaats binnen zekere 
marges rondom een bepaalde redox-potentiaal (de z.g. Nernst curve). Deze potentiaal is 
mede afhankelijk van de geometrie en eiwitomgeving van de cofactor. Veranderingen in 
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de conformatie van een eiwit kunnen dan ook de redox-potentiaal van de cofactor in het 
eiwit veranderen: dit wordt redox-regulatie genoemd. 
In hoofdstuk 4 wordt beschreven hoe redox-regulatie een rol speelt in het nitro-
genase enzym. Hiertoe is de stabiele vorm van het nitrogenase complex, dat het Fe-eiwit 
met het MoFe-eiwit vormt in aanwezigheid van MgADP en aluminiumfluoride, onder-
zocht met behulp van o.a. EPR-spectroscopie. Deze techniek maakt het mogelijk om te 
zien bij welke potentialen de cofactoren van de ene redox-toestand overgaan in de 
andere. Het bleek dat de redox-potentiaal van het ijzer-zwavel cluster in het Fe-eiwit en 
van de P-clusters in het MoFe-eiwit lager waren wanneer deze eiwitten deel uitmaakten 
van het stabiele complex. De redox-potentiaal van de FeMoco clusters, de veronder-
stelde de plaats waar in het MoFe-eiwit stikstof wordt omgezet in ammoniak, bleek niet 
veranderd te zijn in het stabiele complex. Uit deze resultaten blijkt dat het ijzer-zwavel 
cluster in het vrije Fe-eiwit een relatief hogere potentiaal heeft zodat het een electron op 
kan nemen van andere componenten in de cel. Door binding aan het MoFe-eiwit veran-
dert de structuur van het Fe-eiwit met als gevolg dat de redox-potentiaal daalt; hierdoor 
kan het Fe-eiwit zijn electron afstaan aan de P-clusters in het MoFe-eiwit. Structurele 
veranderingen in het MoFe-eiwit, eveneens het gevolg van de complexvorming met het 
Fe-eiwit, verlagen de redox-potentiaal van de P-clusters die zodoende hun electronen af 
kunnen staan aan de FeMoco clusters waar de electronen vervolgens op het substraat 
(N2) worden overgedragen en ammoniak wordt gevormd. 
Biosynthese van het Fe-eiwit. 
In hoofdstuk 5 wordt verslag gedaan van het onderzoek naar de mogelijke rol die 
het NifM eiwit uit Azotobacter vinelandii speelt in de biosynthese van het Fe-eiwit. 
Vergelijking van het voor NifM coderende gen en de ervan afgeleide aminozuur 
volgorde met die van andere eiwitten wees op sterke overeenkomsten van NifM met 
eiwitten die betrokken zijn bij de juiste vouwing van eiwitten; met name met parvuline uit 
Escherichia coli. Parvuline is een z.g. PPIase, een enzym dat het aminozuur proline om 
kan zetten van de z.g. c«-vorm naar de frans-vorm, en andersom. Proline heeft als 
bijzondere eigenschap dat het een knik vormt in de eiwitketen; bij de cw-vorm gaat deze 
knik een andere kant op dan bij de frans-vorm. Om een eiwit tijdens de biosynthese in de 
juiste conformatie te krijgen kan het dus noodzakelijk zijn om een of meerdere prolines 
(tijdelijk) in de andere vorm om te zetten. Het bleek niet mogelijk om een dergelijke 
PPIase activiteit ook daadwerkelijk voor het NifM eiwit aan te tonen. Wel is de rol van 
NifM in de biosynthese van het Fe-eiwit bewezen: wanneer het gen dat NifM codeert uit 
A. vinelandii werd verwijderd, bleek dit organisme niet meer in staat om oplosbaar, 
actief Fe-eiwit te produceren. 
118 Summary in Dutch 
Curriculum vitae 
Johannes Hendrikus Spee werd geboren op 14 februari 1958 te Delft. In 1976 
deed hij eindexamen atheneum B aan het Sint Stanislascollege, eveneens te Delft. In 
afwachting van toelating tot een vervolgstudie heeft hij daarna een jaar als 
uitzendkracht gewerkt bij de gemeente Delft. Vijfjaar later, in 1982, haalde hij de 
tweede graads akte van bekwaamheid tot het geven van onderwijs in de vakken teke-
nen en handvaardigheid aan de lerarenopleiding Z.W.N., nog steeds te Delft. De twee 
daarop volgende jaren studeerde hij aan de Academie voor Beeldende Vorming in 
Tilburg. Na een roemloze, maar aangename carrière als percussionist in het Brabantse 
jazz-circuit begon hij in 1987 aan zijn studie biologie aan de Landbouwuniversiteit in 
Wageningen. In de doctoraalfase deed hij afstudeervakken bij de vakgroep Mole-
culaire Biologie (Dr. T. Bisseling, Prof. Dr. A. van Kammen) en de vakgroep Bio-
chemie (Dr. A de Kok, Prof. Dr. C. Veeger). In augustus 1992 studeerde hij af. 
Van november 1992 tot april 1997 was hij als onderzoeker in opleiding (OIO) 
verbonden aan de vakgroep Biochemie van de Landbouwuniversiteit te Wageningen, 
in dienst van de Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO). 
Het onderzoek werd gefinancieerd door NWO, onder toezicht van de Stichting 
Scheikundig Onderzoek in Nederland (SON). Het onderzoek werd begeleid door Dr. 
Ir. W.M.A.M. van Dongen en Prof. Dr. C. Veeger. De resultaten van het onderzoek 
zijn beschreven in dit proefschrift. 
Curriculum Vitae 119 
Publications 
J.H. Spee, H. Wassink, W.M.A.M Van Dongen and H. Haaker (1997) Protection of 
the nitrogenase Fe protein from Azotobacter vinelandii against oxygen-inactivation by 
complex formation with the MoFe protein, Biochemistry (submitted) 
J.H. Spee, A.F. Arendsen, H. Wassink, S.J. Marritt, W.R. Hagen and H. Haaker 
(1997) Redox properties and electron paramagnetic resonance spectroscopy of the 
transition state complex of Azotobacter vinelandii nitrogenase, J. Biol. Chem. 
(submitted) 
J.H. Spee, M.G. Boersma, C. Veeger, B. Samyn, J. Van Beeumen, G. Warmerdam, 
G.W. Canters, W.M.A.M. Van Dongen and I.M.C.M. Rietjens (1996) The influence 
of the peptide chain on the kinetics and stability of microperoxidases, Eur. J. 
Biochem. 247,215-220 
J.H. Spee, W.M. De Vos and O.P. Kuipers (1993) Efficient random mutagenesis 
method with adjustable mutation frequency by use of PCR and dITP, Nucleic Acids 
Res. 3, 111 - IIS 
J. Frazzon, J.H. Spee, J. Christiansen and D.R. Dean (1997) Nitrogenase: Two 
decades of biochemical genetics, in: Biological fixation of nitrogen for ecology and 
sustainable agriculture, (Logocki, A., Bothe, H. And Puhler, A., Eds.) pp. 3 -8 , 
Springer Verlag, Berlin, Heidelberg, New York 
I.M.C.M. Rietjens, J.H. Spee, R. Weiss, A.X. Trautwein, W. Van Dongen, G.W. 
Canters and C. Veeger (1995) On the role of the axial ligands in heme-based catalysis, 
J. Inorg. Chem. 59, 490 
J. Hendle, A. Mattevi, A.H. Westphal, J.H. Spee, A. De Kok, A.Teplyakov, and W.G. 
Hoi (1995) Crystallographic and enzymatic investigations on the role of Ser558, 
His610 and Asn614 in the catalytic mechanism of Azotobacter vinelandii dihydro-
lipoamide acetyltransferase (E2p), Biochemistry 13, 4278 - 4298 
W. Yang, P. Katinakis, P. Hendriks, A. Smolders, F. De Vries, J.H. Spee, A. Van 
Kammen, T. Bisseling and H. Franssen (1993) Characterization of GmENOD40, a 
gene showing novel patterns of cell-specific expression during soybean nodule 
formation, Plant J. 3, 573 - 585 
Publications 121 
Slotwoord 
Dit boekje is, anders dan de titelpagina doet vermoeden, niet alleen het resultaat 
van mijn eigen inspanningen. De auteurs die bij de verschillende hoofdstukken staan 
vermeld hebben ook daadwerkelijk een wezenlijke bijdrage aan het daar beschreven 
onderzoek geleverd. Daarnaast zijn echter veel personen onvermeld gebleven die een 
belangrijke rol hebben gespeeld bij de totstandkoming van dit proefschrift. In de weten-
schap niet anders dan, helaas, onvolledig te kunnen zijn wil ik een aantal van al deze 
mensen met name noemen. 
Allereerst wil ik Walter van Dongen, mijn co-promotor, bedanken voor zijn 
deskundige en bereidwillige begeleiding en ondersteuning. Je hebt mijn eigen inbreng in 
het onderzoek steeds volop de ruimte gegeven en tegelijkertijd altijd, en ogenblikkelijk, 
klaar gestaan om antwoorden en oplossing te vinden voor de vragen en problemen waar 
ik mee zat, ook als die geen betrekking hadden op het onderzoek. Zonder ooit de moed 
te verliezen, of overmoedig te zijn, heb je voor de stabiliteit gezorgd waar het mij vaak 
aan ontbrak. Het was daarom een geluk om jou als co-promotor te treffen en om onder 
jouw supervisie het hier beschreven onderzoek uit te kunnen voeren. 
In niet mindere mate ben ik mijn promotor, professor Cees Veeger, dankbaar 
voor zijn voortdurende interesse in mijn onderzoek en zijn opbouwende kritieken bij het 
schrijven van dit proefschrift. Ik heb me zeer gesterkt gevoeld doordat je bent blijven 
geloven in het welslagen van mijn promotie, ook wanneer ik daar zelf minder zeker van 
was. Vooral in de eindfase is jouw inzet, medeleven en begrip van doorslaggevend 
belang geweest. Ik zal dat niet vergeten. 
Ook Ivonne Rietjens ben ik veel dank verschuldigd. Je hebt je ingezet om mij 
nieuwe kansen te bieden op een moment dat het onderzoek dreigde vast te lopen, zonder 
dat je daar enige verplichting toe had. Al is het ons niet gelukt om ook al die kansen te 
benutten, het werk aan microperoxidases dat ik op jouw lab heb verricht en het vertrou-
wen datje in mij hebt getoond, heeft mij veel voldoening gegeven. 
Huub Haaker wil ik bedanken voor de vruchtbare en plezierige samenwerking. Ik 
ben erg blij dat je, ondanks de problemen die zich hebben voorgedaan, met veel inzet en 
zonder scrupules hebt meegewerkt aan een belangrijk deel van dit proefschrift. Je hebt 
gelijk gekregen: het werk aan 'Pink' en het 'AlF-complex' heeft twee prima hoofd-
stukken opgeleverd. 
EPR is voor veel onderzoekers, en niet in de laatste plaats voor mij, een 'black 
box'. Wie die doos openmaakt ziet echter dat Fred Hagen erin zit. Fred, bedankt voor je 
uitleg, je grafieken en je andere bijdragen aan het EPR-hoofdstuk. 
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